Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOM,Apolipoprotein M,42199,0.120163249453076,0.00260732989921903,0.115052882850607,0.125273616055545,0
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.179166780594156,0.00289707885598905,0.173488506036417,0.184845055151895,0
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.227006201068872,0.00250649356327696,0.222093473684849,0.231918928452894,0
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.113128840467908,0.00292047421573085,0.107404711005076,0.118852969930741,1.11356381678717e-308
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LDLR,Low-density lipoprotein receptor,42170,0.168277302404602,0.00483538796350388,0.158799941996134,0.177754662813069,2.93623377083573e-254
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOC1,Apolipoprotein C-I,39959,0.124411376259707,0.00365826343826509,0.117241179920707,0.131581572598707,1.67932040753381e-241
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.179007087552022,0.00553484090762547,-0.189855375730968,-0.168158799373076,4.92478443246241e-221
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0746359494462852,0.00243921224547532,0.0698550934451536,0.0794168054474168,5.90708225193807e-199
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS4,Galectin-4,42123,-0.16175451933324,0.00538883157933693,-0.17231662922874,-0.151192409437739,1.07386328643432e-191
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APCS,Serum amyloid P-component,39870,0.0864843158380835,0.00313886782525055,0.0803321349005924,0.0926364967755746,8.75696883434087e-162
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0928535482944108,0.00356107447468156,0.0858738423240349,0.0998332542647866,1.32780784886446e-145
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0819486487260148,0.00339504389441891,-0.0886029347590759,-0.0752943626929537,4.46405912635635e-126
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PROC,Vitamin K-dependent protein C,42199,0.0584791795484761,0.00248662514062792,0.0536053942728454,0.0633529648241068,6.58011241485198e-120
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRSS8,Prostasin,42080,-0.0936147465156069,0.00404121667129067,-0.101535531191337,-0.0856939618398771,1.90316163459863e-116
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOF,Apolipoprotein F,39990,0.0583214651086265,0.00251711456680951,0.0533879205576798,0.0632550096595731,4.3167107806882e-116
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0488147021297609,0.00210703148101205,0.0446849204269773,0.0529444838325446,4.55708400567221e-116
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GDF15,Growth/differentiation factor 15,42310,-0.100651478385848,0.0044385243150605,-0.109350986043366,-0.091951970728329,8.5438713119513e-112
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.176654687839901,0.00779784240964036,-0.191938458962796,-0.161370916717006,1.51676675755892e-111
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REN,Renin,42145,-0.177583430873736,0.00787533119697311,-0.193019080019804,-0.162147781727669,1.46080850622919e-110
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0749965880247906,0.00334028309267784,0.068449633163142,0.0815435428864392,1.18946335993759e-109
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLKB1,Plasma kallikrein,39759,0.0488401655839647,0.00239369288251959,0.0441485275342263,0.0535318036337031,6.98152102681753e-91
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EGFR,Epidermal growth factor receptor,42310,0.0307097489493833,0.00155505857195727,0.027661834148347,0.0337576637504195,1.27991145994482e-85
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0613897317422939,0.00313998067490354,0.055235369619483,0.0675440938651048,5.71012443231459e-84
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0745932165155427,0.00382819217634215,-0.0820964731811733,-0.0670899598499121,2.02400092075018e-83
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0639904868368081,0.00330098813487075,-0.0704604235811548,-0.0575205500924615,1.38015172414539e-82
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.0823515693621009,0.00432180211063821,0.07388083722525,0.0908223014989518,6.64895002034657e-80
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.024951018205858,0.00131225192011997,0.0223790044424229,0.0275230319692931,2.32098452941591e-79
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFP,Properdin,39979,0.0435590779276875,0.00232202102197569,0.0390079167246151,0.0481102391307598,2.38101729697727e-77
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCN1,CCN family member 1,42047,0.129149586167094,0.00700042166574104,0.115428759702241,0.142870412631946,4.48641491892983e-75
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFHR4,Complement factor H-related protein 4,39945,0.130764174518587,0.00717632004818283,0.116698587224149,0.144829761813026,3.82264785314601e-73
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,41907,-0.148277842725381,0.00816141942994056,-0.164274224808065,-0.132281460642698,6.99673672608599e-73
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPB2,Carboxypeptidase B2,39959,0.0398325560697449,0.0022067303289276,0.0355073646250468,0.044157747514443,7.85310639155022e-72
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRP1,Neuropilin-1,42230,-0.0473552765824996,0.0026691689156954,-0.0525868476572626,-0.0421237055077367,1.21265077713085e-69
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AREG,Amphiregulin,42070,-0.0678355189226482,0.00382804286156659,-0.0753384829313187,-0.0603325549139777,1.78101590130179e-69
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0437618251396323,0.00249502621308628,0.0388715737619832,0.0486520765172814,5.57873581065704e-68
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.182680509306966,0.0108184076824682,-0.203884588364603,-0.161476430249328,2.52828418389984e-63
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPOCK1,Testican-1,42016,0.0430395912973125,0.00255211232558746,0.038037451139161,0.0480417314554639,3.67967553585446e-63
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F13B,Coagulation factor XIII B chain,39925,0.0421013910215989,0.00251990874885564,0.0371623698738419,0.047040412169356,6.35456621409322e-62
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPON2,Spondin-2,42070,-0.0569495696505979,0.00341452980087606,-0.063642048060315,-0.0502570912408808,7.81384457655831e-62
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFASC,Neurofascin,42296,-0.0472943368427927,0.00285065384668985,-0.0528816183823048,-0.0417070553032806,3.21700220088507e-61
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0983621684469992,0.00599137285223109,0.0866190776566263,0.110105259237372,5.46888804763796e-60
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0308200174781617,0.0018929759984035,0.0271097845212909,0.0345302504350326,4.899254172588e-59
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FN1,Fibronectin,39979,0.0433179848112603,0.0026830513305186,0.0380592042034439,0.0485767654190768,5.41487908018207e-58
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0419255217078381,0.00264527157862968,0.036740789413724,0.0471102540019523,4.53785519994245e-56
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCHE,Cholinesterase,39806,0.041792835986612,0.00264416935126428,0.036610264058134,0.04697540791509,1.1338503037376e-55
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F7,Coagulation factor VII,42194,0.047877494218371,0.00303719491127652,0.041924592192269,0.0538303962444729,1.71297483132166e-55
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0645259097044232,0.00410432974554139,0.0564814234031621,0.0725703960056843,4.14932004769775e-55
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.0658505813906585,0.00419352557705027,0.05763127125964,0.074069891521677,4.39159673656099e-55
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD27,CD27 antigen,42181,-0.0648514621547973,0.00418112525078715,-0.0730464676463401,-0.0566564566632545,8.51367217331955e-54
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0422382512503595,0.00273073075878678,0.0368860189631374,0.0475904835375816,1.62290008592585e-53
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOL1,Apolipoprotein L1,39990,0.0812756360928824,0.00525618203536,0.0709735193035768,0.091577752882188,2.15203643849307e-53
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGAV,Integrin alpha-V,42262,0.0251026750319352,0.00162797783356818,0.0219118384781415,0.0282935115857288,3.39219230861201e-53
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0575947310136794,0.00373983101343624,0.0502646622273444,0.0649247998000145,4.56929437060417e-53
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",42123,-0.142108999316731,0.0093014235802541,-0.160339789534029,-0.123878209099433,2.91734855891199e-52
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GHR,Growth hormone receptor,39736,0.0425872250627787,0.00279097965154572,0.0371169049457491,0.0480575451798083,4.82184878344826e-52
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0355461939170035,0.00235109115843496,0.030938055246471,0.040154332587536,3.22303998765365e-51
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0997973641839544,0.00663560956839038,-0.112803158938,-0.0867915694299093,1.03904717131701e-50
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0537704368413674,0.00361740834531212,-0.0608605571981792,-0.0466803164845557,1.38111655283297e-49
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC3B,Tetranectin,39726,0.0307938073447774,0.00207226850533492,0.0267321610743209,0.0348554536152338,1.78573952423526e-49
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0585581645610924,0.00396644636486236,0.0507839296859622,0.0663323994362226,6.14741597068491e-49
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOD,Apolipoprotein D,39468,0.061634106583999,0.00417528481273824,0.0534505483510321,0.069817664816966,7.68211678189224e-49
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0607008081238128,0.00413688199515919,-0.0688090968343248,-0.0525925194133008,2.25461788403297e-48
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0432718089436915,0.00297272786107793,0.0374452623359787,0.0490983555514042,1.44276430310611e-47
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F2,Prothrombin,39979,0.0213158562353195,0.00146705324634251,0.0184404318724882,0.0241912805981508,2.08552672736536e-47
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0393526934589354,0.00272063768669785,-0.0446851433248632,-0.0340202435930076,4.53774820949563e-47
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0355360313244007,0.00245783800750756,0.0307186688296859,0.0403533938191155,4.96843930314146e-47
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0281642806045452,0.00195564159492596,0.0243312230784904,0.0319973381306001,1.12358586692319e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0372901493608991,0.00259038269192444,0.0322129992847272,0.042367299437071,1.2180782509134e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATRN,"Attractin, Isoform 2",39979,0.0236439268501046,0.00164414140045519,0.0204214097052124,0.0268664439949967,1.74608630884687e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0365809538135004,0.0025456621189035,0.0315914560604495,0.0415704515665512,1.76088865388417e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F11,Coagulation factor XI,39822,0.0445642969769809,0.00310394405041033,0.0384805666381767,0.0506480273157852,2.46473547924161e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1S,Complement C1s subcomponent,39979,0.0298470371477566,0.00208214544431147,0.0257660320769061,0.0339280422186071,3.3490098296602e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SYAP1,Synapse-associated protein 1,39736,0.0826929648675908,0.00578759263296864,0.0713492833069723,0.0940366464282094,6.61389748372683e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0406837281926783,0.00285535397590959,0.0350872343998955,0.0462802219854611,9.80852793428932e-46
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0389550930862217,0.00273566090869682,0.033593197705176,0.0443169884672675,1.12125640163805e-45
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPT2,Angiopoietin-2,42262,-0.052056216130436,0.00366179281600811,-0.0592333300498119,-0.0448791022110601,1.53834378753679e-45
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THPO,Thrombopoietin,41900,0.0540950442483802,0.00382414773264451,0.046599714692397,0.0615903738043635,4.2170632235524e-45
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0597770148634931,0.00423925218645553,-0.068085949148946,-0.0514680805780403,7.79988702158461e-45
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA14,Carbonic anhydrase 14,42262,0.0507633103779681,0.00360017511565086,0.0437069671512924,0.0578196536046438,7.80425437439254e-45
NMR metabolomics,X23505.Cholesterol in Medium VLDL,P4HB,Protein disulfide-isomerase,42073,0.0533001801081553,0.0037852578616798,0.0458810746992629,0.0607192855170477,1.03115369516913e-44
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,0.068713186287678,0.00488252666868722,0.059143434017051,0.078282938558305,1.31406861281199e-44
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCAN,Brevican core protein,42016,0.0474193260184201,0.00338397007876332,0.040786744664044,0.0540519073727962,2.66632705970627e-44
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINC1,Antithrombin-III,39959,0.0198973321052595,0.00142844865431373,0.0170975727428046,0.0226970914677144,9.61612028446099e-44
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0473988043271319,0.00341624002129868,-0.0540946347688773,-0.0407029738853865,2.0400023898703e-43
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NTRK3,NT-3 growth factor receptor,42249,0.0287836899762295,0.00207893567020818,0.0247089760626215,0.0328584038898375,2.66057971306527e-43
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0506940001355584,0.00366995391281388,-0.0578871098046736,-0.0435008904664432,4.16022198707157e-43
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFF3,Trefoil factor 3,42143,-0.0487718706735876,0.00354054061593989,-0.0557113302808298,-0.0418324110663454,6.98578945662135e-43
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PYY,Peptide YY,39575,-0.135795744370264,0.00987642526008539,-0.155153537880031,-0.116437950860496,1.15697393257147e-42
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFH,Complement factor H,39418,0.0318814996121832,0.0023190845283785,0.0273360939365613,0.036426905287805,1.20332701916698e-42
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DSC2,Desmocollin-2,41984,-0.0470788116328424,0.00344769506756864,-0.0538362939652769,-0.0403213293004078,3.60424343331617e-42
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SDC4,Syndecan-4,42145,0.0633514213795255,0.00464724928911838,0.0542428127728535,0.0724600299861975,4.89101511323318e-42
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCN2,Ficolin-2,42116,0.0539736804073188,0.00397856488918835,0.0461756932245096,0.061771667590128,1.19135082300065e-41
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,42185,0.0389114196327887,0.00287809467864788,0.0332703540626388,0.0445524852029385,2.21105302971999e-41
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0867422292530445,0.00646706376466576,-0.0994176742317894,-0.0740667842742996,9.25451023170069e-41
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADA2,Adenosine deaminase 2,42096,-0.057711584260176,0.00430442446440286,-0.0661482562104056,-0.0492749123099464,9.9567162054508e-41
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0740021548918555,0.00552364275923133,-0.0848284946999489,-0.0631758150837621,1.30559185887113e-40
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,41740,-0.131338406025629,0.00982239897360644,-0.150590308013898,-0.112086504037361,1.63624037562008e-40
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCAN,Neurocan core protein,42249,0.0488628527613624,0.00367393612220318,0.0416619379618442,0.0560637675608807,4.11936191479216e-40
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP10,Stromelysin-2,42124,-0.0748877739912032,0.00565196239328554,-0.0859656202820428,-0.0638099277003635,8.00252915807639e-40
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACAN,Aggrecan core protein,41994,0.0355597501990176,0.00268662860924998,0.0302939581248876,0.0408255422731475,9.67822161748515e-40
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0647246397802122,0.0048947310292868,-0.0743183125976144,-0.0551309669628101,1.13513711185264e-39
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.06618073588889,0.00506835464328968,0.0562467607880422,0.0761147109897377,1.09075533809134e-38
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH17,Cadherin-17,42145,-0.0873873243203534,0.00670085561672127,-0.100521001329127,-0.0742536473115798,1.21835218087963e-38
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REG1B,Lithostathine-1-beta,42310,-0.0726620102783032,0.00560102591016814,-0.0836400210622327,-0.0616839994943736,2.92404040368798e-38
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPC5,Glypican-5,42016,0.0716017241269579,0.00552741538133533,0.0607679899795406,0.0824354582743751,3.77976045219119e-38
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0500632183349991,0.00390083079148657,-0.0577088466863128,-0.0424175899836854,1.73912851681791e-37
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.0973905784754272,0.00760446583914643,0.0824858254307002,0.112295331520154,2.71579282035784e-37
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0306649582713553,0.00239633821887433,0.0259681353623617,0.035361781180349,2.81216767186912e-37
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0572801697750096,0.0044837267840487,-0.066068274271745,-0.0484920652782741,3.67914690684836e-37
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDHR5,Cadherin-related family member 5,42145,0.048547970480036,0.00380233954092698,0.0410953849798192,0.0560005559802529,4.05334796577255e-37
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,0.0339870918230539,0.0026767082795748,0.0287407435950873,0.0392334400510205,1.08400767503302e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GHRL,Appetite-regulating hormone,42145,0.103310675536018,0.00816131946254656,0.0873144893894264,0.119306861682609,1.61462329380649e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.042140531195026,0.00333137544380292,-0.0486700270648797,-0.0356110353251723,1.80791389884453e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F10,Coagulation factor X,39990,0.0362179313527584,0.00286284474006266,0.0306067556622356,0.0418291070432813,1.94079193985934e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0471444565511905,0.00372961455788044,0.0398344120177449,0.0544545010846362,2.04682551543958e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0447791944428721,0.00354158577703079,-0.0517207025658524,-0.0378376863198917,2.13067414234676e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FST,Follistatin,42166,0.0603094218742615,0.00478229604413707,0.0509361216277528,0.0696827221207701,2.93425757153319e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FSTL3,Follistatin-related protein 3,42084,-0.0404493601080799,0.00321046888614422,-0.0467418791249225,-0.0341568410912372,3.41038137386499e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.030497154975813,0.00242224032690995,0.0257495639350695,0.0352447460165565,4.14540736167454e-36
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0311199939388342,0.0024912875027355,-0.0360029174441958,-0.0262370704334726,1.29750344920656e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0347898958215553,0.00279103041592402,-0.0402603154367664,-0.0293194762063442,1.82212509639601e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0379239881664596,0.00304492073246669,-0.0438920328020943,-0.0319559435308249,2.0574594286115e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.150931605956274,0.0121758472221032,0.127066945400952,0.174796266511596,4.26041931955547e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THBS2,Thrombospondin-2,42137,-0.0470142438619683,0.00379345627615756,-0.0544494181632371,-0.0395790695606994,4.39121568100833e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HYAL1,Hyaluronidase-1,42077,-0.0280208904669444,0.0022669235969697,-0.032464060717005,-0.0235777202168838,6.58623371973897e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0250850075516621,0.00203114962768766,0.0211039542813943,0.0290660608219299,7.58835596093234e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GDF2,Growth/differentiation factor 2,42145,0.0428578056345048,0.00347295472483502,0.0360508143738282,0.0496647968951815,8.43581532670371e-35
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASPN,Asporin,39958,0.0338367873471429,0.00274471205371397,0.0284571517218635,0.0392164229724222,1.06673466043212e-34
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA4,Kallistatin,39802,0.028435314497624,0.00231920718749772,0.0238896684101285,0.0329809605851195,2.44040524543509e-34
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0224163340539103,0.00183105941248085,0.0188274576054478,0.0260052105023728,3.03611483175832e-34
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSN,Gelsolin,39943,0.0228858129415806,0.00187122204465067,0.0192182177340653,0.0265534081490959,3.50965340355357e-34
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASET2,Ribonuclease T2,42258,-0.0319850227723168,0.00263242340954956,-0.0371445726550339,-0.0268254728895996,8.52756553184858e-34
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0778497866939474,0.00640437880722576,-0.0904023691561099,-0.0652972042317849,8.65828528418708e-34
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.0298146960732233,0.00247685586638617,-0.0346693335713402,-0.0249600585751064,3.33248223945989e-33
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0605643483270026,0.00504191603478781,-0.0704465037551867,-0.0506821928988185,4.51326475427563e-33
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IDS,Iduronate 2-sulfatase,42296,0.0108199487807152,0.00090407088229072,0.00904796985142536,0.012591927710005,7.61870546551938e-33
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.111913561555106,0.00935906233950291,0.0935697993696802,0.130257323740532,8.64930153518667e-33
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0280948190595152,0.00235525868223278,0.023478512042339,0.0327111260766915,1.22193352203427e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0463540899006337,0.0038931102516693,-0.0539845859939056,-0.0387235938073619,1.58779467755247e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MET,Hepatocyte growth factor receptor,42158,0.0224864678958112,0.00188881432100706,0.0187843918266374,0.0261885439649851,1.61720707662883e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0556234217864392,0.00467436648022549,-0.0647851800876812,-0.0464616634851972,1.7255460745124e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0475322724045906,0.00401280268646025,0.0396671791391285,0.0553973656700527,3.30269472296751e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPPB,Natriuretic peptides B,41900,-0.163217178482081,0.0137909894685309,-0.190247517840401,-0.13618683912376,3.72835981811862e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.0683143532761984,0.00577156151955476,0.0570020926978711,0.0796266138545258,3.91341580206299e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCGN,Secretagogin,41913,-0.0515791799987775,0.00436752638496069,-0.0601395317133004,-0.0430188282842546,5.02479242762746e-32
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C7,Complement component C7,39722,-0.038654979173915,0.00329526514754295,-0.0451136988630991,-0.0321962594847308,1.36536908354194e-31
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOST,Sclerostin,42129,0.0444547125516912,0.00380725493933807,0.0369924928705885,0.0519169322327938,2.38114570409307e-31
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA9,Carbonic anhydrase 9,42262,-0.0535615859282804,0.00459023034378459,-0.0625584374020982,-0.0445647344544626,2.5960616622865e-31
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.028198051751739,0.00243106268587199,0.0234331688874299,0.0329629346160481,5.82933409682945e-31
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0409624548617554,0.00354478745916754,-0.0479102382817238,-0.0340146714417871,9.63026153819589e-31
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TTR,Transthyretin,39862,0.0284295163089708,0.00245970088608319,0.0236085025722477,0.0332505300456938,1.00089451881372e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0329117650990255,0.00286398807896369,-0.0385251817337943,-0.0272983484642566,2.01225562632323e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0277447871551309,0.00241681685985824,0.0230078261098088,0.032481748200453,2.30092508643606e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNCA,Alpha-synuclein,39736,0.133694982954622,0.0116894411052505,0.110783678388331,0.156606287520913,4.01122383451344e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0301238416338865,0.00263877633297207,0.0249518400212613,0.0352958432465118,4.78515447031837e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTD,Biotinidase,39979,0.0231654265947655,0.00203131625193236,0.0191840467409781,0.0271468064485529,5.79752741021018e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPA2,Carboxypeptidase A2,42205,-0.0742949830526659,0.00653328368570298,-0.0871002190766437,-0.061489747028688,7.88185824705675e-30
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGRP,Agouti-related protein,42296,0.0575776859874703,0.00507351788909837,0.0476335909248375,0.0675217810501031,1.02208585175659e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.0458757182468896,0.00406741915279088,-0.0538478597863597,-0.0379035767074195,2.40796045818197e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD209,CD209 antigen,42171,0.0431052022818615,0.00383554907310568,0.0355875260985743,0.0506228784651486,3.55588372948527e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.0263539436506839,0.00234547776474245,-0.0309510800695791,-0.0217568072317887,3.65235934531202e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AFP,Alpha-fetoprotein,41976,0.0719257866623071,0.00640764656253471,0.059366799399739,0.0844847739248751,4.14774335706824e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0428412654709592,0.00381697373482137,-0.0503225339912091,-0.0353599969507093,4.17056475860666e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPY,Pro-neuropeptide Y,42262,0.0696512553726941,0.00624268298974938,0.0574155967127853,0.0818869140326029,8.78745100251947e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0379619760269289,0.00340442831737871,-0.0446346555289912,-0.0312892965248666,9.44986629935391e-29
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0365413579853055,0.00327919735438272,0.0301141311707154,0.0429685847998956,1.02874736406597e-28
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH1,Cadherin-1,41697,-0.0437986276307407,0.00395009511201166,-0.0515408140502836,-0.0360564412111979,1.9200301972517e-28
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0453894806818862,0.00414305771006848,0.037269087570152,0.0535098737936204,8.17059959568413e-28
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REG4,Regenerating islet-derived protein 4,42144,-0.0548593346443788,0.00501166808625863,-0.0646822040934457,-0.0450364651953119,9.04551019462273e-28
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0435448257570451,0.0039972071542495,-0.0513793517793741,-0.0357102997347161,1.60845014177134e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL23,C-C motif chemokine 23,42185,0.0451461659377253,0.00415344080073164,0.0370054219682913,0.0532869099071593,2.08663267075083e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.040241282931216,0.00370271900289862,0.0329839536855347,0.0474986121768973,2.12666454824254e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFF2,Trefoil factor 2,42166,-0.0623050334189724,0.0057436882522577,-0.0735626623933975,-0.0510474044445473,2.65090680730346e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MEP1B,Meprin A subunit beta,42145,0.12191653324683,0.0112807163738096,0.0998063291541629,0.144026737339497,4.09108567303602e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0476263295578525,0.00441286401299058,-0.056275543023314,-0.038977116092391,5.04715616572136e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFF1,Trefoil factor 1,42084,-0.085169934171932,0.00791765342453187,-0.100688534884014,-0.0696513334598495,7.06330033195021e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASE6,Ribonuclease K6,39937,-0.034330133159726,0.00319336962600207,-0.0405891376266901,-0.0280711286927619,7.94225137848894e-27
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK10,Kallikrein-10,42138,0.0430000079352348,0.00402114613370547,0.0351185615131721,0.0508814543572975,1.3942754909454e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0484933559423966,0.00454494741585216,0.0395852590073264,0.0574014528774669,1.79432028947618e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0336520618355505,0.00315914179578772,-0.0398439797552945,-0.0274601439158066,2.16433364208324e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0477467627969044,0.00448969733155126,0.038946956027064,0.0565465695667449,2.73483240955324e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1R,Complement C1r subcomponent,39979,0.019806826253346,0.00186296702316941,0.016155410887934,0.023458241618758,2.81329382935723e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RILPL2,RILP-like protein 2,39958,0.103159195104124,0.00976628629462047,0.084017273966668,0.12230111624158,5.8484299907546e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.032582718402541,0.00309462028144895,-0.038648174154181,-0.0265172626509011,8.03852273701144e-26
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0644218409022307,0.00612886863495545,-0.0764344234267434,-0.052409258377718,1.00748091927292e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0202102920657295,0.00193004153569213,0.0164274106557729,0.0239931734756861,1.46011894733156e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.144347577139048,0.0138831127912464,0.117136676068205,0.171558478209891,3.30940718478665e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0863293145961615,0.00830845778666905,-0.102613891858033,-0.0700447373342902,3.58111665778277e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGBL1,Integrin beta-like protein 1,39966,-0.040415770561799,0.00389215098631377,-0.048044386494974,-0.032787154628624,3.80178671967072e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.0244720268215368,0.00235998693726272,-0.0290976012185718,-0.0198464524245019,4.23595722285446e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0340898789848427,0.00328751138876265,0.0276463566628679,0.0405334013068175,4.23821252970385e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL27,C-C motif chemokine 27,42145,0.0636914608045758,0.00614625246718169,0.0516448059688997,0.0757381156402519,4.54904836018424e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,41987,-0.0377455337544822,0.00365339228175574,-0.0449061826267234,-0.0305848848822409,6.28826331728203e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAYN,Layilin,41997,-0.0362717298884591,0.0035208229241229,-0.04317254281974,-0.0293709169571782,8.53420392877086e-25
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.0582717516594497,0.00566377291106797,0.0471707567537565,0.069372746565143,1.01923971388117e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0307171894607178,0.00299405348345383,-0.0365855342882873,-0.0248488446331483,1.32180260377323e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSD,Cathepsin D,41225,-0.0417548207821912,0.00407187295573477,-0.0497356917754313,-0.033773949788951,1.41092043837119e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPD52L2,Tumor protein D54,39736,0.110400645626818,0.0108043086028822,0.089224200765169,0.131577090488467,2.10586940059699e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD276,CD276 antigen,42123,-0.0359730543971592,0.00353031783883216,-0.0428924773612702,-0.0290536314330481,2.69678674911668e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL18BP,Interleukin-18-binding protein,42217,-0.0314423750871854,0.00309084947463325,-0.0375004400574666,-0.0253843101169043,3.20361028129671e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NT5E,5'-nucleotidase,42181,0.0537661415448685,0.00529070287801571,0.0433963639039577,0.0641359191857793,3.56160684004881e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,-0.126256806089461,0.0124325935079387,-0.150624689365021,-0.101888922813902,4.00388195249698e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INSL3,Insulin-like 3,39929,0.0903551706239004,0.00891570731704236,0.0728803842824974,0.107829956965303,4.9226292077443e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0273601466835299,0.00270819041981519,0.0220520934606921,0.0326681999063676,6.5136469386711e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,39966,-0.0235129570752678,0.00233129805781665,-0.0280823012685884,-0.0189436128819472,8.0424975334037e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GUCA2A,Guanylin,42083,-0.0348881476927439,0.0034634872111977,-0.0416765826266914,-0.0280997127587964,8.81531228969623e-24
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLXNB2,Plexin-B2,42255,-0.0240847662889297,0.00240602659826004,-0.0288005784215194,-0.01936895415634,1.65700935515164e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.110661152871596,0.011076362155223,0.088951483047359,0.132370822695833,2.01767154413402e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C8B,Complement component C8 beta chain,39979,0.0299177817402337,0.00299697209111287,0.0240437164416525,0.035791847038815,2.26468051056156e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LEFTY2,Left-right determination factor 2,42247,0.0505905951086965,0.00507188269957408,0.0406497050175313,0.0605314851998617,2.36409424151743e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.0151262127752159,0.00152818449908785,0.0121309711570037,0.0181214543934281,5.25162431340932e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0443352370498771,0.00449111940978279,-0.0531378310930514,-0.0355326430067029,6.61315320638447e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0301997035424473,0.00306532100778528,-0.0362077327177065,-0.0241916743671882,8.00250273327984e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MVK,Mevalonate kinase,41913,-0.0801873426792197,0.00814399970824708,-0.0961495821073839,-0.0642251032510554,8.51711290822885e-23
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.0933767837348248,0.00955015689550669,0.0746584762196317,0.112095091250018,1.72569568774991e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK13,Kallikrein-13,41839,0.0429509327439356,0.00441701942799857,0.0342935746650584,0.0516082908228128,2.82928987649695e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM3B,Protein FAM3B,42070,-0.0336853323398625,0.00346672789828965,-0.0404801190205102,-0.0268905456592148,3.02657165467581e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0246015114000506,0.00253212399545403,0.0196385483689607,0.0295644744311405,3.17056395483031e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSME2,Proteasome activator complex subunit 2,41955,-0.0336760331366683,0.00346878051248719,-0.0404748429411432,-0.0268772233321934,3.29045040859514e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAST,Gastrin,39929,-0.125820638731127,0.0129606976271557,-0.151223606080352,-0.100417671381901,3.40608567951673e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHAD,Chondroadherin,39736,0.0451794698593276,0.00465617206483639,0.0360533726122483,0.054305567106407,3.57846339738157e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL15,C-C motif chemokine 15,42310,-0.0412106869539832,0.00428545860655117,-0.0496101858228235,-0.0328111880851429,7.98910737596522e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL7,Interleukin-7,42119,0.0610467946404445,0.00635072748266077,0.0485993687744294,0.0734942205064596,8.30870497123366e-22
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.100103829851243,0.0104627779098806,0.0795967851478774,0.120610874554609,1.32398935005541e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.0789902706819705,0.00826077182218524,0.0627991579104874,0.0951813834534535,1.35492175802232e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MUC13,Mucin-13,41839,-0.0494644381060155,0.00517345499833078,-0.0596044099027438,-0.0393244663092872,1.36665356587281e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.0518349984782913,0.00545118815334125,0.0411506696977425,0.0625193272588402,2.24498751308329e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0595531601950102,0.00627358274755855,-0.071849382380225,-0.0472569380097954,2.6242491113621e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPE,Carboxypeptidase E,42134,0.0365007655133122,0.00385383675277392,0.0289472454778753,0.0440542855487491,3.21583446555327e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.100900267572625,0.010652327916714,0.0800217048558655,0.121778830289384,3.28317323869644e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.106203621304764,0.0112145878165747,0.0842230291842774,0.12818421342525,3.35816279236902e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRTAC1,Cartilage acidic protein 1,42310,0.0288024917725981,0.00304859246135959,0.0228272505483333,0.0347777329968629,4.01177236105543e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0372290710916861,0.00394154802821913,-0.0449545052269956,-0.0295036369563766,4.23693962422581e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.057234675230689,0.00606276129004514,0.0453516631022005,0.0691176873591775,4.43986220121306e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.114822627699354,0.0121832462940766,0.0909434649629644,0.138701790435744,5.17532549616379e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHA2,Ephrin type-A receptor 2,41614,-0.0298939867805354,0.00319060398077774,-0.0361475705828598,-0.023640402978211,8.48268073870271e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL17,C-C motif chemokine 17,42107,0.0842496479567848,0.00899334996098129,0.0666226820332615,0.101876613880308,8.54726277707357e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.0842924820001568,0.00900780981159867,0.0666371747694234,0.10194778923089,9.41408110310893e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0582688951921596,0.00623079998692331,-0.0704812631665293,-0.0460565272177899,9.9365158266082e-21
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0381866174059063,0.00408970962917604,0.0301707865327213,0.0462024482790913,1.17277037696019e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCDH17,Protocadherin-17,42145,-0.034385975843002,0.0036909227475181,-0.0416201844281375,-0.0271517672578666,1.38714814917081e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFI,Complement factor I,39979,0.0179137610519347,0.00192638871631159,0.014138039167964,0.0216894829359054,1.673557846267e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NECTIN2,Nectin-2,42129,-0.0283212558163235,0.00304656133223196,-0.0342925160274982,-0.0223499956051489,1.67622767805405e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0279485446225193,0.00300778464349205,-0.0338438025237637,-0.0220532867212749,1.78898359328609e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UMOD,Uromodulin,42274,0.0491214043181882,0.00529686942630296,0.0387395402426344,0.059503268393742,2.06421271362325e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD48,CD48 antigen,42166,-0.0279724720515662,0.00302570070633951,-0.0339028454359916,-0.0220420986671408,2.69938490894481e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.027942348051165,0.00302377132549115,-0.0338689398491276,-0.0220157562532023,2.87968317030574e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIP,Gastric inhibitory polypeptide,39638,-0.0461511690466178,0.0050125385984944,-0.0559757446996669,-0.0363265933935688,3.95286999730383e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0386335665866713,0.00419839497801274,-0.0468624207435763,-0.0304047124297664,4.02175418923161e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MINK1,Misshapen-like kinase 1,39929,0.0849026222447863,0.0092350002810315,0.0668020216939646,0.103003222795608,4.46203079626599e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0438572063874456,0.00479476538913792,0.0344594662247353,0.053254946550156,6.70063301463618e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.023903204086192,0.00261287075107635,0.0187819774140823,0.0290244307583016,6.7672177174365e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLAMF7,SLAM family member 7,42119,-0.0537019208181952,0.00587209857690794,-0.0652112340289348,-0.0421926076074556,6.78675774548434e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0390558618990763,0.00427187693037308,0.030682983115545,0.0474287406826075,7.13792597740275e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.031060475039246,0.00340003365735972,-0.0377245410076711,-0.024396409070821,7.43496141471661e-20
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.035108560854959,0.00385684387614041,-0.0426679748521942,-0.0275491468577238,1.00453967285789e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MENT,Protein MENT,39736,0.0214359603356523,0.00236145494576117,0.0168075086419604,0.0260644120293442,1.29842584526997e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0383262559194149,0.00422402313254248,-0.0466053412591981,-0.0300471705796316,1.31219658087802e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOLR2,Folate receptor beta,42249,-0.0259232643191682,0.00285836499548018,-0.0315256597103093,-0.020320868928027,1.35970309066351e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.0539177051288752,0.0059510598993541,-0.0655817825316093,-0.0422536277261412,1.47653182211876e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTN5,Contactin-5,42170,0.0330106735020509,0.00364397711093002,0.0258684783646281,0.0401528686394738,1.49459219491077e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.0514481989150419,0.00568336793165364,-0.0625876000610831,-0.0403087977690008,1.58883019500733e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.102509207064842,0.0113302046993443,0.0803020058541275,0.124716408275557,1.70177493354106e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0656975474637459,0.00726284572374276,0.05146236984521,0.0799327250822817,1.72738285256949e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC1,Sialoadhesin,42185,-0.0369482632122207,0.00409336926912055,-0.044971266979697,-0.0289252594447444,2.01019648109195e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DAB2,Disabled homolog 2,42262,0.0984464370793612,0.0109168095947978,0.0770494902735575,0.119843383885165,2.16976755343777e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOA1,Apolipoprotein A-I,39979,0.0245331600589702,0.00272154992640255,0.0191989222032212,0.0298673979147192,2.29493495891964e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHGA,Chromogranin-A,39966,-0.0757721426544778,0.00841310329102563,-0.092261825104888,-0.0592824602040676,2.46693517759593e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0571182373160123,0.00634773015694108,0.0446766862084078,0.0695597884236168,2.66564183270823e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL9,C-X-C motif chemokine 9,42185,-0.0575370087539049,0.00639679775575026,-0.0700747323551754,-0.0449992851526344,2.67965200319626e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.0753605452851865,0.00838080296785549,0.0589341714681898,0.0917869191021833,2.75247854360113e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.0740337051163496,0.00825844155683528,0.0578471596649525,0.0902202505677468,3.61004392066533e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0431220084157112,0.00481749354570275,-0.0525642957652886,-0.0336797210661338,3.97195733462557e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,POF1B,Protein POF1B,39657,-0.0403165782637548,0.004511627242966,-0.0491593676599681,-0.0314737888675414,4.66806740577625e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0339637879229872,0.00380694263561404,-0.0414253954887907,-0.0265021803571837,5.17837257971214e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CREG1,Protein CREG1,41960,0.035461727309129,0.00397642727388941,0.0276679298523058,0.0432555247659522,5.35830986881789e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLU,Clusterin,39979,0.0265946339950064,0.00298639884833429,0.0207412922522712,0.0324479757377416,6.13297393270116e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0232181634555679,0.0026139697119257,0.0180947828201935,0.0283415440909422,7.35459748976162e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0291226893717975,0.00327873557344528,-0.0355490110957502,-0.0226963676478447,7.55338953822965e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0250755328902699,0.0028262193467292,-0.0306149228098592,-0.0195361429706807,8.038189486021e-19
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0291042246681371,0.00329149301723304,0.0226528983543603,0.0355555509819138,1.0516057631863e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL17C,Interleukin-17C,41913,-0.0617470676163215,0.00698569333721108,-0.0754390265572552,-0.0480551086753878,1.08503385237646e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0350816117350513,0.00399537107721994,0.0272506844237002,0.0429125390464024,1.82187512148813e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHISA5,Protein shisa-5,39966,-0.0225470670501388,0.0025687239873516,-0.027581766065348,-0.0175123680349297,1.90928336889418e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.0648939749320837,0.00743549270365489,0.0503204092329201,0.0794675406312472,2.89891231065709e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,39958,-0.0295129054398798,0.00338931560490417,-0.036155964025492,-0.0228698468542677,3.53121635423307e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLB,Beta-klotho,41839,-0.0638666733156399,0.00734468543748471,-0.0782622567731099,-0.0494710898581699,3.85162616481136e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0383664500623345,0.00441826280208063,-0.0470262451544126,-0.0297066549702565,4.26506101883892e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD248,Endosialin,39966,0.0347337242036371,0.00400752020744517,0.0268789845970445,0.0425884638102296,5.03053947871935e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL21,C-C motif chemokine 21,42185,-0.0326348842161047,0.00376897208671637,-0.0400220695060688,-0.0252476989261407,5.29829796041109e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0229420337312338,0.002649660140726,0.0177486998554108,0.0281353676070568,5.42334144822625e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0173476135620083,0.00200650999996164,-0.0212803731619331,-0.0134148539620835,5.94251212679484e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SORT1,Sortilin,42129,0.0324432603305067,0.00375643462798192,0.0250806484596621,0.0398058722013513,6.42677863418805e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0353162344345363,0.00408928769780645,-0.0433312383222369,-0.0273012305468357,6.44463713853018e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.02047505667591,0.00237183972147205,0.0158262508218248,0.0251238625299952,6.66280640086069e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLIN3,Perilipin-3,42145,-0.036444072022537,0.0042222337718785,-0.0447196502154189,-0.0281684938296552,6.72621806693336e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0346637317759607,0.00401715512733794,-0.042537355825543,-0.0267901077263783,6.8820837775022e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EBI3_IL27,Interleukin-27,42247,-0.0260162543139364,0.00301775368890178,-0.0319310515441839,-0.0201014570836889,7.35688066052051e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.0605140043554393,0.0070333390688647,0.0467286597804645,0.0742993489304141,8.7217629791862e-18
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPO,Erythropoietin,42119,-0.061600282993021,0.00717639925441357,-0.0756660255316716,-0.0475345404543704,1.01781178177649e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,41900,-0.0460573756304534,0.00537865168519673,-0.056599532933439,-0.0355152183274678,1.21954012595607e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYL4,Myosin light chain 4,39638,-0.0437089633184122,0.00510569278820477,-0.0537161211832935,-0.0337018054535308,1.26903366569567e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FSTL1,Follistatin-related protein 1,39638,-0.0196482286123612,0.00230244971383932,-0.0241610300514863,-0.0151354271732362,1.60380376137751e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.033167758857838,0.00389015513571087,0.0255430547918447,0.0407924629238313,1.67324384471076e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.0612321189587629,0.00718552217718065,0.0471484954914888,0.075315742426037,1.73757106428406e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.093334874832733,0.0109852491771677,0.0718037864454844,0.114865963219982,2.16317828598129e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KAZN,Kazrin,39930,0.0881950568828244,0.0103963401367567,0.0678182302147812,0.108571883550868,2.46094300019159e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0273718844543072,0.003227621513742,0.0210457462873729,0.0336980226212415,2.52704690564067e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.089227988334387,0.0105272047011522,0.0685946671201287,0.109861309548645,2.57216143831598e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLG,Plasminogen,39742,0.0183780746984353,0.0021691530523037,0.01412653471592,0.0226296146809505,2.70427160261495e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ULBP2,UL16-binding protein 2,42016,-0.0327681671584906,0.0038767533622601,-0.0403666037485204,-0.0251697305684608,3.14368486503733e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCG2,Secretogranin-2,42193,-0.0274565249767533,0.00325144455067253,-0.0338293562960715,-0.0210836936574352,3.36310997643454e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.033117252538771,0.00392228404334559,-0.0408049292637284,-0.0254295758138137,3.39462598574751e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0777073021447528,0.00921255365387555,-0.0957639073063489,-0.0596506969831567,3.64718204051104e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.0653383010125398,0.00776448830799902,0.0501199039288617,0.0805566980962179,4.39940106811783e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0275015185079846,0.00327651280806806,-0.033923483611798,-0.0210795534041712,5.28310655561765e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0904823747660163,0.010813695545624,0.0692875314965933,0.111677218035439,6.46178052227467e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MILR1,Allergin-1,41913,-0.0421890265201878,0.00504195575649904,-0.0520712598029259,-0.0323067932374496,6.46260837508323e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.0899304478920889,0.0107893364196636,0.0687833485095483,0.11107754727463,8.48422519674112e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACE,Angiotensin-converting enzyme,39990,-0.0222965423284632,0.00267855604664384,-0.0275465121798851,-0.0170465724770412,9.46675070399674e-17
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0121756773643491,0.00147637109259844,0.00928199002285612,0.015069364705842,1.80255851615446e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0332494461152008,0.00403185821697653,0.0253470040099268,0.0411518882204748,1.8081614793774e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.088703247365901,0.0107826005070739,0.0675693503720361,0.109837144359766,2.14811151011118e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASE1,Ribonuclease pancreatic,39990,-0.0201576943927144,0.00245074316472173,-0.024961150995569,-0.0153542377898598,2.16124009316504e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFNA4,Ephrin-A4,41992,-0.0261717359755251,0.00318431646920496,-0.0324129962551668,-0.0199304756958834,2.24043271770971e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0393830977084167,0.00479381205790772,-0.0487789693419159,-0.0299872260749176,2.30869811043927e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGA2,Integrin alpha-2,39736,0.02821121332202,0.00344052408057016,0.0214677861241025,0.0349546405199375,2.67451681844107e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TJAP1,Tight junction-associated protein 1,42181,0.0669738277421608,0.00818539403767673,0.0509304554283144,0.0830172000560072,3.03552026061957e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDGFC,Platelet-derived growth factor C,41843,0.022494305956808,0.00274915382178973,0.0171059644661001,0.0278826474475159,3.03826810980284e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCARB2,Lysosome membrane protein 2,41777,-0.0265191147440882,0.00324469011106677,-0.032878707361779,-0.0201595221263973,3.2789892005258e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSV,Cathepsin L2,42200,0.0321646565920066,0.00394741701685283,0.0244277192389751,0.0399015939450382,4.01160729361662e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DLL1,Delta-like protein 1,42181,-0.0246195391754162,0.00302409029268412,-0.0305467561490771,-0.0186923222017554,4.25472402860821e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0552166936605747,0.00679057091006075,0.0419071746768556,0.0685262126442938,4.61313261016495e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.0921429324807357,0.0113294044751366,0.0699372997094679,0.114348565252004,4.62814926041863e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0462561323900848,0.00569174309004655,-0.0574119488465761,-0.0351003159335936,4.78427984929884e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0344885916164783,0.00424364221052167,0.0261710528838559,0.0428061303491008,4.86795029082007e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0301474494899693,0.00371029106572906,0.0228752790011404,0.0374196199787983,4.93147587852197e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0494595303306511,0.00609248174542627,-0.0614007945516866,-0.0375182661096156,5.14141602463295e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.0420592805346575,0.0051876217299407,-0.0522270191253412,-0.0318915419439737,5.60431122177558e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEPTIN8,Septin-8,39906,-0.0262023903789855,0.00323179155087435,-0.0325367018186993,-0.0198680789392718,5.69026190916914e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.0437096751308134,0.00539261264310189,-0.0542791959112931,-0.0331401543503337,5.71011038636405e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGA,Fibrinogen alpha chain,39735,0.0250379352987666,0.00308885159104311,0.0189837861803221,0.0310920844172111,5.78302740547284e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,39481,-0.0260257978074527,0.00321324885580652,-0.0323237655648335,-0.0197278300500719,6.10652848391091e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RTBDN,Retbindin,42070,0.0238906749084965,0.00295596316764375,0.0180969870999148,0.0296843627170783,6.90009350656532e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUMB,Protein numb homolog,39657,0.0673780399620342,0.00834054933358501,0.0510305632682075,0.0837255166558608,7.24574833525508e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0160438470669453,0.00199294439466862,0.0121376760533948,0.0199500180804958,9.08250725626091e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.0693997076258544,0.00862502832334247,0.0524946521121031,0.0863047631396056,9.4042909457974e-16
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.0817748291560023,0.0101910662467785,0.0618003393123164,0.101749318999688,1.12562804295834e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK14,Kallikrein-14,42262,0.0364588571684844,0.00456571922623434,0.0275100474850651,0.0454076668519037,1.51264615490493e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.0672184202523796,0.0084202507303384,0.0507147288209164,0.0837221116838429,1.54390248521676e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA11,Annexin A11,42087,0.0519900628363104,0.00651841283458499,0.0392139736805238,0.064766151992097,1.63431098801973e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PODXL,Podocalyxin,42070,0.0119020092271743,0.00149316284472054,0.00897541005152207,0.0148286084028266,1.69990702410885e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EHBP1,EH domain-binding protein 1,39958,0.0591315519910759,0.0074206800732877,0.044587019047432,0.0736760849347198,1.75971682112201e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBC1D23,TBC1 domain family member 23,42070,0.0707061743607192,0.00888430535483213,0.0532929358652482,0.0881194128561902,1.87918297149781e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0595129217306214,0.00749208261308786,0.0448284398089692,0.0741974036522736,2.12447093931489e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBM17,Splicing factor 45,39934,0.0606237562644819,0.00763073943914223,0.0456675069637631,0.0755800055652007,2.13099106336297e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0299923141243597,0.00377629317421163,-0.0373938487458145,-0.0225907795029049,2.14158287279978e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.0711724224608248,0.00897009902158346,0.0535910283785212,0.0887538165431284,2.31392618591168e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.091260052334655,0.0115250995536242,0.0686708572095515,0.113849247459758,2.59389474961071e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD160,CD160 antigen,42296,-0.0378050811274585,0.0047753303055593,-0.0471647285263547,-0.0284454337285622,2.62465999941793e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0221679837661488,0.00280035099507256,-0.027656671716491,-0.0166792958158066,2.63800473319283e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0173513379207388,0.00219336373294019,0.013052345004176,0.0216503308373016,2.79851623313109e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM3C,Protein FAM3C,42129,-0.0236981813177493,0.00299674141119499,-0.0295717944836915,-0.0178245681518071,2.8177784680897e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFAP,Glial fibrillary acidic protein,41820,0.0353712161380147,0.00448315722061006,0.026584227985619,0.0441582042904105,3.26367370323453e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0308077651540653,0.0039091892357349,-0.0384697760561057,-0.0231457542520249,3.55629411756601e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNPY4,Protein canopy homolog 4,42070,0.0584032604680262,0.00741280120905669,0.0438741700982751,0.0729323508377773,3.56053199273119e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0305345926856219,0.00389388840165731,0.0229025714183735,0.0381666139528702,4.7771067580914e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0324132240987781,0.00413692893895706,-0.040521604819134,-0.0243048433784223,5.05270452798523e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.0252721209397485,0.00322666314244018,-0.0315963806989312,-0.0189478611805657,5.14175512299977e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.0983232958758769,0.0125576133324698,0.0737103737442361,0.122936218007518,5.33054416934145e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0283444047947599,0.00362274556020213,-0.0354449860927561,-0.0212438234967637,5.49080641567625e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0271064118546945,0.00346725643882922,0.0203105892345892,0.0339022344747997,5.77710622868453e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.0965272351708799,0.012347553417599,0.0723260304723859,0.120728439869374,5.78244743821673e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.0615707914017904,0.0078894546416463,0.0461074603041636,0.0770341224994171,6.4284304576785e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0292685316985112,0.00374992043359409,0.0219186876486668,0.0366183757483557,6.46777030925147e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OCLN,Occludin,39934,-0.0342591018583586,0.0043918727055464,-0.0428671723612296,-0.0256510313554877,6.70320600060266e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0266785895051129,0.0034215750277835,-0.0333848765595685,-0.0199723024506572,6.79200497333066e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.0916073526515474,0.0117806624625128,0.0685172542250224,0.114697451078072,8.1281793274175e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.0645486867820714,0.00830287954255247,0.0482750428786686,0.0808223306854742,8.2464946619079e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTH,Parathyroid hormone,39649,0.0640657619512515,0.00824696746490139,0.0479017057200448,0.0802298181824583,8.65170099251399e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0361863979645475,0.00466583699721639,-0.0453314384790916,-0.0270413574500034,9.43292848273435e-15
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0292629222793011,0.00377961581499737,-0.0366709692766959,-0.0218548752819062,1.0446447413031e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0564022734113688,0.00728882505158681,0.0421161763102587,0.070688370512479,1.09639801656793e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.02368897584052,0.00306393685738155,-0.0296942920809878,-0.0176836596000521,1.13623336486646e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0368975913754959,0.00477829163931609,0.0275321397624364,0.0462630429885554,1.24543971464835e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0398349153889394,0.00517306020272027,0.0296957173916076,0.0499741133862711,1.45180926560224e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0174652715369756,0.00227158823075811,0.0130129586046897,0.0219175844692615,1.59127924093936e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEMA4D,Semaphorin-4D,42249,0.0227574485660043,0.00296172198581616,0.0169524734738046,0.0285624236582039,1.64869225071371e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFBR2,TGF-beta receptor type-2,42181,-0.0258496617140456,0.00337610233432586,-0.0324668222893243,-0.0192325011387669,2.03694866611495e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0650821895383004,0.00850595648178812,0.0484105148339957,0.0817538642426051,2.12315120387238e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.0807351289266395,0.0105715518658435,0.0600148872695863,0.101455370583693,2.40182829340272e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.0644647252564014,0.00844438120480728,0.0479137380949791,0.0810157124178237,2.42977693030856e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0462120501365896,0.00606124196642087,0.0343320158824047,0.0580920843907745,2.65726705239568e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FYB1,FYN-binding protein 1,42115,0.0693465962502815,0.00911561191483611,0.0514799968972028,0.0872131956033603,2.97994582639575e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.0598673217078274,0.00787432354855259,0.0444336475526644,0.0753009958629905,3.12569754198738e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL24,C-C motif chemokine 24,42166,0.0614977334094627,0.00811316138017943,0.045595937104311,0.0773995297146144,3.6794826653461e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.0797742450111889,0.0105262344556205,0.0591428254781727,0.100405664544205,3.71846116609173e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL22,C-C motif chemokine 22,41991,0.0386185165879775,0.00509858869143453,0.0286252827527658,0.0486117504231892,3.84539569876217e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.0941066143029382,0.0124482356656557,0.069708072398253,0.118505156207623,4.29629678733324e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM3D,Protein FAM3D,39930,-0.0656040947221149,0.0086777787284146,-0.0826125410298075,-0.0485956484144223,4.34138517991285e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.0690440058548271,0.00915425665307693,0.0511016628147964,0.0869863488948579,4.91727699663354e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.0583408316357626,0.00773889148580507,-0.0735090589479405,-0.0431726043235847,5.04927475107665e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0169718723502654,0.00225330896423341,0.0125553867803679,0.0213883579201628,5.31342201256807e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0239820226793123,0.00318498146535811,0.0177394590072104,0.0302245863514142,5.40316599312037e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PMVK,Phosphomevalonate kinase,41832,0.0804126807653697,0.0106865573672333,0.0594670283255925,0.101358333205147,5.62688663827398e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA12,Carbonic anhydrase 12,42070,-0.0242893066551528,0.00323017458892107,-0.0306204488494381,-0.0179581644608675,5.84580830917672e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0441970262439326,0.00588450798458276,-0.0557306618937148,-0.0326633905941504,6.25337555561323e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0381303882254683,0.00507911146154002,-0.0480854466900868,-0.0281753297608499,6.48737354410693e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.0823190026056172,0.0109676075123533,0.0608224918814048,0.10381551332983,6.50264370455319e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GUSB,Beta-glucuronidase,42211,0.0451037406790882,0.00601004322488151,0.0333240559583204,0.0568834253998559,6.53724959311412e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.0569269127253511,0.00760292734308733,0.0420251751329,0.0718286503178023,7.54048012470428e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.0807098298447589,0.0108072810703857,0.0595275589468029,0.101892100742715,8.73364413397403e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0350676253846871,0.00469990922316671,-0.0442794474620939,-0.0258558033072804,9.08092448469806e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEC31A,Protein transport protein Sec31A,39638,0.0572827939839542,0.00768064186171581,0.0422287359349912,0.0723368520329171,9.43823683907942e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.0631142094366217,0.00846641078130177,0.0465200443052702,0.0797083745679732,9.68457158508688e-14
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0350201090159759,0.00470368228705641,-0.0442393262986065,-0.0258008917333453,1.02615938965371e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.0654737007073133,0.00880394337277047,0.0482179716966832,0.0827294297179434,1.10548053986917e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0243696972310388,0.00327793452105362,0.0179449455697737,0.0307944488923039,1.11232278322487e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0197717144452149,0.00266040259680346,-0.0249861035349497,-0.0145573253554801,1.13483628163794e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.0826913013570535,0.0111309292517282,0.0608746800236662,0.104507922690441,1.16007679682166e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0187902454128932,0.00252992783081268,0.0138315868645003,0.023748903961286,1.1756014469779e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AFM,Afamin,39979,0.0149195197635086,0.00200871566458033,0.0109824370609311,0.018856602466086,1.1867697188071e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0216843809827971,0.00292612990520808,-0.0274195955970049,-0.0159491663685893,1.33132078271061e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0431151595280281,0.00582836835219957,-0.0545387614983393,-0.031691557557717,1.46971970066959e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.0723275041270162,0.00978120100595236,0.0531563501553495,0.0914986580986828,1.50240708932976e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,42145,-0.0558678102661002,0.00756981078882531,-0.0707046394121978,-0.0410309811200026,1.67075219440166e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GTPBP2,GTP-binding protein 2,39649,0.0600376944855428,0.00813382067554287,0.0440954059614788,0.0759799830096069,1.68087376935542e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.0663522329603841,0.00901844921721295,0.0486760724946468,0.0840283934261215,1.98299433214861e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.0644645338625204,0.00876908912328842,0.047277119180875,0.0816519485441657,2.09748346691036e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0259548732668425,0.00353279596608828,-0.0328791533603756,-0.0190305931733095,2.14414579001939e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL19,Interleukin-19,41756,-0.0531889974703955,0.00724340977402502,-0.0673860806274845,-0.0389919143133064,2.20991696651463e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0313723636534585,0.00427315998986098,-0.039747757233586,-0.022996970073331,2.22881618587359e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLAT,Tissue-type plasminogen activator,42272,0.0369876390965332,0.00504112563301823,0.0271070328558174,0.0468682453372489,2.304322327788e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DOK1,Docking protein 1,39929,0.0999026007044579,0.0136207995258214,0.073205833633848,0.126599367775068,2.37626846325286e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLA2G15,Phospholipase A2 group XV,42181,-0.0198378070947201,0.00270921828797135,-0.025147874939144,-0.0145277392502963,2.57400565346774e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIFBP,KIF-binding protein,42070,0.059613345704626,0.00814621131148339,0.0436467715341186,0.0755799198751335,2.66091847469048e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.0737987848205689,0.0100964171550859,0.0540098071966005,0.0935877624445373,2.83285201119942e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.02134020139557,0.00292442350448643,0.0156083313267766,0.0270720714643634,3.09886139896725e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0200493593327143,0.00274790682205338,-0.025435256703939,-0.0146634619614897,3.12350114926588e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0516404986649216,0.00708217441404028,0.0377594368134027,0.0655215605164405,3.23198570989483e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.060943097267947,0.0083745260797306,0.044529026151675,0.077357168384219,3.6333946508228e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB6,Integrin beta-6,41913,0.0220385424396104,0.00303058597885992,0.0160985939210449,0.0279784909581758,3.7387393443533e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLXNA4,Plexin-A4,42119,0.0574554994702159,0.00792362320908525,0.0419251979804088,0.072985800960023,4.35656078609949e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRAP1,Proline-rich acidic protein 1,39966,-0.0280342338902436,0.00387353885226357,-0.0356263700406802,-0.020442097739807,4.86944871714472e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DBNL,Drebrin-like protein,42185,0.0660850191340135,0.00913306958175816,0.0481842027537675,0.0839858355142595,4.87622008706999e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SBSN,Suprabasin,39954,0.0254356102691455,0.00352013779229485,0.0185361401962476,0.0323350803420434,5.30308130647588e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.02982187879863,0.00413611014712965,-0.0379286546870041,-0.0217151029102558,5.9458955070258e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AXIN1,Axin-1,42119,0.0684409068908399,0.00950587836312228,0.0498093852991202,0.0870724284825596,6.34617693848897e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0214177140648134,0.0029801494328392,0.0155766211764486,0.0272588069531783,7.04993497527091e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GCG,Pro-glucagon,41843,-0.0876817972222136,0.0122353823509083,-0.111663146629994,-0.0637004478144334,8.1160474662532e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0528698017574001,0.00737636564042836,0.0384121251021605,0.0673274784126397,8.12268127163908e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA10,Annexin A10,41839,-0.0576019606732014,0.00804531512301015,-0.0733707783143013,-0.0418331430321016,8.51254264478997e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0244154243183748,0.00341549265534139,-0.0311097899228439,-0.0177210587139057,9.22937502982006e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,POSTN,Periostin,39966,0.026800293558281,0.00374966871663086,0.0194509428736846,0.0341496442428775,9.38703121034264e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GP5,Platelet glycoprotein V,39736,0.0260007672555315,0.0036389883856287,0.0188683500196993,0.0331331844913638,9.55809106141817e-13
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.0897701790827094,0.0125864842860289,0.0651006698820927,0.114439688283326,1.03723339801348e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEPTIN9,Septin-9,42070,0.0202338968651558,0.00283841235511314,0.014670608649134,0.0257971850811775,1.06561430221353e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0407817044617826,0.00572373230960326,0.0295631891349602,0.052000219788605,1.09469657438807e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0210070900486498,0.00294845699525652,0.015228114337947,0.0267860657593525,1.10560948988547e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.0701180202522567,0.00985207563666792,0.0508079520043876,0.0894280885001258,1.15793928733174e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0167457080477762,0.00235989950075906,-0.021371111069264,-0.0121203050262885,1.34924003802425e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.0762314303694418,0.0107419228012406,0.0551772616790102,0.0972855990598734,1.35471139493939e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.0598815253934969,0.00844361913124446,0.0433320318962578,0.0764310188907361,1.38798414111326e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0298837045040444,0.0042189067589282,0.0216146472565451,0.0381527617515437,1.4774278435569e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0339241703818668,0.00479825321398584,-0.043328746681279,-0.0245195940824545,1.62412277603809e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0208364236994095,0.00295486992053175,0.0150448786551673,0.0266279687436518,1.85480011504271e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.0547712662709194,0.00777915149213595,0.0395241293463329,0.0700184031955059,2.00600126450266e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0369617477613515,0.00525526595653706,0.0266614264865388,0.0472620690361641,2.13670555764341e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EEF1D,Elongation factor 1-delta,39958,0.0635012848475394,0.00903639196849943,0.0457899565892805,0.0812126131057983,2.22650470904071e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DKK1,Dickkopf-related protein 1,42249,0.0407775235471422,0.00580454572322342,0.0294006139296243,0.0521544331646601,2.24045951068203e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.0635267536408645,0.00905488252096454,0.045779183899774,0.081274323381955,2.41734050707575e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSB,Cathepsin B,42153,0.0350497817710545,0.00499947794636151,0.0252508049961859,0.044848758545923,2.48373393435335e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LY96,Lymphocyte antigen 96,42016,-0.0252524095424024,0.00360263119251266,-0.0323135666797273,-0.0181912524050776,2.50718073682769e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.0856156965008923,0.0122172817298714,0.0616698243103444,0.10956156869144,2.53997383217863e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BLMH,Bleomycin hydrolase,42310,0.0213304165442957,0.00304696401415391,0.015358367076554,0.0273024660120373,2.6682218257279e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RETN,Resistin,42105,-0.0295191723996465,0.00422768506675258,-0.0378054351304815,-0.0212329096688114,3.03852794428094e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0481067536384347,0.00689293408902174,0.0345966028239521,0.0616169044529173,3.14122681817104e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA13,Carbonic anhydrase 13,41967,0.0724875449643769,0.0103988495729455,0.0521057998014037,0.0928692901273501,3.30100051608562e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OMD,Osteomodulin,42185,0.0281941546151735,0.00404527281049794,0.0202654199065975,0.0361228893237495,3.32373465200464e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0178767802832801,0.00256658302880855,0.0128462775468153,0.0229072830197448,3.4316639066452e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD6,T-cell differentiation antigen CD6,42284,0.0357722401661055,0.00513618734094105,0.0257053129778611,0.04583916735435,3.44016098749157e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.0657323329505581,0.00944759640288105,0.0472150440009112,0.0842496219002049,3.62078590289794e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CES2,Cocaine esterase,42070,0.0382033965733022,0.00549423561710142,0.0274346947637834,0.0489720983828209,3.73126931369016e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCTN3,Tectonic-3,39958,0.0209481592254703,0.00301293090874799,0.0150428146443242,0.0268535038066163,3.77877493952659e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0172913997635996,0.00248745292920421,0.0124159920223594,0.0221668075048399,3.78106878216307e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RTN4R,Reticulon-4 receptor,42262,-0.0231099192434653,0.0033245144438218,-0.0296259675533561,-0.0165938709335746,3.78179339434979e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0153359538939204,0.00220656167581503,-0.0196608147785179,-0.0110110930093229,3.81460107656014e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL5,C-C motif chemokine 5,42217,0.0690395538714952,0.00995008653009655,0.049537384272506,0.0885417234704844,4.13936241456475e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.0417706328709947,0.00602981404159379,0.0299521973494708,0.0535890683925185,4.48611388604263e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LPO,Lactoperoxidase,41647,-0.041998452395656,0.00606629016451992,-0.053888381118115,-0.030108523673197,4.62047433842225e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.0754765498590841,0.0109062152415256,0.054100367985694,0.0968527317324742,4.74346400714764e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTN3,Contactin-3,42137,0.0193220586280458,0.00279297469107798,0.013847828233533,0.0247962890225587,4.78331936901934e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYH9,Myosin-9,39966,0.0779054417563699,0.0112603851051532,0.0558350869502697,0.0999757965624702,4.80835247529738e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0390288660875669,0.00564539066625116,0.0279639003817146,0.0500938317934191,4.9930558418793e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNM1,Dynamin-1,39930,0.0793382294251073,0.0114799916293092,0.0568374458316613,0.101839013018553,5.07075205126739e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0408502407510221,0.00591149432381851,0.0292637118763378,0.0524367696257063,5.09540956523642e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C9,Complement component C9,39990,0.0394619624898329,0.00571716616044808,0.0282563168153547,0.0506676081643112,5.38605439385728e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BGLAP,Osteocalcin,39966,0.0575786344991538,0.0083454675777295,0.041221518046804,0.0739357509515036,5.50014239991889e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCN2,Transcobalamin-2,42286,-0.0205679466986442,0.00298201269835783,-0.0264126915874255,-0.0147232018098628,5.53125694676786e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.0683043553452422,0.00990922633057059,0.0488822717373238,0.0877264389531605,5.75257500385807e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.0623455897124111,0.0090572557008608,0.044593368538724,0.0800978108860983,6.1569027753036e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH15,Cadherin-15,42230,-0.0468905921321905,0.00681463456563236,-0.0602472758808299,-0.0335339083835511,6.20871766629983e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.0494780028826683,0.00720550808495247,0.0353552070361615,0.0636007987291752,6.85997553346713e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.0699232730743189,0.0101870145094586,0.0499567246357801,0.0898898215128576,7.04741386046192e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0472131844187334,0.00688612501086532,-0.0607099894400294,-0.0337163793974374,7.44448717000925e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGA11,Integrin alpha-11,42119,0.022856568001687,0.00333559318216622,0.0163188053646412,0.0293943306387328,7.58058964970598e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IST1,IST1 homolog,39850,0.066846291998337,0.00977135596540761,0.0476944343061381,0.0859981496905359,8.26971038829358e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB1,Integrin beta-1,42167,0.014222858214392,0.00208067238762114,0.0101447403346546,0.0183009760941295,8.50910805006981e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.057373224471963,0.0084029214778825,0.0409034983753133,0.0738429505686127,8.99393339739322e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.0380817072628329,0.00557885293545353,-0.0490162590163218,-0.027147155509344,9.17261830971006e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0382584395442193,0.00560609670543766,0.0272704900015615,0.0492463890868771,9.20471772467421e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DTYMK,Thymidylate kinase,39958,0.04548791434703,0.00666606018605556,0.0324224363823611,0.058553392311699,9.31687722099636e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0183045705217039,0.00268354134128429,-0.0235643115506211,-0.0130448294927867,9.42011922548983e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C5,Complement C5,39979,0.0101817563502489,0.00149302930514671,0.00725541891216134,0.0131080937883364,9.59659498069361e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.0714324142310671,0.010477282519646,0.0508969404925609,0.0919678879695733,9.63432499366982e-12
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.056221289307711,0.00825280882638973,0.0400457840079872,0.0723967946074349,1.00945351047621e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0442966978699675,0.00651248161151126,0.0315322339114054,0.0570611618285295,1.07595265270995e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0342886888364285,0.00504711638603533,-0.0441810369530578,-0.0243963407197993,1.13832563501985e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0392601997432431,0.00578393453034429,-0.0505967114227179,-0.0279236880637683,1.1870503839681e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL26,C-C motif chemokine 26,42119,0.0599946593179925,0.00884564109959359,0.042657202762789,0.0773321158731959,1.23110283845384e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINB9,Serpin B9,42016,0.0219335392602721,0.00323586621243917,0.0155912414838913,0.0282758370366529,1.26715631283908e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL17A,Interleukin-17A,41877,-0.0287076630082265,0.00423917421062431,-0.0370164444610502,-0.0203988815554029,1.32364156821191e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DOK2,Docking protein 2,42145,0.0819994407197018,0.0121186854216751,0.0582468172932186,0.105752064146185,1.37485721097556e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAX,Protein max,41839,0.0705658940939567,0.0104427054715272,0.0500981913697634,0.0910335968181501,1.46333762273316e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0314588781212205,0.00465492290898827,0.0223352292196035,0.0405825270228375,1.46573960120041e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0164501501388772,0.00243490693495287,0.0116777325463695,0.0212225677313848,1.47757032174467e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0278996511245389,0.00413313778760011,-0.0360006011882351,-0.0197987010608426,1.53568151761998e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MLN,Promotilin,42119,0.0593668827937193,0.00879989101863668,0.0421190963971914,0.0766146691902472,1.57812160313681e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEMA7A,Semaphorin-7A,42272,-0.0189813578096077,0.0028149007833695,-0.0244985633450119,-0.0134641522742035,1.61188749960478e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCDHB15,Protocadherin beta-15,39919,-0.0266225274631252,0.00394740137037484,-0.0343594341490599,-0.0188856207771906,1.61237291249738e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.0675681883417538,0.0100259279170508,0.0479173696243342,0.0872190070591734,1.65549402199067e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TWF2,Twinfilin-2,39966,0.0568819607698767,0.00844338662461775,0.0403329229856259,0.0734309985541275,1.69655044564249e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.0629270359966242,0.00935768220874236,0.0445859788674891,0.0812680931257592,1.83066598536105e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.016653971324854,0.00247973574393649,0.0117936892667384,0.0215142533829695,1.94104509695938e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.062103745881562,0.00925710962001093,0.0439598110263406,0.0802476807367834,2.04122252023628e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.0795261250936273,0.011867710094901,0.0562654133076213,0.102786836879633,2.15082769327277e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0518900319133919,0.00774615491752661,0.0367075682750398,0.0670724955517441,2.20069258132149e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CMIP,C-Maf-inducing protein,39919,0.0556592969960082,0.00831670825838761,0.0393585488095685,0.071960045182448,2.2980268059579e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0131065184879397,0.00195945631078587,0.00926598411879943,0.01694705285708,2.35486636436262e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0307615470522117,0.00460085368858481,-0.039779220281838,-0.0217438738225855,2.40319127181275e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD63,CD63 antigen,41992,0.0332118588857233,0.00497259550759036,0.0234655716908462,0.0429581460806004,2.50110732183301e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0208850654808953,0.00313015464146513,-0.0270201685781669,-0.0147499623836236,2.618179223896e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.0674189614256391,0.0101081063150198,0.0476070730482004,0.0872308498030778,2.6841241195127e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.0418435117492766,0.00627903955485055,0.0295365942217696,0.0541504292767837,2.788313700283e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0295800852052889,0.00444194542457475,-0.0382862982374554,-0.0208738721731224,2.88133150107761e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.0642193331727132,0.00964840052200591,0.0453084681495817,0.0831301981958448,2.94783482168738e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINI1,Neuroserpin,39713,0.0191687174268288,0.00288013493608937,0.0135236529520936,0.0248137819015639,2.9564173707372e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.0844334134151696,0.0126931107682475,0.0595549163094046,0.109311910520935,3.02633871135168e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPIND1,Heparin cofactor 2,39959,0.0192635391041572,0.00289895462205327,0.0135815880449328,0.0249454901633816,3.17096126239353e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRADD,Death domain-containing protein CRADD,41997,0.048890971440238,0.00735925323012123,0.0344668351092004,0.0633151077712756,3.18219485109472e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK7,Kallikrein-7,39475,0.0261725309977284,0.00394609077884784,0.0184381930711866,0.0339068689242701,3.45661737497033e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HAO1,Hydroxyacid oxidase 1,42262,-0.0807280344312383,0.0121888128109399,-0.10461810754068,-0.0568379613217961,3.64837627566919e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.0729133543778945,0.0110195024844734,0.0513151295083265,0.0945115792474624,3.81124636997944e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL13,C-C motif chemokine 13,42275,0.0444006934988612,0.0067132227128288,0.0312427769817168,0.0575586100160057,3.88192815230052e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0347763990150463,0.00526042108825958,0.0244659736820575,0.0450868243480351,3.98915190469707e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,USO1,General vesicular transport factor p115,42070,0.0579971197496829,0.00878715538954764,0.0407742951861695,0.0752199443131962,4.25926697061205e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.071038752527763,0.0107713590460301,0.0499268887975439,0.092150616257982,4.40534918599993e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0647214680530819,0.00981760256610129,0.0454789670235234,0.0839639690826404,4.52027406625686e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.0619599626937149,0.00940624952175495,0.0435237136310752,0.0803962117563546,4.64913510851113e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0286950341339409,0.00438006185243159,0.020110112903175,0.0372799553647068,5.95822543007757e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.0643554527180378,0.00982466088024428,0.045099117392759,0.0836117880433166,5.98685799804396e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,B2M,Beta-2-microglobulin,39979,-0.0197848027480783,0.00302467152808106,-0.0257131589431172,-0.0138564465530394,6.36686397263172e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.0572703036512599,0.00875546527161619,0.0401095917188921,0.0744310155836276,6.37671166508414e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLXNB3,Plexin-B3,42099,0.0309800780204077,0.00474345846100747,0.021682899436833,0.0402772566039823,6.76193605864401e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.0738923829428833,0.0113155916532765,0.0517138233024615,0.0960709425833052,6.85221201446981e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0278339650369934,0.00426445448612489,-0.0361922958297982,-0.0194756342441886,6.94900996609333e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.0214305769100779,0.00328745557107457,0.0149871639907718,0.0278739898293841,7.33559664817486e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP9,Matrix metalloproteinase-9,42125,-0.0384494056417621,0.00590043879948297,-0.0500142656887487,-0.0268845455947755,7.45838579675866e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0530319776887055,0.00813862594227386,0.0370802708418487,0.0689836845355623,7.47183056926787e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VASN,Vasorin,41975,0.0175989584195197,0.00270224985852995,0.012302548696801,0.0228953681422384,7.64474850412424e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLA2,Src-like-adapter 2,39934,0.0690512214495498,0.010602222463573,0.0482708654209467,0.0898315774781529,7.68319800803778e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.0479600360793152,0.00736476851922812,0.0335250897816281,0.0623949823770023,7.73319023944736e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.0779833882905233,0.0119797274668899,0.054503122455419,0.101463654125628,7.80039757496842e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOLR1,Folate receptor alpha,42110,-0.0189238168286946,0.00290939301119261,-0.0246262271306321,-0.0132214065267571,8.07574987255808e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTSS2,Protein MTSS 2,39919,0.0647723007901478,0.00996282112721152,0.0452451713808132,0.0842994301994824,8.29226849702352e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CBS,Cystathionine beta-synthase,39638,-0.0333166666040764,0.00513018357025093,-0.0433718264017682,-0.0232615068063846,8.70369991289859e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAL,Galanin peptides,42185,0.0426227325834194,0.00656500853515226,0.029755315854521,0.0554901493123178,8.74092252699504e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DBN1,Drebrin,39657,0.0329603405388654,0.00507626158175902,0.0230108678386178,0.0429098132391131,8.77303502666167e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EHD3,EH domain-containing protein 3,39638,0.0760300672159148,0.0117178139547675,0.0530631518645705,0.0989969825672592,9.04567386671835e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VNN1,Pantetheinase,39990,0.0471138510222005,0.00726533293377284,0.0328737984720057,0.0613539035723952,9.25579085844528e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,POMC,Pro-opiomelanocortin,39638,0.0472334152932581,0.00728420110577712,0.032956381125935,0.0615104494605813,9.29122718795588e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MESD,LRP chaperone MESD,42137,0.0778824172051549,0.0120134377187964,0.0543360792763139,0.101428755133996,9.3070408229261e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0258350368715781,0.00398582861679927,0.0180228127826515,0.0336472609605046,9.37829426024104e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLIN1,Perilipin-1,41839,0.0216224368754684,0.00333802265167329,0.0150799124781888,0.0281649612727481,9.64759484658044e-11
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP20,Centrosomal protein 20,41843,0.0478645908520932,0.00740662330727836,0.0333476091698276,0.0623815725343588,1.06660899096119e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.0518826012077521,0.00803313859424714,0.0361376495630277,0.0676275528524765,1.09273814341022e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MITD1,MIT domain-containing protein 1,42016,0.0615037926534776,0.00952476499659149,0.0428352532601583,0.080172332046797,1.10295127961162e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100P,Protein S100-P,41900,-0.0340993091141001,0.00528112620039995,-0.044450316466884,-0.0237483017613162,1.10636920973644e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL6,Interleukin-6,42070,-0.0476108736134474,0.00737391118834148,-0.0620637395425967,-0.033158007684298,1.10706176044651e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMOX2,Heme oxygenase 2,41839,0.0303475058684851,0.00470228317289383,0.0211310308496132,0.0395639808873571,1.12894147249678e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0178945032110357,0.00277299187120974,0.0124594391434646,0.0233295672786068,1.14014823600736e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OPHN1,Oligophrenin-1,39929,0.0695010009640535,0.0107714245204883,0.0483890089038965,0.0906129930242105,1.14620007925227e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DSG2,Desmoglein-2,42137,-0.0171907223490994,0.00266703256818594,-0.0224181061827438,-0.0119633385154549,1.19017652176155e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0388329895521639,0.00602720036478932,0.0270196768371768,0.050646302267151,1.21168941765399e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HLA_E,,42119,-0.0186277013079839,0.00289133819807798,-0.0242947241762168,-0.0129606784397511,1.21431523085695e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0243139731174074,0.00377345597563087,-0.0317099468296439,-0.0169179994051709,1.21543738355266e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SELE,E-selectin,42310,-0.0320543260199389,0.00497789313919502,-0.0418109965727612,-0.0222976554671167,1.23996524723185e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.0574924896074274,0.00893104032927756,0.0399876505620434,0.0749973286528114,1.25745294003009e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0145277438106301,0.00225883806142748,0.0101004212102322,0.0189550664110279,1.30531205279719e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.0550009777693304,0.00855756092755823,0.0382281583513162,0.0717737971873445,1.35212405500223e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STAB2,Stabilin-2,39966,0.0179002858861791,0.00278605623160148,0.0124396156722402,0.023360956100118,1.37179968059515e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBCC,Tubulin-specific chaperone C,42016,0.0508843416514513,0.00792646380802346,0.0353484725877253,0.0664202107151773,1.41276293711547e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0327733701256466,0.00510838550728753,0.022760934531363,0.0427858057199301,1.45038643475451e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUGT1,Protein SGT1 homolog,41843,0.0504700174287725,0.0078675503882164,0.0350496186678683,0.0658904161896766,1.45650051805066e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FKBPL,FK506-binding protein-like,39930,0.0377915013323028,0.00589120743098388,0.0262447347675744,0.0493382678970312,1.46530623769602e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0364514420302572,0.00568380170153046,0.0253111906952575,0.0475916933652569,1.48306020690507e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.0441629356214146,0.00690118486384069,0.0306366132882868,0.0576892579545423,1.61291309480371e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.0496536334830949,0.00777179668814369,0.0344209119743333,0.0648863549918566,1.73572782552224e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENO3,Beta-enolase,39638,0.0398518160614668,0.00624112743723677,0.0276192062844827,0.0520844258384508,1.77869083890663e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.0718303207309996,0.0112670868613749,0.0497468304827048,0.0939138109792944,1.88640285301648e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSPN,Persephin,42119,0.0542558026421275,0.00851750600309011,0.0375614908760709,0.0709501144081841,1.95255393502792e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0489347917599549,0.00768364843386677,0.033874840829576,0.0639947426903338,1.96815497127512e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0376921276568762,0.00592338404169158,-0.0493019603785917,-0.0260822949351607,2.03796512854079e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.062585151122283,0.00983390151396936,0.043310704154903,0.0818595980896629,2.04098347171505e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0290550725421454,0.00456768737486888,0.0201024052874024,0.0380077397968884,2.06945556788373e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SELENOP,Selenoprotein P,39979,0.0142903684855364,0.00224740074232268,0.00988546303058391,0.0186952739404888,2.11370809752377e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0238042366786743,0.00374840075920688,-0.0311511021667198,-0.0164573711906289,2.23044819696505e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERBIN,Erbin,42070,0.0640269059401755,0.0101149025719857,0.0442016968990835,0.0838521149812675,2.53002070426506e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL1,Growth-regulated alpha protein,42117,0.0580328812790226,0.00916901931972389,0.0400616034123638,0.0760041591456814,2.54158227158329e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0365974615351711,0.00578632722745568,-0.0479386629009842,-0.0252562601693579,2.61456153064011e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LMNB2,Lamin-B2,39929,-0.0180069471037655,0.00284680830450844,-0.023586691380602,-0.012427202826929,2.62245715350595e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BIN2,Bridging integrator 2,42137,0.0556388125155503,0.00879852211608903,0.0383937091680158,0.0728839158630848,2.63474161876222e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0324334662937573,0.00513052872217619,0.022377629998292,0.0424893025892226,2.66817487619909e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.020406620161205,0.00323052803325408,0.014074785216027,0.026738455106383,2.75327058205741e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MGLL,Monoglyceride lipase,42166,0.0543062013714707,0.00860009661207959,0.0374500120117947,0.0711623907311467,2.79297613129646e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOXO1,Forkhead box protein O1,42119,0.0539015392248555,0.00853792403056351,0.037167208124951,0.07063587032476,2.81883818768362e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0331099378578015,0.00525169482229441,0.0228166160061045,0.0434032597094986,2.97916436734607e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPART,Spartin,39736,0.0487402814901974,0.00774251444900468,0.0335649531701482,0.0639156098102465,3.18658351960134e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CBLN4,Cerebellin-4,42262,0.0197004247171684,0.00313096565521917,0.0135637320329388,0.0258371174013979,3.22706601244603e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.0605716648368959,0.00963044293466699,0.0416959966849486,0.0794473329888432,3.28286272082592e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0153539708994339,0.0024415210864705,0.0105685895699517,0.0201393522289161,3.31941406877806e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0531859926060275,0.0084634180810411,0.0365976931671869,0.069774292044868,3.41593252187798e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMED8,Protein TMED8,39930,0.0644054123095253,0.0102578367022739,0.0443000523730685,0.0845107722459821,3.54009275552801e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0215083636813351,0.00342994720954405,-0.0282310602120415,-0.0147856671506288,3.70210952674316e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.0551126585902507,0.00879026509778646,0.0378837389985893,0.0723415781819122,3.74779335599129e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SELL,L-selectin,39979,0.0145051346662148,0.00231488675528372,0.00996795662585868,0.0190423127065709,3.83767694229335e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0411821298376712,0.00657444457213306,0.0282962184762904,0.054068041199052,3.88892921674469e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FETUB,Fetuin-B,42199,0.0198810572329825,0.0031745038604454,0.0136590296665095,0.0261030847994555,3.89682723110277e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GMFG,Glia maturation factor gamma,39958,0.0446730692516658,0.00713873401028006,0.0306811505915169,0.0586649879118147,4.04398624575054e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0389427062414451,0.00622544638287166,0.0267408313310167,0.0511445811518736,4.08678765155707e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCRL6,Fc receptor-like protein 6,42119,-0.0423030914697919,0.00676296673744525,-0.0555585062751846,-0.0290476766643992,4.09208113262318e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0444111006132628,0.00710734015112241,0.0304807139170628,0.0583414873094627,4.28960237021942e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPHS1,Nephrin,39657,0.020679080243984,0.00331210774988999,0.0141873490541996,0.0271708114337684,4.43633602908323e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGF,Placenta growth factor,42296,-0.016123322763547,0.00258301293046168,-0.0211860281072519,-0.0110606174198421,4.44579468053102e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.018270886297948,0.00292771823681494,0.0125325585537907,0.0240092140421053,4.48684691446731e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUDC,Nuclear migration protein nudC,42296,0.0390328442670584,0.00626299127888179,0.0267573813604501,0.0513083071736667,4.73105696741347e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCN2,CCN family member 2,42146,0.0346697743701077,0.00556759752683327,0.0237572832175145,0.0455822655227009,4.89302177289545e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0321738545424325,0.00516717793316486,0.0220461857934294,0.0423015232914357,4.93611771058457e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRP,Gastrin-releasing peptide,39638,0.0329940428547359,0.00530157704150092,0.0226029518533941,0.0433851338560777,5.04014616672978e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0376374348240635,0.00605554727249568,0.025768562169972,0.049506307478155,5.30533400198716e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MSTN,Growth/differentiation factor 8,41900,0.0330599769179832,0.00532878337999466,0.0226155614931937,0.0435043923427727,5.66642885927364e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FURIN,Furin,42181,0.0201931853946734,0.00325716636490229,0.0138091393194649,0.0265772314698819,5.82392401013018e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOB,Apolipoprotein B-100,39990,0.0140299982943652,0.00226367393474812,0.00959319738225887,0.0184667992064715,5.92037284067765e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.058147175459169,0.00938511338037165,0.0397523532336406,0.0765419976846975,5.97450838994057e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0320696833454512,0.00518134169919628,0.0219142536150265,0.0422251130758759,6.21306249036577e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0174061929205918,0.0028127241731117,-0.0229191322998907,-0.0118932535412929,6.2539450397823e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MBL2,Mannose-binding protein C,39826,0.0678569092587623,0.010965138151683,0.0463652384814637,0.0893485800360609,6.28879801887301e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.0580747579893829,0.00938927977051938,0.0396717696391649,0.0764777463396009,6.41558579626608e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BID,BH3-interacting domain death agonist,42119,0.0403311182353978,0.00652603058871082,0.0275400982815246,0.053122138189271,6.59269290579365e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.0548121963709393,0.00887386367252174,0.0374194235727967,0.0722049691690819,6.73014152889504e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CETN3,Centrin-3,39930,0.0482411886692871,0.00780924936715373,0.0329350599096658,0.0635473174289084,6.73828039976221e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0181197748083269,0.00293783716334004,-0.0238779356484734,-0.0123616139681804,7.12436889769173e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTC,Probetacellulin,41843,0.0445759890236442,0.00722745133506444,0.0304101844069179,0.0587417936403705,7.1354215734579e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.0403605653368368,0.00654458413916139,0.0275331804240805,0.0531879502495931,7.16141882090173e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0166340657774437,0.00269765222742537,0.01134666741169,0.0219214641431974,7.23582447008551e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0371995371853968,0.00603734657037361,-0.0490327364633291,-0.0253663379074645,7.4079060221288e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRSS53,Serine protease 53,39929,0.0233478033758654,0.00379138577106682,0.0159166872645745,0.0307789194871564,7.61081376858356e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.0479332202045297,0.00778980665420625,0.0326651991622854,0.0632012412467739,7.84417837354256e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRKL,Crk-like protein,42143,0.0639597491321463,0.0103971062750689,0.0435814208330113,0.0843380774312812,7.88213451596556e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADM,Pro-adrenomedullin,42262,-0.0158784206144469,0.00258131346656164,-0.0209377950089077,-0.0108190462199861,7.89970975574771e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0246795399263535,0.00401331075585475,-0.0325456290078289,-0.0168134508448782,7.99644178201775e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.027993183868663,0.00455697252463174,0.0190615177203848,0.0369248500169412,8.33308589717077e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0470644975038682,0.00766690945826966,0.0320373549656596,0.0620916400420767,8.60829238971279e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0407278266673664,0.00663472706569828,0.0277237616185978,0.053731891716135,8.60895170472709e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0240481264201148,0.00391933976969537,0.0163662204715119,0.0317300323687177,8.71188206318812e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFB,Complement factor B,39794,0.0199743689256874,0.00325817664426485,0.0135883427029283,0.0263603951484465,9.05340956502227e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.0730198423620616,0.0119211008634509,0.0496544846696979,0.0963852000544254,9.35913184983183e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BMP10,Bone morphogenetic protein 10,39736,0.0172266010027435,0.00281411419128347,0.0117109371878279,0.0227422648176592,9.58193880307077e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.0532070602688032,0.00869697941982569,0.0361609806059449,0.0702531399316615,9.74339057958427e-10
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.0626428693558791,0.0102511137415485,0.0425506864224441,0.0827350522893141,1.01820505933781e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTF1,Cardiotrophin-1,41900,0.050953488511945,0.00834267172638006,0.0346018519282401,0.0673051250956499,1.03976185900107e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0299010122978174,0.00490009174133539,-0.0395051921108348,-0.0202968324848,1.07521476311705e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCTD,Deoxycytidylate deaminase,39736,0.0581842289485167,0.0095354658734293,0.0394947158365953,0.0768737420604382,1.08315750913151e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0222358156966057,0.00364618087996707,0.0150893011718703,0.0293823302213412,1.10051885656051e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.0441245773646124,0.00723696187302396,0.0299401320934854,0.0583090226357393,1.1161239055746e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.0290577597002331,0.00477017922920733,0.0197082084109867,0.0384073109894794,1.1483560253745e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,39919,-0.0341869891838142,0.00561153768519722,-0.0451856030468007,-0.0231883753208276,1.14939856580862e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0192863728151413,0.00316600853535122,0.0130809960858529,0.0254917495444297,1.15440887180894e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.0461844723626531,0.00758830468419586,0.0313113951816292,0.061057549543677,1.18748539250049e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VGF,Neurosecretory protein VGF,39934,0.0182448012457927,0.00299818756612786,0.0123683536161821,0.0241212488754033,1.20046937465952e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0285904785717409,0.00470181134788632,0.0193749283298837,0.0378060288135981,1.23486301420759e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.0408972866621023,0.00672741548114489,0.0277115523190583,0.0540830210051462,1.24105293919886e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0261036585901852,0.00429843873986235,-0.0345285985203155,-0.017678718660055,1.29696589404622e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0221819629323134,0.00365508684687089,-0.0293459331521803,-0.0150179927124465,1.32333885105436e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CKB,Creatine kinase B-type,39966,-0.0345523693336586,0.00569435564585229,-0.0457133063995291,-0.0233914322677881,1.33781047776703e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0528055344373949,0.00870528013667265,0.0357431853695165,0.0698678835052733,1.35461014553097e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0257165123851919,0.00424081989673269,0.0174045053875959,0.034028519382788,1.3632036297731e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEXN,Nexilin,39990,0.0419628584005216,0.00692656091886404,0.0283867989995481,0.0555389178014951,1.41953866486588e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.0646718369590275,0.0107010575212886,0.0436977642173018,0.0856459097007532,1.55553890327013e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0337513997258281,0.00558755050724861,0.0227998007316208,0.0447029987200354,1.57719445165724e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL17RB,Interleukin-17 receptor B,41934,0.0320691895489287,0.0053204221735948,0.0216411620886829,0.0424972170091746,1.70841229379984e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0332892660708136,0.00552689836143294,0.0224565452824051,0.0441219868592222,1.76374961216034e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0372230274524819,0.00618132115492072,0.0251076379888373,0.0493384169161265,1.77779303168946e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0343852211218329,0.00571548539995497,0.0231828697379212,0.0455875725057446,1.83324546639444e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GH1,Somatotropin,42129,-0.10543670300939,0.0175273813400842,-0.139790370435955,-0.0710830355828245,1.83911518438072e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LPP,Lipoma-preferred partner,39575,0.0394800116422898,0.0065649704158087,0.0266126696273048,0.0523473536572749,1.87067823261329e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0205309935044787,0.00341452737964079,-0.0272234671685747,-0.0138385198403828,1.87082649647721e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.00987720646520975,0.00164332895935589,0.00665628170487221,0.0130981312255473,1.9063476039894e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP7,Caspase-7,39929,0.0504007535964879,0.0083958074089952,0.0339449710748573,0.0668565361181184,1.99531498403678e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOE,Apolipoprotein E,39979,0.0416539603114634,0.00694078198113142,0.0280500276284458,0.055257892994481,2.01661508884776e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLAMF8,SLAM family member 8,41843,-0.0318453848894314,0.00530798591027101,-0.0422490372735626,-0.0214417325053003,2.0306084617189e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0189945606252698,0.00316616279328264,-0.0252002397001038,-0.0127888815504358,2.0327992519147e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0336298536876221,0.00560868873790579,-0.0446228836139175,-0.0226368237613268,2.07357131267243e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0251888969163153,0.00420124169504075,0.0169544631940354,0.0334233306385951,2.07855454089094e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0239235119091362,0.00399236116098752,0.0160984840336006,0.0317485397846717,2.13362900877502e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0163900974556626,0.00274099156288506,-0.0217624409189174,-0.0110177539924079,2.29268326445844e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THY1,Thy-1 membrane glycoprotein,42249,-0.0172103146002258,0.00288075040326466,-0.0228565853906246,-0.0115640438098271,2.3690827030742e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ISM1,Isthmin-1,42119,0.0232377348332698,0.00389189302404569,0.0156096245061402,0.0308658451603993,2.42004934744276e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLC,Galectin-10,42119,-0.0395325615031082,0.0066276400329676,-0.0525227359677247,-0.0265423870384917,2.51047457903213e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK6,Kallikrein-6,42158,0.018147348407767,0.00304614704580316,0.0121769001979928,0.0241177966175412,2.62510986060141e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RLN2,Prorelaxin H2,39709,0.0305222116895608,0.00512348357419923,0.0204801838841303,0.0405642394949913,2.641859862445e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNX15,Sorting nexin-15,39736,0.0319678569840616,0.00537135142255358,0.0214400081958566,0.0424957057722667,2.7361843278869e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0329095765413657,0.00553729547992469,0.0220564774007133,0.0437626756820181,2.8634440348741e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.0431088145750787,0.00725565136154172,0.028887737906457,0.0573298912437005,2.90882192850272e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SELP,P-selectin,42217,0.0327029217403837,0.00550633943055337,0.0219104964564991,0.0434953470242683,2.93504607817582e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.0463322799035032,0.00782377871231026,0.0309976736273751,0.0616668861796314,3.25864998295748e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0327229257509763,0.00553003970647946,0.0218840479262766,0.0435618035756761,3.35104958370343e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRYBB1,Beta-crystallin B1,39958,0.0387516371653195,0.00655849030215803,0.0258969961730897,0.0516062781575492,3.54880926066862e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0426822152725049,0.00722506742809293,0.0285210831134428,0.0568433474315671,3.57540433200849e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SH2B3,SH2B adapter protein 3,41843,0.0572894820825007,0.0097106919380854,0.0382565258838533,0.0763224382811481,3.7321589826218e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F12,Coagulation factor XII,39979,0.0241997612069114,0.00410157519651773,0.0161606738217366,0.0322388485920861,3.73594978160711e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL8,C-C motif chemokine 8,42239,0.0351701905228724,0.00597831669853636,0.0234526897937411,0.0468876912520037,4.12443077909099e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.0796184136322049,0.0135348840759422,0.0530900408433583,0.106146786421052,4.13805225145918e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTGR1,Prostaglandin reductase 1,39958,-0.0487770260877371,0.00829343504534021,-0.065032158776604,-0.0325218933988703,4.18267588856822e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.0642720251013225,0.0109400735293264,0.0428294809838427,0.0857145692188023,4.34978314285497e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GP6,Platelet glycoprotein VI,42115,0.0508808180645688,0.00868791589752199,0.0338525029054257,0.0679091332237119,4.83697942208341e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOXJ3,Forkhead box protein J3,39657,0.026337167115627,0.0045059767037228,0.0175054527763304,0.0351688814549237,5.21064411518318e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NECTIN4,Nectin-4,42181,-0.0193720962478387,0.00331600900135915,-0.0258714738905026,-0.0128727186051748,5.27618453764805e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0484837264438438,0.00830334384351058,0.0322091725105631,0.0647582803771246,5.37269520242996e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPRY2,Protein sprouty homolog 2,41913,0.0534174306826786,0.00916533863729261,0.0354533669535851,0.0713814944117721,5.73254981896904e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.0652617245785399,0.0112117577631926,0.0432866793626824,0.0872367697943975,5.98765688549145e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0192232795001362,0.0033064520243441,-0.0257039254678506,-0.0127426335324218,6.24088134101903e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0178468340568264,0.00306930677380273,0.011830992780173,0.0238626753334797,6.24109494504716e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OXT,Oxytocin-neurophysin 1,42249,-0.0828309967722158,0.014276346135613,-0.110812635198017,-0.0548493583464144,6.69922372459088e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0210802601304711,0.00363382362527229,0.0139579658249374,0.0282025544360048,6.735187220865e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRGN,Neurogranin,39990,0.0531651775622487,0.00917628863861467,0.0351796518305639,0.0711507032939334,7.06521456184405e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1R9B,Neurabin-2,42296,0.0541342760933291,0.00934951046101063,0.0358092355897482,0.0724593165969099,7.1901800557373e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACHE,Acetylcholinesterase,39736,-0.0197331075475859,0.00340935856347006,-0.0264154503319873,-0.0130507647631846,7.31847476904699e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0191111834045319,0.00330284401709598,-0.02558475767804,-0.0126376091310238,7.35340301137402e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EGF,Pro-epidermal growth factor,42081,0.0593282974370984,0.0102563722197283,0.0392258078864309,0.0794307869877659,7.43291374861229e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0181553053457098,0.00313899052170032,-0.0243077267682425,-0.0120028839231772,7.50129812864285e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCR,Breakpoint cluster region protein,42119,0.0526149656247112,0.00910030588716855,0.0347783660858608,0.0704515651635615,7.55965246400357e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0382163030869703,0.00661831287901261,0.0252444098441056,0.051188196329835,7.92904585689662e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0169221376653245,0.00294424863499324,-0.0226928649899113,-0.0111514103407378,9.28963052070518e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0202090975692504,0.00351941530199592,-0.0271071515611624,-0.0133110435773384,9.55204619836452e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EREG,Proepiregulin,41997,0.0454255568926722,0.00791176082102026,0.0299185056834725,0.0609326081018719,9.58640644614436e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0154318557570931,0.00268781856508181,0.0101637313695328,0.0206999801446535,9.63132512741719e-09
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP2,Caspase-2,42119,0.0386052887816065,0.00673456573131579,0.0254055399482276,0.0518050376149855,1.01128796345953e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0192992280393024,0.00336636821239299,-0.0258973097355926,-0.0127011463430121,1.01281192586869e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL12B,Interleukin-12 subunit beta,42296,-0.0309926839360928,0.00540766279629772,-0.0415917030168364,-0.0203936648553493,1.01791396686669e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL25,C-C motif chemokine 25,42296,-0.0277300601779207,0.00484637120761012,-0.0372289477448365,-0.0182311726110049,1.07595094537196e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARSB,Arylsulfatase B,42070,0.0313758593625933,0.00548350328906145,0.0206281929160328,0.0421235258091537,1.07604244730186e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0173109756056016,0.00302515565910232,-0.0232402806974422,-0.0113816705137611,1.07771205534432e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0262582391469782,0.00458975477641126,0.0172623197852121,0.0352541585087442,1.0815560497239e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD36,Platelet glycoprotein 4,39657,0.0264990817890366,0.00463322562263758,0.017417959568667,0.0355802040094063,1.09699651751202e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.0481421592345605,0.00841949665679386,0.0316399457872445,0.0646443726818765,1.10623076435686e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0436807522600011,0.00764179172946218,-0.0586586640497469,-0.0287028404702552,1.11783897359872e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0346757048456296,0.00606627705794626,0.0227858018120549,0.0465656078792042,1.11791228884094e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0231464258599617,0.00405227439640251,-0.0310888836769107,-0.0152039680430128,1.14479542426648e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.0494590084214799,0.0086589279567625,0.0324875096262254,0.0664305072167344,1.14577701858157e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.0585029381229876,0.0102548999460871,0.038403334228657,0.0786025420173183,1.18867796552742e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0301417575368724,0.00528511187032961,-0.0405005768027185,-0.0197829382710264,1.20124335170984e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM13A,Protein FAM13A,39930,0.0384788715730187,0.00674674076811226,0.0252552596675187,0.0517024834785187,1.20431293834021e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSPB1,Heat shock protein beta-1,41949,0.0393928564921329,0.00690817357359086,0.0258528362878948,0.052932876696371,1.20667793211721e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0488893676251224,0.00857264514513431,0.0320869831406591,0.0656917521095856,1.20755646377675e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0370911972836111,0.00650811839626174,0.0243352852269381,0.0498471093402841,1.22909103957865e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0396965996266163,0.00696872248647633,0.0260379035531227,0.05335529570011,1.25419704212795e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0398085816254871,0.00699164596741298,0.0261049555293576,0.0535122077216165,1.27480664334106e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.0507266758376806,0.0089151358959761,0.0332530094815674,0.0682003421937937,1.30227967355465e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICA1,Islet cell autoantigen 1,41913,0.0448585304624166,0.00789273508407507,0.0293887696976295,0.0603282912272038,1.34716872093032e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NID1,Nidogen-1,42189,0.0202069451275561,0.00355601363797921,0.0132371583971168,0.0271767318579953,1.35488131622954e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINB6,Serpin B6,42216,0.0326864610499173,0.00577249632374372,0.0213723682553797,0.044000553844455,1.52244270980484e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRAP,BRCA1-associated protein,39813,0.0618538449008065,0.0109272231867214,0.0404364874548326,0.0832712023467804,1.54613702547771e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.0669336129450908,0.0118332103180346,0.0437405207217429,0.0901267051684387,1.57695630364435e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C3,Complement C3,39445,0.0259039467686736,0.00458048007511782,0.0169262058214426,0.0348816877159045,1.59519151469297e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD226,CD226 antigen,39657,0.0239570329074946,0.00423856311286916,0.015649449206271,0.0322646166087181,1.62367583925947e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.0133157878177516,0.00235627631251472,0.00869748624522276,0.0179340893902805,1.62544007292287e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA3,Annexin A3,42224,0.038665170397266,0.00684473557836942,0.025249488663662,0.0520808521308701,1.64716538703546e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGR3,Anterior gradient protein 3,41827,0.0329480061537937,0.00583571039159121,0.0215100137862749,0.0443859985213125,1.6767145707888e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0159374473488041,0.00283718933048252,-0.0214983384365498,-0.0103765562610583,1.97773997168187e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0458187607797548,0.00815685321413056,0.0298313284800589,0.0618061930794507,1.97893052528203e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0164335518928244,0.00292745971777491,0.0106957308459855,0.0221713729396632,2.02115298496338e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOA4,Apolipoprotein A-IV,39979,-0.0191738544262007,0.00342062974837503,-0.0258782887330157,-0.0124694201193856,2.12662594918871e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYL3,Myosin light chain 3,39638,-0.043659014196059,0.00779669162060175,-0.0589405297724384,-0.0283774986196796,2.19876341695175e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0340265816964965,0.00607862639475784,0.0221124739627711,0.0459406894302219,2.22195650864282e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FADD,FAS-associated death domain protein,42145,0.0421462257987235,0.00753172985421728,0.0273840352844577,0.0569084163129894,2.23836608126061e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0396652264160341,0.00709527666145957,0.0257584841595734,0.0535719686724949,2.31065360007081e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0188205690517204,0.00336695250211159,0.0122213421475817,0.0254197959558591,2.31740735566369e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.0403403092474732,0.00721718418570235,0.0261946282434966,0.0544859902514498,2.32248914175198e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0304548959645771,0.00545373511488189,0.0197655751394086,0.0411442167897456,2.39207497489646e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.0450003843943218,0.00805803852439142,0.0292066288865147,0.060794139902129,2.39725729853021e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPON1,Spondin-1,42144,-0.0179536719964323,0.00321618480429023,-0.0242573942128412,-0.0116499497800235,2.41934745662342e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0141644488587002,0.00254352647928262,-0.0191497607580941,-0.00917913695930622,2.62292794499559e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.070937731533728,0.0127415281790106,0.0459643363028673,0.0959111267645888,2.63419537410738e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0553245284544544,0.00994724227818474,0.0358279335892123,0.0748211233196965,2.73065174166051e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBP2,Retinol-binding protein 2,42070,-0.0427919625956553,0.0076967050661393,-0.0578775045252883,-0.0277064206660223,2.7525658301545e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFA,Protransforming growth factor alpha,42119,-0.0247730179418554,0.00446027208953868,-0.0335151512373512,-0.0160308846463596,2.84231397842384e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0166101912970128,0.00299220297365774,-0.022474909125382,-0.0107454734686436,2.89169247030316e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.0290024924036948,0.005228452536409,0.0187547254323331,0.0392502593750564,2.95983704729332e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CORO1A,Coronin-1A,41883,0.048491259071411,0.00875140726569758,0.0313385008306438,0.0656440173121783,3.06530909497749e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0192571134118668,0.00347865607935155,0.0124389474963377,0.0260752793273958,3.15721532314419e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.0533046242211019,0.00964946631368613,0.0343916702462771,0.0722175781959267,3.37318571156128e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDHD2,Phospholipase DDHD2,39934,0.0363690640164115,0.00659408252224123,0.0234446622728187,0.0492934657600043,3.55601735604193e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOMO1,Nodal modulator 1,42137,0.0126388206662907,0.00229502310965547,0.00814057537136602,0.0171370659612155,3.71535929774817e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.0515234171367729,0.00935746888908014,0.0331827781141758,0.06986405615937,3.73555914954836e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.023547276257968,0.00428355044547234,0.0151515173848422,0.0319430351310938,3.9314379699573e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSF,Cathepsin F,42181,-0.0218569702931043,0.00397674839560126,-0.0296513971484827,-0.0140625434377258,3.9507844803399e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.0357173844514299,0.00649905420419752,0.0229792382112028,0.048455530691657,3.95992287667917e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.0366124420348531,0.00666257230068014,0.02355380032552,0.0496710837441861,3.97265206187581e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTSS1,Protein MTSS 1,39930,0.0607803973718225,0.0110730251490423,0.0390772680796996,0.0824835266639453,4.1280150761246e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.0469158731224079,0.00855179464077795,0.0301543556264832,0.0636773906183327,4.19778300160297e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.0790193155205881,0.0144319602880255,0.0507326733560582,0.107305957685118,4.44681630237156e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CES3,Carboxylesterase 3,42070,0.0384019273533921,0.00701637737665704,0.0246498276951443,0.0521540270116399,4.49924776283378e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.0492706102201576,0.00900737968358171,0.0316161460403375,0.0669250743999778,4.57966756970624e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0147084671795445,0.00269041182194275,-0.0199816743505523,-0.00943526000853671,4.65791025591851e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0237817989497901,0.00435081371758496,0.0152542040633236,0.0323093938362567,4.6991173832607e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0350410278001289,0.00641806910291181,-0.047620443241836,-0.0224616123584217,4.87128987001231e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0355988904858517,0.00652132572257576,0.0228170920696032,0.0483806889021001,4.89677853156799e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATXN2L,Ataxin-2-like protein,39934,0.026096442397264,0.00478162847729632,0.0167244505817632,0.0354684342127648,4.92640122624902e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PVR,Poliovirus receptor,42249,-0.0201111257281568,0.00368570242271477,-0.0273351024766778,-0.0128871489796359,4.94011478179691e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH6,Cadherin-6,42145,-0.020968559118388,0.0038429684560912,-0.0285007772923268,-0.0134363409444493,4.94577343447525e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEL1L,Protein sel-1 homolog 1,39638,-0.0170004056668426,0.00311918379566347,-0.023114005906343,-0.0108868054273422,5.13738245617087e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.0320682784387012,0.00589112049935637,0.0205216822599628,0.0436148746174397,5.3334589784884e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0143605830166835,0.00264295103507844,0.00918039898792976,0.0195407670454373,5.62069156522151e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.0364938034649935,0.00671902789783196,0.0233245087852429,0.0496630981447442,5.71030897883377e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.0348399966372842,0.00641662624473176,0.0222634091976099,0.0474165840769584,5.7462272070857e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CACYBP,Calcyclin-binding protein,39713,0.0560588207351555,0.0103305830575844,0.0358108779422901,0.076306763528021,5.86792231614027e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.0557452401302537,0.0102783894194658,0.0355995968681008,0.0758908833924067,5.94353835685302e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0411109378661306,0.00759296064029221,0.0262287350111579,0.0559931407211033,6.27671511878854e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNXB,Tenascin-X,42137,0.0139582303151026,0.00257902128051886,0.00890334860528569,0.0190131120249196,6.33084428698098e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RP2,Protein XRP2,42070,0.0227661290286805,0.00420674442708785,0.0145209099515883,0.0310113481057727,6.34562643422955e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASC3,Protein CASC3,39649,0.0231634530192225,0.00427994536006905,0.0147747601134872,0.0315521459249578,6.35949702273663e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.0463667744375583,0.00857362217744342,0.0295624749697692,0.0631710739053474,6.47876857359763e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL15,Interleukin-15,42119,-0.0175129602248113,0.00324681046125331,-0.0238767087288678,-0.0111492117207548,7.01063199405773e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0451505576478162,0.00837387168180627,0.0287377691514759,0.0615633461441565,7.09377656266846e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CERT,Ceramide transfer protein,41839,0.0325532088842346,0.0060420755504162,0.0207107408054188,0.0443956769630503,7.25650764247998e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OSM,Oncostatin-M,42051,-0.0366551484200569,0.00680830695300246,-0.0499994300479417,-0.0233108667921721,7.41189389319385e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP8,Neutrophil collagenase,42224,-0.0379670831133323,0.00705374089058803,-0.0517924152588848,-0.0241417509677797,7.46561550505162e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.0451262805477096,0.00838606424865138,-0.0615629664750663,-0.0286895946203529,7.5269632494923e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0200458084748576,0.00373053450413171,-0.0273576561029558,-0.0127339608467595,7.8528975699615e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COLEC12,Collectin-12,42123,-0.0144346609418945,0.0026981136457961,-0.0197229636876549,-0.00914635819613414,8.94328770397849e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.0161249102161792,0.00301620205950513,0.0102131541795492,0.0220366662528093,9.16163592203409e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBCB,Tubulin-folding cofactor B,42016,0.052734451059969,0.00986537211890324,0.0333983217069187,0.0720705804130193,9.16901706932604e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0383098123541516,0.00718665258886991,0.0242239732799666,0.0523956514283366,9.97526926240559e-08
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.0771755749930698,0.0145027487821649,0.0487501873800266,0.105600962606113,1.04910164037145e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASAH2,Neutral ceramidase,42016,0.0278805024322976,0.00524675585707116,0.0175968609524381,0.038164143912157,1.09047070608356e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0255807832723824,0.00481603575089664,-0.0350202133441398,-0.016141353200625,1.10390982433644e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DLG4,Disks large homolog 4,39929,0.0380448379821456,0.00716667407747937,0.023998156790286,0.0520915191740052,1.12572565225124e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMTN,Smoothelin,39897,0.0488338774376433,0.00920174467995259,0.0307984578649362,0.0668692970103504,1.1353901668091e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.0456260048857297,0.00859904699189931,0.028771872781607,0.0624801369898523,1.13871424434401e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYDGF,Myeloid-derived growth factor,39958,0.0523088524070571,0.00986982399912654,0.0329639973687691,0.0716537074453451,1.18051058843007e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.0113093022248142,0.00213519826053631,-0.0154942908154654,-0.00712431363416307,1.20185064425698e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MICALL2,MICAL-like protein 2,39649,0.0359762855086151,0.00679304547560202,0.0226619163764351,0.049290654640795,1.20608969133282e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD300C,CMRF35-like molecule 6,42249,-0.0183914375398364,0.00347340695081418,-0.0251993151634322,-0.0115835599162406,1.20910204966622e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARFIP1,Arfaptin-1,39934,0.0364077334480485,0.00688219834154572,0.0229186246986189,0.0498968421974781,1.24506161581594e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA3,Carbonic anhydrase 3,42287,-0.0306896510288628,0.00580355278115148,-0.0420646144799197,-0.0193146875778059,1.25508933128042e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UPB1,Beta-ureidopropionase,39958,-0.0475256929301418,0.00898773196575355,-0.0651416475830188,-0.0299097382772649,1.26066379518664e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LCN15,Lipocalin-15,39934,-0.0318550251994691,0.00602630893996318,-0.0436665907217969,-0.0200434596771412,1.27347504323667e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HEPH,Hephaestin,39958,-0.0146267315373531,0.00276780522877811,-0.0200516297857582,-0.00920183328894801,1.28315738861395e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PKD2,Polycystin-2,39575,0.0307313983480772,0.00581808762209377,0.0193279466087734,0.042134850087381,1.30194451953265e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PALM2,Paralemmin-2,39929,-0.0203294001133441,0.00385097048632989,-0.0278773022665506,-0.0127814979601375,1.32268747425285e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0283349461083012,0.00536748180892882,0.0178146817628007,0.0388552104538017,1.32328494011508e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0180372916884987,0.00342052976773165,-0.0247415300332528,-0.0113330533437447,1.36097234951384e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.034815880826131,0.00662095409379808,0.0218388108022868,0.0477929508499753,1.47544536354041e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0394324373261842,0.00750711442393568,0.0247184930552703,0.0541463815970981,1.52172589096673e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.0396528335004766,0.00755648798521556,-0.0544635499514991,-0.0248421170494541,1.56936532748055e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NXPH3,Neurexophilin-3,39657,0.0156657647859503,0.00298600782081555,0.00981318945715184,0.0215183401147488,1.57976313001142e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0304564878471838,0.0058091620731903,0.0190705301837308,0.0418424455106368,1.61043471366386e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0208709181953889,0.00398220262659512,0.0130658010472624,0.0286760353435153,1.62087538118219e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0194805998336091,0.00371824231652771,-0.0267683547740034,-0.0121928448932148,1.6373889854657e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PKLR,Pyruvate kinase PKLR,42143,-0.032198804388202,0.00614664318533523,-0.0442462250314591,-0.020151383744945,1.64369709569442e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OGN,Mimecan,42137,-0.0223354154672531,0.0042668045347607,-0.0306983523553841,-0.0139724785791221,1.67730138878478e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.0140149211205611,0.00267887996677907,0.00876431638567413,0.0192655258554481,1.71007129327127e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0335883350049969,0.00642730622732253,0.0209908147994447,0.046185855210549,1.7594710450928e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,0.027362106906888,0.00524101709672106,0.0170897133973147,0.0376345004164612,1.8080086316402e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.0375860055602997,0.00720074273758466,-0.0516994613259656,-0.0234725497946338,1.82336497459079e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0156139589973917,0.00299171612235272,-0.021477722597203,-0.00975019539758034,1.82470573875982e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.0376474503861264,0.00721511738408933,0.0235058203133113,0.0517890804589415,1.84195086847932e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DKK4,Dickkopf-related protein 4,41992,-0.0236613242807161,0.00454910482657765,-0.0325775697408083,-0.0147450788206239,2.00802262017364e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0244299069110174,0.00469931865709711,-0.0336405714789277,-0.0152192423431071,2.04378264637177e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0141586265072854,0.00272429546426831,-0.0194982456172513,-0.00881900739731955,2.05277605048063e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",39958,-0.0280254616787353,0.00539230698514198,-0.0385943833696136,-0.017456539987857,2.05707988807873e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0140206359018468,0.00270439288169717,-0.0193212459499733,-0.0087200258537204,2.19830889043565e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.057280190786663,0.0110514910258221,0.0356192683760517,0.0789411131972743,2.21509628801899e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.0424074398214854,0.00818510272064944,0.0263646384890125,0.0584502411539583,2.24421024187686e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA4,Annexin A4,42088,0.0370280804262193,0.00714872141544261,0.0230165864519518,0.0510395744004868,2.25470316860606e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0112975856283331,0.00218170645238119,0.00702144098166598,0.0155737302750003,2.27714379717712e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFC1,Cryptic protein,41843,-0.0244091286803286,0.00471685319054968,-0.033654160933806,-0.0151640964268513,2.31397376112461e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPB1,Carboxypeptidase B,42310,-0.0316664868734037,0.00612176088708624,-0.0436651382120928,-0.0196678355347147,2.3389526371255e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.0371728149594859,0.00720388040630665,0.0230532093631248,0.0512924205558469,2.50358163409707e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,41839,-0.0279602611958309,0.00542957783902959,-0.0386022337603289,-0.0173182886313329,2.64760661642894e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0135185780485065,0.0026253324891526,0.00837292636976736,0.0186642297272455,2.65849555316052e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0333139378869684,0.00647896396455215,0.0206151685164462,0.0460127072574907,2.75888164233155e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOA2,Apolipoprotein A-II,39990,-0.0252203911041964,0.0049065721049746,-0.0348372724299466,-0.0156035097784462,2.7910758514485e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0266148092330724,0.00519267895161322,-0.0367924599782343,-0.0164371584879105,3.0172656236473e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0258246867342661,0.00503903096093406,0.0159481860508353,0.0357011874176968,3.02671598309879e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL18,C-C motif chemokine 18,42020,0.0354926422101728,0.00692667031741409,0.0219163683880411,0.0490689160323044,3.03184925764711e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GMPR,GMP reductase 1,42296,0.024075306328533,0.00469858446082457,0.0148660807853168,0.0332845318717492,3.03271879849606e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0268910521415487,0.00525149391209011,0.0165981240738521,0.0371839802092453,3.08762038986115e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.0380656936110225,0.00743630709551087,0.0234905317038212,0.0526408555182239,3.1253062864838e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARF6,ADP-ribosylation factor 6,39930,0.055251138684611,0.0107951889682517,0.0340925683068377,0.0764097090623842,3.13643446877306e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0189717997064685,0.0037073330355124,0.0117054269568641,0.0262381724560728,3.14896097958625e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ABHD14B,Protein ABHD14B,41976,0.0281895154299268,0.00551538307311292,0.0173793646066255,0.0389996662532282,3.24755804640241e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.0198911451072072,0.00389899328537715,0.0122491182678679,0.0275331719465464,3.41409196170022e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0242855121920575,0.0047610874309005,0.0149537808274925,0.0336172435566225,3.4362922815262e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TP53,Cellular tumor antigen p53,41843,0.0223538123087862,0.00438405481645834,0.0137610648685278,0.0309465597490445,3.46367610078842e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNPEP,Aspartyl aminopeptidase,39929,-0.0287886634804229,0.00565401416177252,-0.0398705312374971,-0.0177067957233488,3.60527435210328e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0135959934878855,0.00267208732808017,-0.0188332846509227,-0.0083587023248484,3.66345404563813e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.050351437262844,0.00990334263584524,0.0309408856965873,0.0697619888291007,3.74903380028612e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0153011853739561,0.0030103430127619,-0.0212014576789694,-0.00940091306894278,3.76696672052173e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD40LG,CD40 ligand,42296,0.039688204136947,0.00782095164004975,0.0243591389224494,0.0550172693514445,3.93398069574526e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYOM2,Myomesin-2,39575,-0.0281009989358072,0.00554052705944713,-0.0389604319723235,-0.0172415658992908,4.00297358719862e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0216989260795042,0.004285482348493,0.0132993806764579,0.0300984714825504,4.18573200558052e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0291387067854323,0.00575891124943881,0.0178512407365322,0.0404261728343324,4.26364837583901e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.0595373265405713,0.0117785796419567,0.0364513104423362,0.0826233426388065,4.36655747045783e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ROBO2,Roundabout homolog 2,42249,0.0112651872616741,0.0022314249968538,0.00689159426784067,0.0156387802555076,4.51200890957078e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0428704317916386,0.00849471931778691,0.0262207819287762,0.0595200816545009,4.56617657432621e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0143576791911386,0.00284747943660983,-0.0199387388868939,-0.00877661949538335,4.66112888551279e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STAMBP,STAM-binding protein,41997,0.031334368069025,0.00621502418776894,0.0191529206609979,0.0435158154770521,4.67408695304419e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP3,Caspase-3,42310,0.0437689422423722,0.00868589758425069,0.0267445829772408,0.0607933015075035,4.73729176592987e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0249518828658213,0.00495713081265827,0.0152359064730111,0.0346678592586315,4.89032955094251e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFRA1,GDNF family receptor alpha-1,42247,-0.0141641475276826,0.00281735658985437,-0.0196861664437971,-0.00864212861156803,5.03321156295262e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0404398615553835,0.00804629784260067,0.0246691177838862,0.0562106053268808,5.08927368629195e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0208631734744377,0.00415241867708621,-0.0290019140815266,-0.0127244328673487,5.11717690464363e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CST3,Cystatin-C,42184,-0.0142196302806461,0.0028304821227732,-0.0197673752412816,-0.00867188532001061,5.13162461698738e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0116424326554365,0.00231817238956318,0.00709881477189266,0.0161860505389803,5.17215376772826e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0385353491981495,0.00767234811794044,0.0234975468869863,0.0535731515093128,5.17591998952996e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGA6,Integrin alpha-6,42119,0.0251689858747435,0.00502046884935481,0.015328866930008,0.0350091048194789,5.41891125329106e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXLNA,Alpha-taxilin,42016,0.0435249129031859,0.0086830073563287,0.0265062184847816,0.0605436073215901,5.4368936449481e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0179758112918449,0.00358841260555126,0.0109425225849645,0.0250090999987254,5.52878224413505e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPARCL1,SPARC-like protein 1,42169,0.0135224553005468,0.00269969256792702,0.00823105786740987,0.0188138527336838,5.54338858639585e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0109051588365271,0.0021828614766895,0.0066267503422157,0.0151835673308385,5.93335823956725e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0132893535814158,0.00266025959421373,0.00807524477675693,0.0185034623860747,5.95534981058382e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0376351088840833,0.00753623171663495,-0.0524061230486878,-0.0228640947194788,5.99127302582831e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD300E,CMRF35-like molecule 2,42232,-0.020579645534415,0.00412692782997928,-0.0286684240811743,-0.0124908669876556,6.21829388667832e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA6,Carbonic anhydrase 6,42103,0.0307301387879267,0.00617979089089277,0.0186177486417769,0.0428425289340766,6.68437676568075e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0394763757043289,0.0079441093540167,-0.0550468300382016,-0.0239059213704561,6.80301041723604e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0200557982426155,0.0040483726645483,0.0121209878201009,0.0279906086651302,7.37390838138212e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0375181977626801,0.00757794331962995,0.0226654288562054,0.0523709666691548,7.47325861551917e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IMMT,MICOS complex subunit MIC60,39919,-0.0218838536375855,0.00442298705655984,-0.0305529082684428,-0.0132147990067282,7.61543711611817e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0254268695959117,0.00514193233733523,-0.0355050569770888,-0.0153486822147347,7.70760630278871e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A4,Protein S100-A4,42181,0.0273106273356359,0.00552708903779925,0.0164775328215494,0.0381437218497225,7.85555865813441e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.0336671037888582,0.00681616847992665,0.020307413568202,0.0470267940095144,7.95522752358335e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDHR2,Cadherin-related family member 2,42070,0.0320696479136217,0.00650321095317468,0.0193233544453993,0.0448159413818441,8.26342703103098e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF19,Fibroblast growth factor 19,42185,0.0377281455371984,0.00766276113476072,0.0227091337130674,0.0527471573613294,8.59774969248051e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0196131144290165,0.00398517358106272,0.0118021742101336,0.0274240546478994,8.71042563853972e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0406006822140011,0.00825391965963728,0.0244229996811121,0.0567783647468902,8.80249541362492e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.0429531840626152,0.00873228665619289,0.0258379022164772,0.0600684659087533,8.82575929268767e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.0434083241314955,0.00883340597200324,0.0260948484263691,0.0607217998366218,9.02339855075191e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNMBP,Dynamin-binding protein,42016,0.0293660393088509,0.0059818240462659,0.0176416641781697,0.041090414439532,9.25189310752079e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCRLB,Fc receptor-like B,41843,-0.0298206856900043,0.00607727687348216,-0.0417321483620293,-0.0179092230179792,9.36203033989773e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0207388776493883,0.00422954920485435,-0.0290287940909028,-0.0124489612078738,9.53120884050347e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPM1F,Protein phosphatase 1F,39958,0.0259502836033618,0.00529192562864346,0.0155781093712206,0.036322457835503,9.53256802463809e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0269276556156614,0.00549666321326534,0.0161541957176613,0.0377011155136614,9.77038483995666e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.029327709415359,0.00599023421772464,0.0175868503486187,0.0410685684820993,9.9000573254836e-07
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WIF1,Wnt inhibitory factor 1,42262,0.0162529013134852,0.00332192718605728,0.0097419240288129,0.0227638785981575,1.00640691595653e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINH1,Serpin H1,39757,0.0626958577850636,0.012818551000677,0.0375714978237368,0.0878202177463905,1.01711948088229e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMCN2,Hemicentin-2,39721,-0.0282465226537768,0.00577655313913816,-0.0395685668064875,-0.016924478501066,1.02320423581296e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0298292304062579,0.00610442061288021,-0.0417938948075031,-0.0178645660050127,1.03821369200397e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NIT1,Deaminated glutathione amidase,39638,0.0215467248460979,0.00440998227589121,0.0129031595853512,0.0301902901068447,1.04404863207598e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0215457512264857,0.00441022360526385,0.0129017129601686,0.0301897894928028,1.04420833034834e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.034981377976477,0.00716571384214223,0.0209365788458782,0.0490261771070758,1.06337897909437e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPARC,SPARC,42181,0.033660439377385,0.00689613843618643,0.0201440080424596,0.0471768707123104,1.06718195102055e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0151878880150265,0.00311211177554057,-0.021287627095086,-0.00908814893496696,1.07157142541963e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0179213204015692,0.00367459243875633,-0.0251235215815316,-0.0107191192216068,1.08881519048709e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCDH9,Protocadherin-9,39930,0.0163945758214655,0.00336281587574784,0.00980345670499974,0.0229856949379313,1.1014416523502e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.0373099876297323,0.00765677031396451,0.0223027178143618,0.0523172574451027,1.11512122220133e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0311670220605022,0.00639737196160465,0.0186281730157571,0.0437058711052473,1.12055648512071e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0299009627239292,0.00613885018808343,0.0178688163552857,0.0419331090925727,1.12407556873434e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GC,Vitamin D-binding protein,39979,0.0124902400119249,0.00256868711017329,0.00745561327598523,0.0175248667478645,1.17462990237991e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NGF,Beta-nerve growth factor,42016,0.00583897507323458,0.00120171065529211,0.00348362218886204,0.00819432795760712,1.1938235913667e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.0438854343936606,0.00904356263657969,0.0261600516259644,0.0616108171613567,1.23473522334827e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BLNK,B-cell linker protein,39657,0.0201873208359489,0.00416543602925143,0.0120230662186161,0.0283515754532817,1.27438077228939e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.0373575925066925,0.00772244327869296,0.0222216036804543,0.0524935813329307,1.33189504615272e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.0178635320830065,0.00369319369724989,0.0106248724363968,0.0251021917296163,1.33656464299816e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.0504695709523903,0.0104351996868627,0.0300165795661393,0.0709225623386412,1.33931979376481e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CYTL1,Cytokine-like protein 1,39966,0.0122368080956308,0.00253209073980784,0.00727391024560747,0.0171997059456542,1.36462175586031e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DSG4,Desmoglein-4,42018,0.0228443964435804,0.00473800226448976,0.0135579120051804,0.0321308808819803,1.44027534861414e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPBP,Platelet basic protein,39908,0.0410140223822129,0.00851969602466317,0.0243154181738731,0.0577126265905527,1.49836195342009e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0174188950900739,0.00362330066933305,-0.0245205644019666,-0.0103172257781811,1.5482042768584e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0294224709112183,0.00612124288221988,0.0174248348620673,0.0414201069603692,1.55191915709586e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0131711882188788,0.00274345273510832,0.00779402085806646,0.0185483555796911,1.59603126723375e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCL2L15,Bcl-2-like protein 15,39657,-0.0270079466946921,0.00563543414997123,-0.0380533976286357,-0.0159624957607485,1.66840760107047e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0111720287328518,0.00233317245124499,-0.0157450467372919,-0.00659901072841158,1.69937165334255e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0146698643763469,0.0030639887093034,0.00866444650611219,0.0206752822465815,1.70813213520886e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSTB,Cystatin-B,41959,-0.0204995490754304,0.00428586482728148,-0.0288998441369021,-0.0120992540139587,1.74490660666791e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENO2,Gamma-enolase,42249,0.0306745744203203,0.00641886626185065,0.0180935965470931,0.0432555522935476,1.78168393238303e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,XCL1,Lymphotactin,42262,-0.0256922800878081,0.00538390329444904,-0.0362447305449282,-0.0151398296306879,1.84243780266163e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD69,Early activation antigen CD69,42082,0.0412555632045697,0.00864574532520946,0.0243099023671592,0.0582012240419802,1.84523379921972e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0193079653882937,0.00405099040413654,-0.0272479065804013,-0.0113680241961861,1.900283175749e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0281877138065275,0.0059180163686542,0.0165884017239652,0.0397870258890897,1.92708686568846e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0111223099112423,0.00233620877368612,-0.0157012791076671,-0.00654334071481746,1.94770940245182e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0141671501436675,0.00297755838068777,-0.0200031645698155,-0.00833113571751943,1.97563901313817e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BSG,Basigin,42284,-0.00980593561584495,0.00206154497541505,-0.0138465637676584,-0.00576530746403144,1.98894535584997e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.0160348778708367,0.00337161160151139,0.00942651913187442,0.0226432366097991,1.99649930150993e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MB,Myoglobin,42310,-0.0262990505509927,0.00553659313593981,-0.0371507730974348,-0.0154473280045507,2.05435023371922e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0185977645876858,0.00391607214620608,-0.0262732659942497,-0.0109222631811218,2.06924748990978e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0161073590812917,0.00340022633954241,0.00944291545578854,0.0227718027067948,2.19377561043731e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,42137,0.0125875111512649,0.00265869111128228,0.00737647657315167,0.0177985457293782,2.21846528562676e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YJU2,Splicing factor YJU2,39919,0.0155343402167631,0.00328200389576237,0.00910161258106889,0.0219670678524574,2.23698885677718e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMEM25,Transmembrane protein 25,39934,-0.0219963873702907,0.0046579713328013,-0.0311260111825812,-0.0128667635580001,2.35976707507588e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MPO,Myeloperoxidase,42137,-0.0209248594577335,0.00443860545700628,-0.0296245261534658,-0.0122251927620012,2.44976531371904e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD5,T-cell surface glycoprotein CD5,42239,-0.0165499285547242,0.00351233288969977,-0.0234341010185358,-0.00966575609091268,2.47783196764601e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL12A_IL12B,Interleukin-12,42070,-0.0358375758972017,0.00760591235444324,-0.0507451641119105,-0.020929987682493,2.47986938533257e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.0333989847163509,0.0070900506633567,0.0195024854161718,0.0472954840165301,2.49310008513413e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0242252214012505,0.00514335100797833,0.014144253425613,0.0343061893768881,2.50168271032089e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KEL,Kell blood group glycoprotein,41839,-0.0167710466737051,0.00356541086273888,-0.0237592519646733,-0.00978284138273687,2.57920380467548e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0247390856326358,0.00526226077977667,0.0144250545042736,0.0350531167609981,2.61651428548813e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0373180411776464,0.00795335668184038,0.0217294620812392,0.0529066202740535,2.73044068363024e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0350285399661956,0.00747536555372939,0.020376823480886,0.0496802564515052,2.81515585327488e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0277931981466037,0.00593096016164254,0.0161685162297843,0.039417880063423,2.81730836754188e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.0301222850748493,0.00643133710897525,-0.0427277058084408,-0.0175168643412578,2.84578443239517e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,42145,-0.0132815173796424,0.00283698890040194,-0.0188420156244302,-0.00772101913485458,2.87469153688817e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0388972162451146,0.00832562889238614,0.0225789836160378,0.0552154488741915,3.01796170838746e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0421197920845068,0.00901698677611672,0.024446498003318,0.0597930861656956,3.03039733265402e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL16,Pro-interleukin-16,42296,0.0194830382957274,0.00417472137099135,0.0113005844085843,0.0276654921828704,3.086642772547e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0127706038622057,0.00273819900002066,0.00740373382216524,0.0181374739022462,3.13888075713467e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0147257386683648,0.00316554883089762,-0.0209302143769241,-0.00852126295980545,3.32004999413836e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0217674707464795,0.00468042757589834,-0.0309411087952403,-0.0125938326977188,3.34480848960313e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0278734234576881,0.00600245915462595,0.0161086035146213,0.039638243400755,3.4548709718622e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TADA3,Transcriptional adapter 3,39919,0.0186309645179291,0.0040147239678606,0.0107621055409223,0.0264998234949359,3.51199316050961e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PROK1,Prokineticin-1,42119,0.0227469181974909,0.00490229445804237,0.0131384210597278,0.0323554153352539,3.51586041605522e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.04015617508557,0.00866522852814602,0.0231723271704038,0.0571400230007362,3.62426117024017e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BLVRB,Flavin reductase,42137,-0.0290449230622456,0.00628727486403342,-0.0413679817957511,-0.0167218643287401,3.87957113912889e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0353892796490156,0.00766143693877274,0.0203728632490211,0.0504056960490102,3.88895056270008e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RRAS,Ras-related protein R-Ras,39649,0.0602504679078468,0.0130461579149298,0.0346799983945845,0.0858209374211092,3.91352092937135e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0209340443953582,0.00453655635837066,-0.0298256948577647,-0.0120423939329517,3.98333025375903e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0270879173396696,0.00587289675419784,-0.0385987949778974,-0.0155770397014418,4.01727091816724e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0423793375318451,0.00920981220590656,0.0243281056082682,0.060430569455422,4.23926029833027e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0230574053309596,0.00501213369746033,-0.0328811873779819,-0.0132336232839374,4.26423085774662e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0257966994663258,0.00561427820961524,0.0147927141754799,0.0368006847571716,4.37885167632813e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0143485954869252,0.00312381371472756,-0.0204712703677912,-0.00822592060605918,4.4025365951469e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0128484908805221,0.00280128177015705,0.00735797861101424,0.0183390031500299,4.5440932103609e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0181118986758706,0.00395505057414722,0.010359999550542,0.0258637978011991,4.70467441484087e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0401983595786475,0.00878457683793165,0.0229805889763014,0.0574161301809935,4.7820311939101e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.0136250707985494,0.00297957295457822,0.00778510780757603,0.0194650337895227,4.86377057510357e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0223707746254773,0.0048933635173856,0.0127797821314015,0.0319617671195531,4.89108624440814e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK3,Prostate-specific antigen,39966,0.0519208986964825,0.0113596058855661,0.0296560711607729,0.0741857262321921,4.91317075150047e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0446535773457827,0.00977477128055356,0.0254950256358977,0.0638121290556677,4.96997906670754e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.00902425421241386,0.00197662626005823,0.00515006674269974,0.012898441682128,5.02752511326358e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0121045620017318,0.0026518826298998,-0.0173022519563354,-0.00690687204712817,5.05075233014106e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP12,Macrophage metalloelastase,42146,-0.0246443539090681,0.00539986343872394,-0.035228086248967,-0.0140606215691691,5.06571790004207e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0129167314846378,0.00283054036680116,-0.0184645906035681,-0.00736887236570749,5.08730610272918e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.0427542588861156,0.00938522302541738,0.0243592217562976,0.0611492960159337,5.28100984049796e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,JAM2,Junctional adhesion molecule B,42249,-0.0122638275881512,0.00269399193700666,-0.0175440517846842,-0.0069836033916181,5.35241075757741e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0104738899876943,0.0023009599197516,0.00596400854498117,0.0149837714304074,5.36046273829104e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0379041728858618,0.00833186140392778,0.0215737245341633,0.0542346212375602,5.4381016052182e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.0119512247151451,0.00263566358927249,-0.0171171253501192,-0.00678532408017098,5.82577645346303e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0132860343717723,0.00293581930868482,-0.0190402402167946,-0.00753182852675008,6.07790447490321e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYOM3,Myomesin-3,39736,-0.0437022097565131,0.00966071049282457,-0.0626372023224493,-0.024767217190577,6.13948655435527e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0318460614861138,0.00704713598596049,0.0180336749536313,0.0456584480185964,6.27577544081038e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPY,Pancreatic prohormone,42089,-0.0457133066747776,0.0101503137618824,-0.0656079216480671,-0.025818691701488,6.736140698406e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0139273462552315,0.00310376086534844,-0.0200107175513144,-0.00784397495914853,7.27537380827302e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL10,Interleukin-10,41913,-0.0340651686254319,0.00759530909885864,-0.0489519744591949,-0.019178362791669,7.35146068268149e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSE,Cathepsin E,39736,-0.0236851172721381,0.00528537507414135,-0.0340444524174551,-0.0133257821268211,7.49454669933593e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.0432208436451946,0.00964926984259802,0.0243082747537025,0.0621334125366867,7.55356599497112e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MATN3,Matrilin-3,41992,0.0145552223091389,0.00325655069449913,0.00817238294792061,0.0209380616703572,7.90383489786199e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0258433654783298,0.00578566234086298,-0.0371832636664213,-0.0145034672902384,8.00492512121531e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0215887418492046,0.00483538944034097,-0.0310661051522729,-0.0121113785461363,8.09563093961884e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0238299056671218,0.00533815956796329,0.0133671129139137,0.0342926984203298,8.10825291410448e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS9,Galectin-9,42129,-0.0138099161683794,0.00309661949054565,-0.0198792903698489,-0.00774054196690997,8.27453434142705e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SRPK2,SRSF protein kinase 2,42119,0.0374072107081238,0.00839366832421893,0.0209556207926547,0.0538588006235929,8.39398518739431e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OGA,Protein O-GlcNAcase,39930,0.0316122555904515,0.00709439359704194,0.0177072441402493,0.0455172670406537,8.43242712942261e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WASHC3,WASH complex subunit 3,39929,0.0336393550035314,0.00754947211676502,0.0188423896546719,0.0484363203523908,8.43611125754736e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.032121738220846,0.00721416569095827,-0.0462615029751242,-0.0179819734665678,8.56777657767572e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0325325309541426,0.00731759117510084,0.018190052250945,0.0468750096573403,8.82784260465662e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ROBO4,Roundabout homolog 4,39638,-0.0080500598416251,0.00181101724451441,-0.0115996536408734,-0.00450046604237685,8.87293345121657e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0318888271396803,0.0071749399588506,0.0178259448203331,0.0459517094590275,8.88086412595343e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF23,Fibroblast growth factor 23,42250,-0.0221716699019912,0.00498925945368237,-0.0319506184312086,-0.0123927213727737,8.9046823086673e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMPRSS15,Enteropeptidase,42070,-0.0385814028882536,0.00868391661250917,-0.0556018794487716,-0.0215609263277357,8.94799763672948e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PF4,Platelet factor 4,39914,0.0431068753802865,0.00970458057363766,0.0240858974559567,0.0621278533046163,9.00101568908627e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0181637573913769,0.00408965537386808,0.0101480328585955,0.0261794819241583,9.00912385486931e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,METAP2,Methionine aminopeptidase 2,42247,0.0244306108155397,0.00550247101883374,0.0136457676186256,0.0352154540124539,9.06927905930998e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRSS27,Serine protease 27,42107,0.0175984397742093,0.00396599150922885,0.00982509641612079,0.0253717831322979,9.17996734023993e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,0.0221359843043946,0.00499341289386226,0.0123488950324246,0.0319230735763646,9.37889048407016e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSHB,Thyrotropin subunit beta,42145,0.0297779631539513,0.00672453328785246,0.0165978779097604,0.0429580483981421,9.57415175286242e-06
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.0146837283234039,0.0033236092841405,-0.0211980025203193,-0.00816945412648854,1.00406442485306e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD2,T-cell surface antigen CD2,39575,-0.0170753483428774,0.0038694815230488,-0.0246595321280531,-0.0094911645577018,1.03003725990705e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0123439371471741,0.00279903063437408,-0.0178300371905473,-0.00685783710380086,1.0412507197321e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0142753325785714,0.00323906818782791,0.00792675893042866,0.020623906226714,1.0550849433228e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UNC79,Protein unc-79 homolog,39560,0.0243666959890153,0.00555052545854922,0.0134876660902588,0.0352457258877717,1.14423029892382e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,39919,-0.0126236103336263,0.00287988914494614,-0.0182681930577208,-0.00697902760953191,1.17912925110198e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0153572068795435,0.0035109558139434,0.00847573348421442,0.0222386802748725,1.23035569907669e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0387660844689773,0.00888819442626892,0.0213452233934903,0.0561869455444644,1.30297575867265e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0402341775914458,0.00923370457694254,0.0221361166206384,0.0583322385622531,1.32645140807744e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACY1,Aminoacylase-1,42145,-0.0270350445701788,0.00620500777141519,-0.0391968598021526,-0.014873229338205,1.3284468725787e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0265464767501823,0.0060933484121356,-0.0384894396379681,-0.0146035138623965,1.33067748304498e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.039161665059069,0.00900333524714313,0.0215151279746685,0.0568082021434696,1.37555714214072e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0285532868782962,0.00656515863105161,0.015685575961435,0.0414209977951574,1.37819755058856e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APLP1,Amyloid-like protein 1,42145,0.0218295049810747,0.00501980689668267,0.0119906834635767,0.0316683264985727,1.37963601283362e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.02487282640799,0.00572089834882903,0.0136598656442851,0.0360857871716949,1.38578052874582e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDN1,Endothelin-1,39638,-0.0126697225277583,0.0029171551933596,-0.0183873467067431,-0.00695209834877345,1.41690367596804e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMN,Protein amnionless,41913,0.0202535805035241,0.00466503367696248,0.0111101144966776,0.0293970465103706,1.4251181466499e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0223678772552083,0.00515247135230557,0.0122690334046894,0.0324667211057273,1.4276262526024e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOXO3,Forkhead box protein O3,41843,0.0410985100084901,0.00947317387254059,0.0225310892183106,0.0596659307986697,1.44580225324555e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0310253428152992,0.00716399109501531,0.0169839202690692,0.0450667653615292,1.49892389363934e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0159496198342247,0.0036872003805266,0.00872270708839257,0.0231765325800568,1.53370931935338e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,42070,0.0103377068747205,0.00239085121218876,0.00565163849883055,0.0150237752506105,1.54424349681243e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HEXIM1,Protein HEXIM1,42119,0.0343932402922804,0.00795890211067278,0.0187937921553617,0.0499926884291991,1.56182136461726e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0321277479608278,0.00743481363350886,0.0175555132391505,0.0466999826825052,1.5627670468569e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMPD3,AMP deaminase 3,39929,-0.0295712057902846,0.00684491757754165,-0.0429872442422662,-0.0161551673383029,1.57237936610617e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INSL5,Insulin-like peptide INSL5,39930,-0.0439119755770628,0.0101743069397975,-0.0638536171790658,-0.0239703339750598,1.60254626693363e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0192375799512112,0.00446096028806975,0.0104940977865945,0.0279810621158279,1.62638482724146e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC4A1,Band 3 anion transport protein,39966,-0.0203499399470487,0.00472508118348298,-0.0296110990666753,-0.011088780827422,1.67029955347495e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OLFM4,Olfactomedin-4,39347,-0.0530521242802701,0.0123293625750407,-0.07721767492735,-0.0288865736331903,1.70061796905692e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0206236913547903,0.00480082890351916,0.0112140667038927,0.0300333160056878,1.75469621838039e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HGF,Hepatocyte growth factor,42296,-0.0146324840277611,0.00340711234824247,-0.0213104242303163,-0.00795454382520585,1.76144286741448e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TTN,Titin,39575,-0.0295626107755623,0.00688626377450117,-0.0430596877735846,-0.01606553377754,1.7780280135101e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0300957615828798,0.00701225822739661,0.0163517354571825,0.0438397877085772,1.78395371637106e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0279277009358014,0.00650805595146361,0.0151719112709327,0.04068349060067,1.78903127453783e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.0335889985989884,0.00783065569456583,0.0182409134376394,0.0489370837603374,1.80659681260211e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0294549513272568,0.00687604164381361,0.0159779097053822,0.0429319929491315,1.85370043095084e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.0205196975299622,0.0047932088116504,0.0111250082591274,0.029914386800797,1.87591860637063e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C2,Complement C2,42199,0.00954559788557408,0.00223187960338674,0.00517111386293607,0.0139200819082121,1.90780308418214e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.0263870503525089,0.00617009090615333,0.0142936721764484,0.0384804285285695,1.91319613399134e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0304074596951765,0.00711873969071476,0.0164547299013756,0.0443601894889774,1.95531003946775e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.0386783833092952,0.00905628863678087,-0.0564287090373857,-0.0209280575812047,1.96049350984348e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNST,Consortin,42145,0.045886040078519,0.0107532193469567,0.0248097301584839,0.0669623499985541,1.99295040678937e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINE2,Glia-derived nexin,39958,0.0274585110705449,0.00643637146735309,0.0148432229945328,0.0400737991465569,2.00488317011867e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0292750991749019,0.00686442578360338,-0.0427293737107645,-0.0158208246390392,2.01744371533071e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.02010033032626,0.0047162795636671,0.0108564223814725,0.0293442382710475,2.04329280014549e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKAP12,A-kinase anchor protein 12,39736,0.00901831284326075,0.00211720544650647,0.00486859016810806,0.0131680355184134,2.06534414992594e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ST13,Hsc70-interacting protein,39736,0.0230599609981386,0.00541600396926679,0.0124445932183757,0.0336753287779016,2.08193314358497e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRSS2,Trypsin-2,42217,-0.024013219443804,0.00564520854292466,-0.0350778281879364,-0.0129486106996717,2.11638554106436e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0264906664554791,0.00623665191518821,0.0142668287017102,0.038714504209248,2.17875733928665e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VIT,Vitrin,39958,0.0161979714371066,0.00381373326433881,0.0087230542390025,0.0236728886352106,2.18110476657163e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.027283971137654,0.00643091280067564,0.0146793820483298,0.0398885602269783,2.22419643541392e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP2,Microtubule-associated protein 2,39929,0.0197354488947073,0.00465526769908238,0.0106111242045058,0.0288597735849088,2.25915137628735e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SDHB,Succinate dehydrogenase,39930,0.0276314997453434,0.0065213594923851,0.0148496351402686,0.0404133643504181,2.28240527702317e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLPS,Colipase,42115,0.0308140247020637,0.00727864342326104,0.0165478835924721,0.0450801658116554,2.31618499908126e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0222276922533896,0.00525510187225332,0.0119276925837731,0.0325276919230062,2.35538582272813e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0109889226237908,0.00259890205409579,0.00589507459776303,0.0160827706498185,2.37318013044324e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0128593379974519,0.00304167569238105,0.00689765364038505,0.0188210223545188,2.37928803900977e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FXN,"Frataxin, mitochondrial",42262,0.0303125003950849,0.00717555496326135,0.0162484126670927,0.0443765881230772,2.41118707888812e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0322011769265432,0.00762456341997307,0.0172570326233959,0.0471453212296904,2.42309376666593e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CIAPIN1,Anamorsin,42181,0.0255342449406293,0.0060489404708432,0.0136783216177767,0.037390168263482,2.44503650249809e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0205230252222766,0.00486538812053574,0.0109868645060265,0.0300591859385267,2.47933385695641e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.010762767403099,0.00255271909401861,0.00575943797882254,0.0157660968273755,2.50384733414763e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0202166846706696,0.00479858355474986,0.0108114609033598,0.0296219084379793,2.53888135388677e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD109,CD109 antigen,42137,-0.0141801944731838,0.00336758736786014,-0.0207806657141897,-0.00757972323217794,2.5612699313599e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0112032763310609,0.00266245656631342,-0.0164216912010352,-0.00598486146108656,2.59444617968486e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDCD1,Programmed cell death protein 1,42232,-0.0174168949520899,0.00413925091886146,-0.0255298267530584,-0.00930396315112143,2.59587455892502e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0284391953748873,0.00676348477377172,-0.0416956255314798,-0.0151827652182947,2.62965991537505e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0231931490248295,0.00551593759212333,0.0123819113442678,0.0340043867053913,2.63426784927336e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0196484945259533,0.00467366305891014,-0.0288088741214172,-0.0104881149304894,2.6382847635101e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA12,Serpin A12,41751,0.0448916346855395,0.0106878493957518,0.0239434498698661,0.065839819501213,2.68378083067318e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0152795796546549,0.00363807621207416,0.00814895027898956,0.0224102090303203,2.69134387282119e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PVALB,Parvalbumin alpha,42208,0.0463225522824591,0.0110379266515582,0.0246882160454049,0.0679568885195132,2.72585793588969e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0238025783998786,0.00567470298739222,-0.0349249962551673,-0.0126801605445898,2.75580555044619e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL17D,Interleukin-17D,41913,0.0141020846511075,0.00336691706126043,0.00750292721103708,0.020701242091178,2.82704337273069e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0136019060283719,0.00324838672657938,0.00723506804427628,0.0199687440124675,2.84102271853226e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0198570307565008,0.00474805701614664,0.0105508390048534,0.0291632225081482,2.90954099249188e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTPN,Myotrophin,41900,0.0134178269243906,0.00320969329264277,0.00712682807081073,0.0197088257779704,2.92849025244625e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0261062570659546,0.00625260202307254,0.0138511571007325,0.0383613570311768,2.99861578726642e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPT1,Angiopoietin-1,42085,0.0344067878079083,0.00824116272316174,0.0182541088705113,0.0505594667453053,2.99868259687362e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0212098398077678,0.00508111705704754,0.0112508503759546,0.031168829239581,3.0087534330386e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NTF4,Neurotrophin-4,41843,0.0155790237943634,0.003734178554063,0.00826003382839992,0.0228980137603269,3.038524785158e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0216686737536948,0.00519494020877342,0.0114865909444989,0.0318507565628907,3.05050166717749e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0300575695230745,0.00720744497625251,0.0159309773696196,0.0441841616765294,3.06391185650031e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPM1A,Protein phosphatase 1A,41843,0.0128743564862173,0.00309180235762857,0.00681442386526535,0.0189342891071693,3.14659463272509e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF21,Fibroblast growth factor 21,42247,-0.0493146043767413,0.011849645413413,-0.0725399093870308,-0.0260892993664519,3.17831508051963e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0326393148764676,0.0078468933003473,0.0172594040077869,0.0480192257451483,3.20928137438527e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNR,Tenascin-R,42016,0.0171637138550326,0.00413224029273378,0.00906452288127439,0.0252629048287908,3.29297107346238e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGA4,Pepsin A-4,39990,-0.0309288243910209,0.00744842376261259,-0.0455277349657415,-0.0163299138163002,3.31405977066145e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HPSE,Heparanase,39866,0.0392824373124987,0.00947853002602136,0.0207045184614969,0.0578603561635006,3.43256617421973e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD22,B-cell receptor CD22,42296,0.017443570469089,0.00421034433965761,0.0091912955633601,0.0256958453748179,3.44809846805671e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0155588196702629,0.00375870918506227,-0.0229258896729849,-0.00819174966754081,3.50316413756814e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0362782960525937,0.00878137988253648,0.0190667914828222,0.0534898006223651,3.63348413169519e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.0286466219806924,0.00694195045831273,0.0150403990823994,0.0422528448789853,3.70807049988733e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NXPH1,Neurexophilin-1,41839,0.0157836452940166,0.00382509419516266,0.00828646067149779,0.0232808299165354,3.70834781442027e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PALM,Paralemmin-1,39859,0.012538141304125,0.00304008470246186,0.00657957528729981,0.0184967073209503,3.74578052564973e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THTPA,Thiamine-triphosphatase,39897,0.035860378475204,0.0087082740477424,0.0187921613416289,0.0529285956087791,3.8495125712301e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0249298338019945,0.00607082335615575,-0.0368286475800597,-0.0130310200239292,4.04081307803059e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0217194792873003,0.00529644229219881,0.0113384523945907,0.03210050618001,4.14734281699268e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0148938657466006,0.00363504078907048,0.00776918580002245,0.0220185456931787,4.20396906652781e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.00970008648879939,0.00236905525816965,0.00505673818278688,0.0143434347948119,4.2554630944532e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YWHAQ,14-3-3 protein theta,39736,0.0302404783312111,0.00738797020278468,0.0157600567337531,0.0447208999286691,4.28453201809816e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0145814511266658,0.00356688810665861,0.00759035043761496,0.0215725518157167,4.37656491930413e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.02269674890833,0.00555481194286203,0.0118093175003204,0.0335841803163396,4.41521311088807e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0146503352882373,0.00358808950246387,0.0076176798634081,0.0216829907130665,4.47548653271402e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCTN1,Dynactin subunit 1,42262,0.0257473511545413,0.00630657564126821,0.0133864628976556,0.038108239411427,4.47843458165958e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,42217,0.0129109613816538,0.00316329171888829,0.00671090961263279,0.0191110131506749,4.50021416844321e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0143413005012239,0.00351571774651964,0.00745049371804544,0.0212321072844024,4.55059832291958e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0243197400425358,0.00596580661480995,0.0126267590775083,0.0360127210075633,4.6026461700301e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0217245054240451,0.00533477576273907,-0.0321806659190137,-0.0112683449290766,4.68790735616882e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACTN2,Alpha-actinin-2,39575,-0.0261522317708705,0.00642470566931344,-0.0387446548827248,-0.0135598086590161,4.72265071817893e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GZMA,Granzyme A,42296,-0.0136151453059563,0.00334939577158186,-0.0201799610182568,-0.00705032959365586,4.83099616112855e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0361180180602478,0.00889007727209145,0.0186934666069486,0.053542569513547,4.88339952781754e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0163761983744345,0.00403125594107997,-0.0242774600189512,-0.00847493672991776,4.89282174241912e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFNA1,Ephrin-A1,42113,-0.0117892191410942,0.00290621877692695,-0.0174854079438711,-0.00609303033831743,5.00828718946359e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0263813006735623,0.00650634959648018,0.0136288554644612,0.0391337458826635,5.05452888297058e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.0275043056889986,0.00678434474953123,0.0142069899799174,0.0408016213980798,5.06140501550891e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.0201753860537383,0.00497670402992908,-0.0299297259523993,-0.0104210461550773,5.06992450284908e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0315802754849404,0.00779132035211062,0.0163092875948036,0.0468512633750772,5.07929387123819e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0296871412330963,0.00732690888407371,0.0153263998203118,0.0440478826458807,5.11703597898786e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSPAN8,Tetraspanin-8,39930,-0.0383540842079774,0.00947736461960165,-0.0569297188623966,-0.0197784495535581,5.22419033550178e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0136000462016772,0.00336746131454156,-0.0202002703781787,-0.00699982202517578,5.40578322517019e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0196032086768022,0.00485488906298204,0.0100876261133574,0.0291187912402469,5.43039422193041e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0235442407801283,0.00583426962659857,0.0121090723119951,0.0349794092482616,5.48512220056404e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.017490840607817,0.00434859360225825,0.00896759714739081,0.0260140840682432,5.80353393809436e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0447260585729093,0.0111224215808862,-0.0665260048714463,-0.0229261122743723,5.820653102063e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACRBP,Acrosin-binding protein,39919,0.0159262358832918,0.00396168538026196,0.00816133253797838,0.0236911392286053,5.85590680709628e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CETN2,Centrin-2,41839,0.0269375855622681,0.00670347710708961,0.0137987704323725,0.0400764006921637,5.89064046326843e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0254613773822306,0.00634227453109499,-0.0378922354631768,-0.0130305193012844,5.99431108075047e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0225123461565858,0.0056103272891008,0.0115161046699482,0.0335085876432233,6.03681269082938e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCTN6,Dynactin subunit 6,41839,0.028529164677452,0.00711274391594669,0.0145881866021965,0.0424701427527075,6.07961061201998e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MDM1,Nuclear protein MDM1,39649,0.012511433128406,0.00311979852707282,0.00639662801534323,0.0186262382414687,6.10320035478763e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0104673053031652,0.00261264949482706,-0.0155880983130263,-0.00534651229330419,6.20536108038191e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0149214941527079,0.00372681351697648,0.00761693965943399,0.0222260486459818,6.2665716163914e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100G,Protein S100-G,39934,0.0194258365818447,0.00486338041619622,0.00989361096610014,0.0289580621975893,6.52935683133901e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0138987085744064,0.0034819368362519,-0.0207233047734601,-0.00707411237535265,6.59562212406178e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0265239681246413,0.00664961201943646,0.0134907285665458,0.0395572076827367,6.68367362839784e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.0374918765863081,0.0094014030453284,0.0190651266174644,0.0559186265551518,6.70167227995104e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.0334311336515924,0.0083846995162487,0.0169971225997449,0.0498651447034398,6.72220535800641e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.027276657953237,0.00684161657875569,0.0138670894588758,0.0406862264475981,6.73017798706546e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UBXN1,UBX domain-containing protein 1,39736,0.027348741150232,0.00686014302316928,0.0139028608248202,0.0407946214756437,6.74508375895433e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.0301393694802888,0.00756699055978871,0.015308067983103,0.0449706709774747,6.84053225821068e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0147053416378467,0.00369699210949165,-0.0219514461724503,-0.00745923710324305,7.00393422190089e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD84,SLAM family member 5,42119,0.0124979737426147,0.00314259180377033,0.00633849380722489,0.0186574536780046,7.01643431679418e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0134217631397458,0.00337538532298174,0.00680600790670164,0.02003751837279,7.03392578140696e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0423021220640997,0.0106464525665911,0.0214350750335812,0.0631691690946182,7.13067805306756e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0171270695287422,0.00431134415388379,0.00867683498712993,0.0255773040703544,7.14715727237017e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0220816973357238,0.00555921883425923,0.0111856284205757,0.0329777662508719,7.16152304523599e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL14,C-C motif chemokine 14,42152,-0.0158516999015731,0.00399115016878187,-0.0236743542323855,-0.0080290455707606,7.17267899097368e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0109572606771673,0.00276034235430566,-0.0163675316916064,-0.00554698966272815,7.23822942467426e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRNN,Cornulin,41749,0.0262868369492158,0.00664900085234368,0.0132547952786222,0.0393188786198094,7.74189674986783e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PI3,Elafin,41966,-0.0219082217972445,0.00554585079660273,-0.0327780893585859,-0.0110383542359031,7.84277303279751e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNL1,Interferon lambda-1,41839,-0.0176588334899206,0.00447964320686895,-0.0264389341753838,-0.0088787328044575,8.12145741410234e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BECN1,Beclin-1,39638,0.0232866843137459,0.0059084167968172,0.0117061873919841,0.0348671812355076,8.15501341198951e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TYMP,Thymidine phosphorylase,42070,-0.0258714059591441,0.00656474423872119,-0.0387383046670376,-0.0130045072512506,8.15654265483858e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MUC16,Mucin-16,42070,0.0743341558530445,0.0188680917275103,0.0373526960671244,0.111315615638965,8.20035022446255e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRC1,Macrophage mannose receptor 1,39990,-0.0111247568455638,0.00282370208886385,-0.016659212939737,-0.00559030075139066,8.20440576056107e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHPK,Sedoheptulokinase,39757,-0.0156619474759809,0.00397715890346884,-0.0234571789267799,-0.00786671602518203,8.26723474503446e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0132401633785488,0.00336667809834289,-0.0198388524513009,-0.00664147430579678,8.44203204642958e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,39657,-0.0219080675665056,0.0055704286835304,-0.0328261077862252,-0.010990027346786,8.44316221760365e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0183869324966217,0.00467796909466484,0.00921811307107859,0.0275557519221648,8.51872559413599e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0277033777472085,0.00705379103584389,0.0138779473169545,0.0415288081774625,8.6288302102199e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANPEP,Aminopeptidase N,42187,0.0105821777817083,0.00269453258646986,0.00530089391222733,0.0158634616511892,8.63372740789336e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HRG,Histidine-rich glycoprotein,39925,0.0121593327695288,0.00309603933388526,0.00609109567511367,0.0182275698639439,8.63844214205912e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.0335999193696781,0.0085588180288083,0.0168246360332138,0.0503752027061423,8.68827801693715e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.0319192491426597,0.00813194534993435,-0.047857862028531,-0.0159806362567883,8.71078446934291e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICOSLG,ICOS ligand,42070,0.00741712934039516,0.00188983465968945,0.00371305340740384,0.0111212052733865,8.72513846486519e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD70,CD70 antigen,42119,0.0171093775834186,0.00435952776893291,0.00856470315631007,0.0256540520105271,8.7306366447343e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0143645643506128,0.00366377111371059,-0.0215455557334856,-0.00718357296774009,8.88088182961669e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0336790940543999,0.00860053091542527,0.0168220534601664,0.0505361346486334,9.05834478230506e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBP7,Retinoid-binding protein 7,39930,-0.0242735813304323,0.00620419773870424,-0.0364338088982926,-0.012113353762572,9.19002957230219e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPRR3,Small proline-rich protein 3,39929,-0.0244768251787952,0.00626076970018255,-0.036747933791153,-0.0122057165664374,9.30050407973612e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS1,Galectin-1,42145,0.0135008042829806,0.00345732708604571,0.00672444319433096,0.0202771653716302,9.46890326677926e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.00903562980472723,0.00231456565161431,0.00449908112756319,0.0135721784818913,9.51506056524504e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.017593447492987,0.00451353591126205,0.00874691710691335,0.0264399778790606,9.74845898249874e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BACH1,Transcription regulator protein BACH1,42119,0.0288171095096903,0.00739606584052802,0.0143208204622553,0.0433133985571252,9.81540777547034e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0148928533709446,0.00382498964443221,0.00739587366785748,0.0223898330740317,9.92657861064752e-05
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0146411713793035,0.00377158258959607,-0.0220334732549118,-0.00724886950369515,0.000104116449653507
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MEP1A,Meprin A subunit alpha,39930,-0.0293325166702259,0.00755620725210842,-0.0441426828843584,-0.0145223504560934,0.000104227127274696
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LCP1,Plastin-2,39966,0.0184313138469994,0.00475299547089874,0.00911544272403787,0.0277471849699609,0.000105985404530714
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.02271860209679,0.00586073440747765,0.0112315626581338,0.0342056415354462,0.000106627059947727
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.015422829780614,0.00398782146782314,0.00760669970368061,0.0232389598575473,0.000110578254806074
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.0295801706203385,0.00764946486684562,0.0145872194813211,0.0445731217593559,0.000110815278199653
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,39736,-0.00889310759318228,0.00230250565754213,-0.0134060186819649,-0.0043801965043997,0.000112932427335594
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLNS1A,Methylosome subunit pICln,39649,-0.0128571178806001,0.00333122523137027,-0.0193863193340858,-0.00632791642711435,0.000114230272334285
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.0364115161986642,0.009444985678136,0.0178993442695177,0.0549236881278108,0.00011621027478057
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0304501604951269,0.00789975448770862,-0.0459336792910358,-0.014966641699218,0.000116468404613369
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0214043151259144,0.00555572969491908,0.010515084923873,0.0322935453279558,0.00011750783265349
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,0.0225959186297951,0.00588157588519241,0.0110680298948179,0.0341238073647722,0.00012268077824295
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTRC,Chymotrypsin-C,42122,0.0247462222928767,0.00644900729224256,0.0121061680000813,0.0373862765856721,0.000125003884647873
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TTF2,Transcription termination factor 2,39649,0.0189292724206163,0.00493893325116784,0.00924896324832737,0.0286095815929053,0.000127465617395385
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA7,Carbonic anhydrase 7,39757,-0.0127960071410148,0.0033390224790347,-0.0193404911999228,-0.00625152308210678,0.000127667401948482
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MME,Neprilysin,42070,-0.0294211095060956,0.00769300616980508,-0.0444994015989135,-0.0143428174132776,0.000131683562523692
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0185972879060424,0.00486352264393455,0.00906478352393073,0.0281297922881541,0.00013211680788935
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS8,Galectin-8,42249,0.0229338386418615,0.00600093996380557,0.0111719963128026,0.0346956809709205,0.000133118793378834
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0332848743082289,0.00871560282786881,0.016202292765606,0.0503674558508517,0.00013471010114571
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0198891008879139,0.00522479827773865,0.00964849626354618,0.0301297055122817,0.000141603501286348
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.0315678567300197,0.00829762077179539,0.0153045200173007,0.0478311934427387,0.000142747389880036
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL20,C-C motif chemokine 20,42296,-0.0324989617982806,0.008543458530404,-0.0492441405178724,-0.0157537830786887,0.000143020793310321
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSTA3,Glutathione S-transferase A3,41843,0.0289137706649709,0.00760778336415297,0.014002515271231,0.0438250260587107,0.000145021172467135
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0240989585946369,0.00634145186317537,0.0116697129428132,0.0365282042464606,0.000145210876434609
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD7,T-cell antigen CD7,39636,-0.0169376783544033,0.00445726709361696,-0.0256739218578926,-0.00820143485091406,0.000145465229124261
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0215725236452908,0.00567737576246837,0.0104448671508528,0.0327001801397288,0.000145610497740492
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNF,Tumor necrosis factor,41880,-0.0136356018287866,0.00359232216894184,-0.0206765532799126,-0.00659465037766055,0.000147844629683405
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0191838524053148,0.00505567016455657,0.00927473888278389,0.0290929659278457,0.000148723011960295
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHA4,Ephrin type-A receptor 4,39736,-0.011035075089992,0.00291042570275357,-0.016739509467389,-0.00533064071259504,0.000150490009955904
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.0217246955884158,0.00573603049215139,0.0104820758237991,0.0329673153530325,0.000153014278148977
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KYNU,Kynureninase,42296,0.0169636225280133,0.0044867988530641,0.00816949677600768,0.025757748280019,0.000156998358749949
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0231349195859134,0.00612117501195067,-0.0351324226093367,-0.0111374165624901,0.000157825079185647
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.0416220821024523,0.0110152554169395,-0.0632119827196538,-0.0200321814852508,0.000158579053031332
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F2R,Proteinase-activated receptor 1,42166,0.0213099139864636,0.0056542033735893,0.0102276753742286,0.0323921525986986,0.000164688019227907
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD83,CD83 antigen,42119,-0.0127876023206324,0.00340399590099384,-0.0194594342865804,-0.00611577035468451,0.000172930024307142
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCAM,Basal cell adhesion molecule,42137,-0.00909829088003747,0.00242318449719629,-0.0138477324945422,-0.00434884926553275,0.000174287066470439
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.010987192269579,0.0029284290879542,-0.0167269132819692,-0.00524747125718875,0.000176231390986752
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UNC5D,Netrin receptor UNC5D,39657,0.00972875511629953,0.00259993590333027,0.00463288074577221,0.0148246294868268,0.000183542964699088
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0142646705248385,0.00381367049162402,-0.0217394646884216,-0.00678987636125546,0.000184482302698719
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OBP2B,Odorant-binding protein 2b,41979,0.0211372676488337,0.00565513406318209,0.0100532048849968,0.0322213304126706,0.000186474939952956
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.0108432823000682,0.00290933142922043,0.0051409926987962,0.0165455719013403,0.000194521204263955
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0171539631390598,0.00460461716731279,-0.0261790127869929,-0.00812891349112671,0.000195996615754373
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0134317104546115,0.00360549808705449,0.00636493420398468,0.0204984867052383,0.000196023331022021
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0266227399015824,0.0071574356396617,0.0125941660478454,0.0406513137553193,0.000200355092595283
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,-0.019542059908035,0.00525456354691539,-0.0298410044599892,-0.00924311535608086,0.000200769545356334
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0248993866260937,0.00669660037591846,-0.0380247233628938,-0.0117740498892935,0.000201449100068776
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0228361607745402,0.00614237421052999,0.0107971073219014,0.034875214227179,0.000201762838914635
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0274430923657292,0.00738507170210668,0.0129683518296001,0.0419178329018582,0.000203372362769822
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",42070,-0.0382462257180908,0.0103005498738724,-0.0584353034708807,-0.0180571479653008,0.000205620560596848
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGA5,Integrin alpha-5,42137,0.00910911891454272,0.0024541508747994,0.0042989831999359,0.0139192546291495,0.000206681358385252
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRIP2,Cysteine-rich protein 2,42016,0.0133252094154601,0.00359162642813834,0.00628562161630895,0.0203647972146112,0.000208033037737927
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0288666379342102,0.00778680145779079,-0.0441287687914802,-0.0136045070769403,0.000210625465790313
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPP1,Osteopontin,42286,-0.0160643405626963,0.00434143348651964,-0.0245735501962748,-0.0075551309291178,0.000216240702777501
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A14,Protein S100-A14,39934,-0.019046841533406,0.00514949799132289,-0.0291398575963988,-0.00895382547041309,0.00021766516129295
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.0222083574768897,0.00600855970896717,0.010431580447314,0.0339851345064653,0.000219802402416058
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRR4,Proline-rich protein 4,39652,-0.026131415932448,0.00707122477039459,-0.0399910164824214,-0.0122718153824746,0.000220550732537714
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCRN1,Secernin-1,42119,0.0201378051580808,0.00545951446145717,0.00943715681362478,0.0308384535025369,0.000226401387252133
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,42057,-0.0172133307548546,0.00467233968172948,-0.0263711165310444,-0.00805554497866482,0.000230418803361695
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HJV,Hemojuvelin,39934,0.0153937578539611,0.00418816216202386,0.00718496001639436,0.0236025556915279,0.000238442167719797
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0133729286023683,0.00364150234268062,0.00623558401071426,0.0205102731940223,0.000241256318442707
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0164437824444438,0.00448103638656012,0.00766095112678593,0.0252266137621016,0.000243831289417062
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PER3,Period circadian protein homolog 3,39657,0.0449001990034736,0.0122400209686969,0.0209097579048277,0.0688906401021195,0.000245305020844949
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF9,Fibroblast growth factor 9,39539,0.0150346040157421,0.00409946705178671,0.00699964859424012,0.023069559437244,0.000246140105101303
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0195976225746744,0.00535285337221965,0.00910602996512386,0.0300892151842249,0.0002522527260578
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COMT,Catechol O-methyltransferase,41740,0.0301499569714308,0.00823701867565973,0.0140054003671378,0.0462945135757239,0.000252907532473666
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.023897658037544,0.00654613128345214,0.0110672407219778,0.0367280753531102,0.000262581012319219
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RSPO3,R-spondin-3,42262,-0.0101255557962767,0.00277481034095334,-0.0155641840645453,-0.00468692752800817,0.000264142730395086
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0230433324354804,0.00631543352813152,-0.0354215821506182,-0.0106650827203426,0.00026471981510068
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MDK,Midkine,42129,-0.0184208344519339,0.00505064950545509,-0.0283201074826259,-0.00852156142124195,0.000266087360620475
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA9,Serpin A9,42025,-0.0260609804363005,0.00714644501951561,-0.0400680126745511,-0.0120539481980499,0.000266628603183264
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UBQLN3,Ubiquilin-3,39575,-0.0203496492551418,0.00559306627944861,-0.0313120591628611,-0.00938723934742254,0.00027562691944968
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ABO,Histo-blood group ABO system transferase,39990,0.052367420287367,0.0144065417675481,0.0241305984229727,0.0806042421517613,0.000279232119484539
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0237701540489622,0.00655686176854191,0.0109187049826201,0.0366216031153043,0.000289746308740037
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.0227853397565392,0.00630628927321663,0.0104250127810346,0.0351456667320438,0.000303640617344471
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INHBC,Inhibin beta C chain,42137,0.0141711824940044,0.00392269830408097,0.00648269381800571,0.0218596711700031,0.00030422698019748
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0167533815194812,0.00463759373841449,0.00766369779218878,0.0258430652467736,0.000304362639081448
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCOF1,Treacle protein,39958,-0.0116307592756048,0.00322077121712062,-0.0179434708611612,-0.00531804769004841,0.000306129968134247
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PMM2,Phosphomannomutase 2,39575,0.021537092807401,0.00596927584311216,0.0098373121549012,0.0332368734599008,0.000309949192843611
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ECM1,Extracellular matrix protein 1,39720,0.0130899394286956,0.00362946447101394,0.00597618906550825,0.0202036897918829,0.000311623369460886
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0128353516560568,0.00356172120897142,0.00585437808647283,0.0198163252256408,0.000315095392234372
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP43,Centrosomal protein 43,41797,0.0250140811334402,0.00695671385824783,0.0113789219712745,0.038649240295606,0.000324732430368732
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0266625560936272,0.0074350838696956,0.0120897917090238,0.0412353204782306,0.000337186554375302
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LEG1,Protein LEG1 homolog,39398,-0.0251609342070025,0.0070280523290975,-0.0389359167720336,-0.0113859516419714,0.000345007035587149
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APP,Amyloid-beta precursor protein,42112,0.0233454095608417,0.00652618032468136,0.0105540961244662,0.0361367229972172,0.000348517293749707
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0193266497232617,0.00541009155698863,-0.0299304291749594,-0.008722870271564,0.000355282790707386
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0152716044557251,0.00428341245512879,-0.0236670928677775,-0.00687611604367267,0.000364728741467532
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0221122935308098,0.00620566026127066,0.00994919941871927,0.0342753876429003,0.000367802040143634
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0169210710846904,0.00475847791252923,0.00759445437613316,0.0262476877932477,0.000377880732359581
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.018938244787517,0.00532600678082273,0.00849927149710439,0.0293772180779295,0.000378359280093209
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0137012762135146,0.00385486749706827,0.00614573591926084,0.0212568165077684,0.00038033723607773
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00763588626646654,0.00214919317707451,0.00342346763940051,0.0118483048935326,0.000382302448368227
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FRMD7,FERM domain-containing protein 7,39649,0.0119690961486179,0.00337108824765716,0.00536176318320985,0.0185764291140259,0.000386078356524204
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTN1,Contactin-1,42310,0.00935753114107432,0.00263684590367443,0.00418931316987245,0.0145257491122762,0.000388345175404426
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,42119,-0.0172407438060669,0.00487421742420874,-0.026794209957516,-0.00768727765461773,0.000405854585008025
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0254678176922716,0.00722780551540242,-0.0396343165024604,-0.0113013188820829,0.000427149529950121
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0304073320683516,0.00863312332668208,0.0134864103480548,0.0473282537886485,0.000429437436423749
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SYT1,Synaptotagmin-1,39929,0.0140180860653399,0.00398068583673756,0.00621594182533433,0.0218202303053456,0.000430759108086681
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OGFR,Opioid growth factor receptor,42070,0.0111529525631125,0.00317246548889491,0.00493492020487851,0.0173709849213466,0.000440290648347722
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.00930466945225285,0.00264812832515382,-0.0144950009695544,-0.00411433793495136,0.000443664777583245
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRND,Prion-like protein doppel,39929,-0.0170671769507997,0.00485767508414603,-0.0265882201157259,-0.00754613378587345,0.000444059800938533
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLTA,Clathrin light chain A,41900,0.0162380009386979,0.00462259367892106,0.00717771732801267,0.0252982845493832,0.000444971631716926
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0271236312274479,0.00772562962876247,-0.0422658652998223,-0.0119813971550734,0.00044813917926397
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0306768514982339,0.00873750990317783,-0.0478023709084624,-0.0135513320880053,0.000448311611843465
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCN3,CCN family member 3,42299,-0.0117577192517784,0.00335283729099254,-0.0183292803421237,-0.00518615816143298,0.000454987107363565
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLGN,Calmegin,39649,-0.0158718501017619,0.0045308053826871,-0.0247522286518286,-0.00699147155169516,0.000461700725606949
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0217785544687838,0.00622616017601124,-0.0339818284137658,-0.00957528052380177,0.00047076335806049
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.0248891570952622,0.00713411589307827,0.0109062899448288,0.0388720242456956,0.000486840407391831
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0173808439487974,0.0049878515420983,-0.02715703297131,-0.00760465492628472,0.000494671297701162
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD302,CD302 antigen,42070,-0.0107141555738212,0.00307791126712101,-0.0167468616573783,-0.00468144949026398,0.000501160156732622
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBKS,Ribokinase,41830,-0.0170226615086715,0.00489145902041205,-0.0266099211886792,-0.00743540182866392,0.000502881663411962
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0246581130970432,0.00708864592743012,0.0107643670792801,0.0385518591148062,0.000506103765238085
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.0210045778496814,0.00604753701062527,0.00915140530885589,0.032857750390507,0.00051618837185968
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0165190034234761,0.00476339206810399,0.00718275496999225,0.0258552518769599,0.000526538585367534
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.0298131509758413,0.00860898089176686,-0.0466867535237044,-0.0129395484279783,0.000536107319139128
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.102239306924966,0.029532086133645,-0.160122195746911,-0.0443564181030221,0.0005378868930841
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.026024085275873,0.00751863252358807,0.0112875655296404,0.0407606050221056,0.000539649966022163
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F9,Coagulation factor IX,42199,0.00626527625916154,0.00181130243601046,0.00271512348458104,0.00981542903374204,0.000543867057584635
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDCD5,Programmed cell death protein 5,42249,0.0195317645718713,0.00564707680682568,0.00846349403049299,0.0306000351132497,0.000544366797245395
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0132204335400552,0.00382463073466811,-0.0207167097800047,-0.00572415730010565,0.000548923719426666
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CIT,Citron Rho-interacting kinase,39649,-0.0157066217850949,0.00454428705402708,-0.0246134244109879,-0.00679981915920178,0.000549614248837365
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX16,Syntaxin-16,41843,0.0194420984783287,0.0056279987947582,0.00841122084060267,0.0304729761160548,0.000552976070259798
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MATN2,Matrilin-2,42144,0.0100941634560798,0.00292406379076217,0.00436299842618595,0.0158253284859737,0.000557937968835964
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0228002361514652,0.00660804348939764,0.00984847091224581,0.0357520013906846,0.000561516885301316
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LEP,Leptin,42145,0.0236834541225171,0.00687011772310761,0.0102180233852262,0.0371488848598081,0.000567909555494485
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0191833475093274,0.00557225324152997,-0.0301049638627262,-0.00826173115592869,0.000578167491212365
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0129202808693834,0.0037583346477461,-0.0202866167789658,-0.00555394495980105,0.000588710588252423
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA4,Carbonic anhydrase 4,42310,-0.00822667718906728,0.00239528794703768,-0.0129214415652611,-0.00353191281287342,0.000595349334845434
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0186106546282759,0.00541929188105914,0.00798884254139993,0.0292324667151518,0.000596600350613707
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSS,Cathepsin S,39358,-0.0082391500093804,0.00239925157017401,-0.0129416830869215,-0.00353661693183934,0.000596876564343269
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0151349186779015,0.00441700834126015,0.00647758232903157,0.0237922550267714,0.000613210331557209
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0176006641442079,0.00513799572911404,-0.0276711357732714,-0.00753019251514438,0.000615696824814801
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD93,Complement component C1q receptor,41654,-0.0106554653998753,0.00311425826912179,-0.016759411607354,-0.00455151919239659,0.00062465326186508
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0122268108165045,0.00358082352205541,-0.0192452249197331,-0.00520839671327586,0.000641245642254343
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0153380066514933,0.00450587894345128,0.00650648392232877,0.0241695293806578,0.000666371513696826
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCT,Secretin,39649,0.0162576982200316,0.00477610326473462,0.00689653582115178,0.0256188606189115,0.000666507309998568
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0175244478091493,0.00515060092248907,0.00742927000107071,0.0276196256172278,0.000669876640156105
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.0192696436299561,0.00566625699560627,0.00816377991856782,0.0303755073413444,0.00067388596722852
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WNT9A,Protein Wnt-9a,41913,-0.00979058437647886,0.00287917121953387,-0.0154337599667652,-0.00414740878619248,0.000674634893549363
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0109206046872087,0.00321388895361752,0.00462138233811839,0.0172198270362991,0.000681282071203036
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMOD4,Tropomodulin-4,39560,-0.0135358505098739,0.00398504710128181,-0.0213465428283863,-0.00572515819136155,0.000684560256019617
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TF,Serotransferrin,39979,0.00723432160578808,0.00213298063958437,0.00305367955220272,0.0114149636593734,0.000697098440875698
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.021668149872013,0.00639054557173362,-0.0341936191926109,-0.00914268055141512,0.000699250460970973
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00618611954698703,0.0018262348849632,0.00260669917245915,0.00976553992151491,0.0007080714276718
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB10,Ras-related protein Rab-10,39958,0.0178370163381571,0.0053056822155145,0.00743787919574867,0.0282361534805655,0.000776719026608851
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0222290430411929,0.00661513055287857,0.0092633871575509,0.0351946989248349,0.000781139336589543
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCRL2,Fc receptor-like protein 2,42229,-0.0165729807334537,0.00494382719952126,-0.0262628820445154,-0.00688307942239201,0.000803735581534428
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0169599107072141,0.00506005428236893,0.00704220431377103,0.0268776171006572,0.000805344624079416
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,41946,0.0127528846346451,0.00380571148543162,0.00529369012319914,0.0202120791460911,0.00080747875842244
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.00660764050809393,0.00197330610240139,0.00273996054738721,0.0104753204688006,0.000814687878795482
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP9,Caspase-9,39657,0.0212957915205225,0.00635988573923141,0.00883041547162896,0.0337611675694161,0.000815348759471129
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0296896826726598,0.00886725308561429,0.0123098666248558,0.0470694987204638,0.000815481359320216
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.02128009778151,0.00636386203979776,0.00880692818350643,0.0337532673795136,0.000828783914140237
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.0254197869408682,0.00760357868103374,0.0105167727260421,0.0403228011556943,0.000831108007394659
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSME1,Proteasome activator complex subunit 1,42002,-0.0119722815404025,0.00358326811721382,-0.0189954870501416,-0.00494907603066347,0.000836563341651395
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRTN3,Myeloblastin,41800,-0.015812591513616,0.00475126381594062,-0.0251250685928596,-0.00650011443437235,0.00087685523409508
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.022050682640307,0.00663354498665711,0.00904893446645906,0.0350524308141549,0.000889341630200776
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCF2,Neutrophil cytosol factor 2,42097,-0.0272084124962617,0.0081975087915352,-0.0432755297276707,-0.0111412952648527,0.000905447797784046
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GMPR2,GMP reductase 2,39736,0.0219672088106346,0.00662209205001976,0.00898790839259588,0.0349465092286733,0.000911957681705419
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP8,Caspase-8,42224,0.0200173183331395,0.00603509955783445,0.00818852319978402,0.0318461134664951,0.000912875817742129
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0143629375679878,0.0043450813679364,-0.0228792970491431,-0.00584657808683242,0.000950366105400451
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0179359029140539,0.0054615602545629,-0.0286405610129972,-0.00723124481511059,0.00102655773424167
NMR metabolomics,X23505.Cholesterol in Medium VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0198771768308894,0.00605499471110956,-0.0317449664646641,-0.00800938719711462,0.00103056084329585
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0187435924522908,0.00571030894093753,-0.0299357979765284,-0.00755138692805328,0.00103182667777535
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0162192565121016,0.00494201732650851,-0.0259056104720583,-0.00653290255214493,0.00103433457994719
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0180841356628327,0.00552138476926044,0.00726222151508221,0.0289060498105831,0.00105878422699807
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,0.0143872818810764,0.00439831929130233,0.00576657607012386,0.023007987692029,0.00107403543355227
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0155944600681276,0.00476788486041196,0.00624940574172016,0.024939514394535,0.00107545222660129
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0383257755488676,0.0117272404880497,-0.0613111669054451,-0.0153403841922902,0.00108542623597308
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RFC4,Replication factor C subunit 4,39919,0.00719105731293818,0.00220060986213919,0.00287786198314538,0.011504252642731,0.00108726661489644
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0183019126481034,0.00560194797208952,0.00732209462280793,0.0292817306733988,0.00108993110627133
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DAG1,Dystroglycan,42185,0.0152917196054878,0.00468383300388087,0.00611140691788134,0.0244720322930944,0.00109817302329438
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCXR,L-xylulose reductase,42181,0.017466114340052,0.00535390521787722,0.00697246011301264,0.0279597685670913,0.00110779853922724
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0111884071506763,0.00343103773711266,0.00446357318593551,0.0179132411154171,0.00111314756197559
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.0113569257162082,0.00348288390053362,0.00453047327116235,0.0181833781612541,0.00111386134307834
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CGN,Cingulin,39649,-0.0120804445675609,0.00371270794772429,-0.0193573521451005,-0.00480353699002127,0.00114210821155101
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.02015848391865,0.00619978984335082,0.00800689582568239,0.0323100720116176,0.00115084956945599
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENSA,Alpha-endosulfine,39919,0.0171008093749872,0.00525992400650873,0.00679135832223008,0.0274102604277443,0.00115274807043128
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VWF,von Willebrand factor,42310,-0.0237635104740454,0.00731126152510903,-0.0380935830632591,-0.00943343788483168,0.00115577108778364
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0226690594408549,0.00697952389727281,0.00898919260220018,0.0363489262795096,0.00116589013566417
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.0242948513678778,0.00748378783043385,0.00962662722022744,0.0389630755155282,0.00117183886942884
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0225775551346455,0.00695588087529571,0.00894402861906594,0.0362110816502251,0.00117460598026996
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DLK1,Protein delta homolog 1,42310,0.0185247920226397,0.0057109038728822,0.0073314204317906,0.0297181636134888,0.00118246213091396
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.00874612880464481,0.00269806066006973,0.00345792991090813,0.0140343276983815,0.00119189392330029
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPT,Dermatopontin,42310,0.00812372287259867,0.00250703901630939,0.00320992640063227,0.0130375193445651,0.00119661258563653
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00914484334968954,0.00282259512110537,-0.0146771297870561,-0.00361255691232301,0.00119927768440792
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTB,Lymphotoxin-beta,39919,0.0110581558098588,0.00341399019834773,0.00436673502109729,0.0177495765986204,0.00120265777079587
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLUL1,Clusterin-like protein 1,42123,0.0142899177264442,0.00441210538533975,0.00564219117117828,0.0229376442817101,0.00120324307743733
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0197808654542901,0.00610911425383728,0.00780700151676906,0.0317547293918112,0.00120747351582139
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCDH1,Protocadherin-1,42264,0.0065755003098698,0.00203368131298499,0.00258948493641921,0.0105615156833204,0.00122659772137943
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGSF9,Protein turtle homolog A,39958,-0.0276037594278801,0.00854289918593161,-0.0443478418323061,-0.0108596770234542,0.00123625738623831
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1B,Interleukin-1 beta,41825,0.0180097629586089,0.00557492025744308,0.00708291925402049,0.0289366066631973,0.00123877330477522
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GET3,ATPase GET3,39958,0.01733230922651,0.00536523649127743,0.00681644570360621,0.0278481727494137,0.00123932760938345
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0159498142235134,0.00494030940299373,0.00626680779364571,0.0256328206533811,0.0012474214928633
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,42126,-0.00927746923608709,0.00287449074158381,-0.0149114710895914,-0.00364346738258283,0.00125166856556688
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPA1,Carboxypeptidase A1,42310,-0.0206144050052719,0.00638755717683577,-0.03313401707187,-0.00809479293867375,0.0012526882490277
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0179771435941556,0.00557268233803656,0.00705468621160392,0.0288996009767072,0.00125919832459525
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH3,Cadherin-3,42249,-0.011694652522127,0.00363344754924859,-0.0188162097186543,-0.0045730953255998,0.00129114322197945
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0212481997713676,0.00660768364122155,0.00829713983457338,0.0341992597081619,0.0013051258320359
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0103942496833571,0.00323431504258922,-0.0167335071668319,-0.00405499219988222,0.00131325114655423
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENAH,Protein enabled homolog,41913,0.0152964435917972,0.00476032625326861,0.00596620413539069,0.0246266830482036,0.00131523224431808
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PENK,Proenkephalin-A,39736,0.00991633996282875,0.00309006675641037,0.00385980912026442,0.0159728708053931,0.00133527431960194
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0135406285130992,0.00422274004955737,0.00526405801596676,0.0218171990102317,0.00134628364481591
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0607697172235464,0.0189729040553925,0.0235828252749771,0.0979566091721156,0.00136332264651356
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0161282320735526,0.00504412537537376,0.00624174633782006,0.0260147178092852,0.00139051926130422
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.019811417640964,0.00619825120533332,-0.0319599900034173,-0.00766284527851069,0.00139525878054651
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSZ,Cathepsin Z,42168,-0.0101809001281595,0.00318737834418378,-0.0164281616827597,-0.00393363857355934,0.00140573582437354
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0133529535071265,0.00418494251608781,0.00515046617559439,0.0215554408386586,0.00142321844748556
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0230995003016243,0.00725113930958029,0.00888726725484694,0.0373117333484017,0.00144770520133028
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0215928829635086,0.0067845578596161,0.00829514955866108,0.0348906163683562,0.00146260336842753
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00682502350736609,0.00214705541631057,0.00261679489139737,0.0110332521233348,0.00148302932302476
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK4,Kallikrein-4,42262,-0.0196429885485387,0.00618214436295918,-0.0317599914999386,-0.00752598559713867,0.0014894577139542
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCTN2,Dynactin subunit 2,42070,0.0297835943122524,0.0093784895126641,0.0114017548674308,0.048165433757074,0.00149794396325003
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00505698008083657,0.00159313586406064,0.00193443378727772,0.00817952637439542,0.00150566507698158
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0153860286939852,0.00485070581558935,0.00587864529543009,0.0248934120925403,0.00151842802197817
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.046292996871649,0.0146022893290706,-0.0749134839566274,-0.0176725097866705,0.00152723856225916
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.00944057724297802,0.00297891086080526,-0.0152792425301563,-0.00360191195579972,0.00153235503180103
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0209272036450432,0.00660366683567614,-0.0338703906429684,-0.00798401664711797,0.00153354290698317
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0328537613501119,0.0103757072550232,-0.0531901475699573,-0.0125173751302665,0.00154677607676935
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.019886067590477,0.00628536239774226,0.00756675729090213,0.0322053778900518,0.00156038468292045
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL22,Interleukin-22,39919,-0.0220927019049852,0.00698608923321889,-0.0357854368020942,-0.00839996700787615,0.00156895924664791
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0221282272105282,0.00700333439605253,0.00840169179426528,0.0358547626267912,0.00158301284976244
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NIT2,Omega-amidase NIT2,39903,0.0228767486811716,0.00724252585804235,0.00868139799940863,0.0370720993629346,0.00158908214780335
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.012505124236501,0.00396057515842345,0.00474239692599102,0.0202678515470109,0.00159539426801973
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.00972336070073805,0.00308340729265462,0.00367988240713498,0.0157668389943411,0.00161786363852717
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0228869508598787,0.00727051078630913,-0.0371371520010446,-0.0086367497187128,0.00164796210932762
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.00913239920726885,0.00290336612457353,-0.014822996811433,-0.00344180160310473,0.00166189667155407
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.0235680677558763,0.00749947612047624,-0.0382670409520098,-0.00886909455974291,0.00167883380647228
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0114863335765896,0.00365709945612564,-0.0186542485105959,-0.00431841864258338,0.00168831368809163
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0209688642665854,0.00667943888225569,0.0078771640573642,0.0340605644758065,0.00169704184953621
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERMAP,Erythroid membrane-associated protein,39657,-0.0139474143255296,0.00444334392979243,-0.0226563684279228,-0.00523846022313643,0.00170003010106754
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INSL4,Early placenta insulin-like peptide,39919,-0.0149745503986647,0.00477631252634701,-0.0243361229503048,-0.00561297784702453,0.00172194095295861
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUCB2,Nucleobindin-2,42231,0.011566749606109,0.00369928972787719,0.00431614173946968,0.0188173574727483,0.00177122628103748
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD72,B-cell differentiation antigen CD72,39736,-0.0135067811503434,0.00432762326455218,-0.0219889227488657,-0.00502463955182118,0.00180660865726867
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.00749958637456228,0.00240846426937482,0.00277899640658764,0.0122201763425369,0.0018505306332832
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEB,Nebulin,39575,-0.0123264233651481,0.0039594959882568,-0.0200870355021314,-0.00456581122816477,0.0018559074873627
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0125634578620729,0.00403631203301837,0.00465228627735693,0.020474629446789,0.00185914959388353
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0157984391830726,0.00508481871069431,0.00583219451011171,0.0257646838560334,0.00189489301341513
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.00972683103056272,0.00313384113067518,-0.0158691596466861,-0.00358450241443938,0.00191440234084863
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0104250676778211,0.00335908868055062,0.0038412538639419,0.0170088814917003,0.0019161282460468
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRL,Prolactin,42249,-0.0225067388439153,0.00725954322076517,-0.036735443556615,-0.00827803413121552,0.00193720374077715
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,41839,-0.0179016229338575,0.00578327214086125,-0.0292368363299455,-0.00656640953776944,0.00196948338129863
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.014701939400346,0.00475134744039129,0.00538929841717903,0.0240145803835129,0.00197780120966187
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.010465944642007,0.00338462589055207,0.00383207789652491,0.017099811387489,0.00199082915150438
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.0103539798964903,0.00335594701055788,0.0037763237557968,0.0169316360371837,0.0020378843625541
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RPL14,60S ribosomal protein L14,39638,-0.0119573510773296,0.00388058202117017,-0.0195632918388231,-0.00435141031583604,0.00206585899587152
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSC1,Hamartin,39657,0.0227063958419939,0.0073693001808317,0.00826256748756377,0.037150224196424,0.00206664508604868
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0127947887546302,0.00416771933040737,-0.0209635186422286,-0.00462605886703177,0.00214592942914744
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0119224604765356,0.00388903189727557,0.00429995795787545,0.0195449629951957,0.00217712982452098
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.018891208397517,0.00617396595711391,-0.0309921816734603,-0.00679023512157372,0.0022199895715168
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPR15L,Protein GPR15L,39930,0.0189618834591662,0.00619734041563717,0.0068150962445174,0.0311086706738151,0.00222090823750578
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0129366194423284,0.00423426905251991,-0.0212357867852674,-0.00463745209938936,0.00225334292261235
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0154587591256344,0.00506306767208719,-0.0253823717629253,-0.00553514648834355,0.00226828364710612
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0131902464901703,0.00432945332232612,0.0047045179784111,0.0216759750019295,0.00231967633870472
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00908884504299756,0.00298467966591936,-0.0149388171881995,-0.00323887289779561,0.00233085819013612
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCN4,CCN family member 4,42262,-0.0117600498508536,0.00386279446401057,-0.0193311270003143,-0.00418897270139289,0.00233556709164837
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0147705881461751,0.00487216037325118,0.00522115381460284,0.0243200224777474,0.00243786655872084
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00553576608061785,0.0018269461493874,0.00195495162781855,0.00911658053341714,0.00245049928273288
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.00865584370002088,0.00286276999732413,0.00304481450526559,0.0142668728947762,0.00250263505447946
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHRDL2,Chordin-like protein 2,42145,0.013625666917508,0.00451588236721475,0.00477453747776712,0.022476796357249,0.00255530551225133
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0255182455499808,0.00846472228372276,0.00892738987388417,0.0421091012260774,0.00257756224094961
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0188740959419252,0.00626607318276574,-0.031155599380146,-0.00659259250370436,0.00260030405484961
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AZU1,Azurocidin,41751,-0.0223468461470402,0.0074206340771597,-0.0368912889382732,-0.00780240335580719,0.00260499684313762
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AP2B1,AP-2 complex subunit beta,39649,0.0145260243630774,0.00482728749806283,0.00506454086687429,0.0239875078592806,0.00262571850370215
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00902972517762737,0.0030020005259381,-0.014913646208466,-0.0031458041467887,0.00263547186393443
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNM3,Dynamin-3,39934,0.016483919045685,0.00548326982028635,0.00573671019792372,0.0272311278934462,0.00265096328604063
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STC1,Stanniocalcin-1,42249,0.0135642480582928,0.00451850496721156,0.00470797832255815,0.0224205177940275,0.00268756773032934
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0162189853360438,0.00541356459472093,0.00560839873039081,0.0268295719416969,0.00274059154247671
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0263808970248676,0.00882942193173209,0.00907523003867272,0.0436865640110625,0.00281573737340766
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YAP1,Transcriptional coactivator YAP1,39929,-0.00817322791671307,0.00274281548146305,-0.0135491462603806,-0.0027973095730455,0.00288984581731482
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0170841690785816,0.00573636883757841,0.00584088615692789,0.0283274520002353,0.00290552297734127
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.00696690802470889,0.0023451684190612,-0.0115634381260688,-0.00237037792334893,0.00297713744523803
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0184389392577728,0.00621398413001398,0.00625953036294537,0.0306183481526002,0.00301024801819864
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.00774055125842323,0.0026099430002769,0.00262506297788051,0.0128560395389659,0.00302539453364495
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0195339791076784,0.0065960331308233,0.00660575417126476,0.0324622040440921,0.00306695916568937
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.00872965147098225,0.00294919170189687,0.0029492357352644,0.0145100672067001,0.00308259543887823
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00989776304205572,0.00334978689890921,-0.0164633453639178,-0.00333218072019367,0.00313589313321066
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0437070522018405,0.0147989814708303,-0.0727130558846678,-0.0147010485190132,0.00314853248124637
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRDX1,Peroxiredoxin-1,41742,-0.0266917801399944,0.00904546316609267,-0.044420887945536,-0.00896267233445272,0.00317462916023681
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0142476550048336,0.00483358284111251,-0.0237214773734141,-0.0047738326362531,0.00320770047879583
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALCAM,CD166 antigen,42310,-0.00572384466937972,0.00194356800337811,-0.00953323795600081,-0.00191445138275862,0.00323477270807686
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBP5,Retinol-binding protein 5,42070,-0.0163485558877957,0.00556260418511239,-0.027251260090616,-0.00544585168497537,0.00329819937093411
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0134995170267325,0.00459613197818599,-0.0225079357039771,-0.004491098349488,0.00331800088691665
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RSPO1,R-spondin-1,42016,0.00988031858237461,0.00336442817092526,0.00328603936736111,0.0164745977973881,0.00332287655832699
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEFL,Neurofilament light polypeptide,41797,-0.0136922843006749,0.00466521291777912,-0.022836101619522,-0.00454846698182785,0.00334149219954978
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0231027960804549,0.00787798981718265,0.00766193603877691,0.0385436561221329,0.00336853692027719
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.00709190862167761,0.00242025036251873,-0.0118355993322143,-0.0023482179111409,0.00339261498371556
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD59,CD59 glycoprotein,41638,-0.00682032521213897,0.00233302465877485,-0.0113930535433377,-0.00224759688094027,0.00346845430390415
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.00666454688995527,0.00227972555556779,0.0021962848010424,0.0111328089788681,0.0034691680054662
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PI16,Peptidase inhibitor 16,39990,0.00699545664411269,0.00239971262238306,0.00229201990424188,0.0116988933839835,0.00356241485454312
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSPB6,Heat shock protein beta-6,42262,-0.0117005338057022,0.00401740502918375,-0.0195746476629024,-0.00382641994850207,0.00359173933651102
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPL,N-acetylneuraminate lyase,39958,0.0134128077798992,0.00460920106424143,0.00437877369398595,0.0224468418658124,0.00362122201966536
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0095073767632408,0.00326981789684629,0.00309853368542207,0.0159162198410595,0.00364782746849853
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.021113789794037,0.00727019607861539,0.00686420547995086,0.0353633741081232,0.00368832104496499
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP13,Collagenase 3,41839,-0.00922434316353721,0.00318053311066019,-0.0154581880604312,-0.00299049826664325,0.00373477832353249
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLSTN2,Calsyntenin-2,42296,-0.011464238832668,0.00395425182291411,-0.0192145724055796,-0.00371390525975633,0.00374688612647387
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0256552003405716,0.00885020296164578,-0.0430015981453973,-0.00830880253574585,0.00375281973304881
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0115761155938164,0.00399483966616252,0.00374622984813789,0.019406001339495,0.00376568746116461
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0141692185726205,0.00489046266860288,0.00458391174215882,0.0237545254030821,0.00377108493367136
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0196674035917205,0.00679028262300511,0.00635844965063051,0.0329763575328105,0.00378068243893589
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0143798645448347,0.00496807854733416,-0.0241172984976097,-0.00464243059205974,0.003804201018601
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.00792908513367016,0.00275078209801618,0.00253755222155844,0.0133206180457819,0.00395314738699495
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEZ6L,Seizure 6-like protein,42181,0.00782573714849329,0.00271739997282495,0.00249963320175639,0.0131518410952302,0.00398471094047725
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DRAXIN,Draxin,42016,-0.0120402352605123,0.00419831614690586,-0.0202689349084478,-0.00381153561257683,0.00413886200867617
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0158132580556466,0.00551678875823926,0.00500035208949767,0.0266261640217956,0.00415968623603499
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSH,Pro-cathepsin H,41865,0.0211170902744615,0.00737397739661341,0.00666409457709919,0.0355700859718237,0.00419339524136153
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOBR,Apolipoprotein B receptor,39638,0.0121845066928371,0.00426565901910559,0.00382381501539018,0.0205451983702841,0.00429250270002932
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.0357233643856553,0.0125283114481324,0.0111678739473158,0.0602788548239948,0.00435908039692312
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0169276771743834,0.00594215714945354,0.00528104916145443,0.0285743051873123,0.00439577780316807
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF2,Fibroblast growth factor 2,42119,0.019406809949641,0.00681625958331817,0.00604694116633735,0.0327666787329446,0.00441811433267755
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL4,C-C motif chemokine 4,42148,0.0174599519182407,0.00613852691762956,0.00542843915968676,0.0294914646767946,0.00445726111272993
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.00928996453801928,0.00326615897161075,-0.0156916361223764,-0.00288829295366221,0.00445749585730245
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0150742587005992,0.00530618943238415,0.00467412741312632,0.0254743899880722,0.0045057738083583
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00943201696212067,0.0033305627467788,-0.0159599199458071,-0.00290411397843421,0.00463328070217395
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0102327964124821,0.00361369168271373,0.00314996071436323,0.0173156321106011,0.00463739783048341
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.00838977142370965,0.00297668438370759,0.00255547003164277,0.0142240728157765,0.00483208624386489
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0102739404964701,0.00364790203985582,0.00312405249835266,0.0174238284945875,0.00486371222835609
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.00932237277724642,0.00331114210055341,-0.0158122112943311,-0.00283253426016174,0.00487779028100815
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ELAVL4,ELAV-like protein 4,39586,-0.0228904591222484,0.00815476959264676,-0.038873807523836,-0.00690711072066071,0.0050092925592947
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0113062177543281,0.00403558730688378,-0.0192159688758203,-0.00339646663283589,0.00509315471001928
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NECTIN1,Nectin-1,39657,0.00919391623695181,0.00328691786729478,0.00275155721705404,0.0156362752568496,0.0051648866247556
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CR1,Complement receptor type 1,39970,0.00978519510094157,0.00352687533033277,0.00287251945348933,0.0166978707483938,0.00553826699794105
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0181589825160753,0.00654566601901232,0.00532947711881119,0.0309884879133395,0.00554283121170401
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00751245992837916,0.002713920805776,-0.0128317447077001,-0.00219317514905819,0.0056456267447123
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCLY,Selenocysteine lyase,42224,-0.0132977746821825,0.00480603636775683,-0.0227176059629859,-0.00387794340137909,0.00566701340203783
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0161667314722417,0.00585082023118682,0.00469912381911548,0.0276343391253678,0.00573400515934551
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0349835332976742,0.0126800241405668,-0.0598363806131852,-0.0101306859821633,0.00580649217142668
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0130817126087113,0.00474244440993608,0.00378652156523654,0.022376903652186,0.0058158572323082
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COCH,Cochlin,39958,0.0125725026316783,0.00455838966236437,0.0036380588934441,0.0215069463699124,0.00582310632149188
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0125980532491138,0.00456929246674938,0.00364224001428503,0.0215538664839426,0.00583917839038233
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTO1,Protein LTO1 homolog,41913,0.0112516623306247,0.0040811343086863,0.0032526390855995,0.0192506855756498,0.00584149097497621
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCS1,Neuronal calcium sensor 1,42262,0.00769590315181805,0.00279193139508952,0.00222371761744259,0.0131680886861935,0.00585046856325167
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBC1D17,TBC1 domain family member 17,41839,-0.0116824452410553,0.00424463598670272,-0.0200019317749926,-0.003362958707118,0.00592616805031603
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERVV_1,,39575,0.0119278791214024,0.0043356131443661,0.00343007735844485,0.02042568088436,0.00594856349105855
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL8,Interleukin-8,42035,-0.0183744118710882,0.00669588510690748,-0.0314983466806269,-0.00525047706154957,0.00607511355858964
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0159539790364111,0.00581620560182851,0.00455421605682721,0.027353742015995,0.00609586037308201
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.0227577391643205,0.00830536525570839,-0.039036255065509,-0.00647922326313207,0.006151199065372
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0145790322243165,0.00532128459862968,0.00414931441100235,0.0250087500376307,0.00615663193234002
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",41900,-0.0117622089372267,0.00430992208452834,-0.0202096562229022,-0.00331476165155115,0.00635909042625017
NMR metabolomics,X23505.Cholesterol in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0222302211596977,0.00815756075408513,0.00624140208169081,0.0382190402377045,0.00643634635772843
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0139240980817525,0.00511893895662482,-0.0239572184367372,-0.00389097772676788,0.00653445373871413
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.010582232967424,0.00389712799204717,-0.0182206038318364,-0.00294386210301149,0.0066280890862355
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HLA_DRA,,42060,-0.00974086509960822,0.00358744792992612,-0.0167722630422634,-0.00270946715695303,0.00663075968409665
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00694489844730928,0.00256588851673875,0.00191575695450133,0.0119740399401172,0.00680565994333979
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,-0.0134349392982168,0.00498434535996204,-0.0232042562037424,-0.00366562239269124,0.00703872648258701
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM20A,Pseudokinase FAM20A,39958,-0.00753250325727393,0.00279555925975907,-0.0130117994064017,-0.00205320710814615,0.00706079264447321
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0148537960590261,0.00551863597705955,0.00403726954398939,0.0256703225740628,0.00712225839769246
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0158073831941009,0.00587813089234877,0.00428624664509731,0.0273285197431045,0.00717158724062995
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PARK7,Parkinson disease protein 7,42137,0.0134124666229706,0.00499762370094419,0.00361712416912004,0.0232078090768212,0.0072885967437802
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.00996014228153902,0.00371316689391269,0.00268233516947016,0.0172379493936079,0.00732054718146191
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FEN1,Flap endonuclease 1,41843,-0.0169886702125597,0.00634354698304047,-0.029422022299319,-0.00455531812580037,0.00741318741006266
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PFDN2,Prefoldin subunit 2,41839,0.0145617852732544,0.00543905109074314,0.00390124513539787,0.025222325411111,0.00743172448819076
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SDC1,Syndecan-1,42145,-0.010694895979295,0.00399977064868814,-0.0185344464507237,-0.00285534550786622,0.00750698218493225
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRDX2,Peroxiredoxin-2,39819,-0.0159597098296249,0.00599137978054142,-0.027702814199486,-0.00421660545976367,0.00773787843616677
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNPY2,Protein canopy homolog 2,41900,0.0160086121084896,0.00601744370818662,0.00421442244044378,0.0278028017765353,0.00781490620290526
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCDH7,Protocadherin-7,39930,0.00922404545147689,0.00346823310685321,0.00242630856204461,0.0160217823409092,0.00783480851178371
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.00972429883828742,0.00367113699376999,-0.0169197273460766,-0.00252887033049824,0.00808614928511198
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0125948792761648,0.004755357379403,0.00327437881253493,0.0219153797397947,0.00809454555699646
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A16,Protein S100-A16,41814,-0.0158745161371262,0.00600050161857831,-0.0276354993095397,-0.00411353296471272,0.0081659231518222
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.00599106072732866,0.00226680463555903,0.00154812364163295,0.0104339978130244,0.00822992398857119
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD300A,CMRF35-like molecule 8,39736,-0.00805307681338496,0.00304739037478782,-0.0140259619479691,-0.00208019167880084,0.0082383837678313
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0135322413989673,0.00512211121160282,-0.0235715793737088,-0.00349290342422579,0.00825324146671487
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LMOD1,Leiomodin-1,39934,-0.00911436034995256,0.00345054659397009,-0.0158774316741339,-0.00235128902577117,0.00826713658173084
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0130760967750686,0.00495745252985734,-0.0227927037335889,-0.00335948981654816,0.00835766958822908
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRN,Progranulin,42077,-0.00652640180656765,0.00248005835952331,-0.0113873161912333,-0.00166548742190196,0.00850927266209326
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LY6D,Lymphocyte antigen 6D,42041,-0.0103182903452792,0.00392217745323556,-0.0180057581536209,-0.00263082253693755,0.00852924514933636
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0116279770833072,0.00444075166507738,0.00292410381975555,0.0203318503468589,0.00884443031396364
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.00710128237993328,0.00271317764215409,0.00178345420131128,0.0124191105585553,0.0088737973108839
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLHL41,Kelch-like protein 41,39934,-0.013637716907288,0.00521680050987125,-0.0238626459066356,-0.00341278790794034,0.00895571145265249
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.00733528866526452,0.00280791438770287,0.00183177646536689,0.0128388008651622,0.00900376755184564
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00768289993264574,0.00294470542134634,0.00191127730680691,0.0134545225584846,0.0090897421380674
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP6,Gastrotropin,41881,0.0146496373006851,0.00561689593276123,0.00364052127247315,0.0256587533288972,0.00911382634584936
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0115946773107355,0.00445183173515384,0.00286908710983395,0.020320267511637,0.00921386697691415
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0076598582905177,0.00294787173138918,0.00188202969699491,0.0134376868840405,0.00937746513124257
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HLA_A,,39934,-0.00847760910644464,0.00326422300967089,-0.0148754862053996,-0.0020797320074897,0.00941280058334699
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZNRD2,Protein ZNRD2,39930,0.0180021529872531,0.00693678985768654,0.00440604486618752,0.0315982611083188,0.00946658593869637
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SH3GLB2,Endophilin-B2,39929,0.0169688083280519,0.00654008190235995,0.00415024779942642,0.0297873688566774,0.00948267716425025
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRH,Corticoliberin,41830,0.0219206633014491,0.00845703884245465,0.00534486717023794,0.0384964594326602,0.00955240396001283
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0217353420997567,0.00839872720483092,-0.0381968474212253,-0.00527383677828813,0.00966570765216704
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0294887933514029,0.0113959598693911,0.00715271200739638,0.0518248746954094,0.00967554711912921
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BOC,Brother of CDO,41900,0.00594241319038761,0.00229756293054844,0.00143918984651268,0.0104456365342625,0.00970899706384205
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0179314371311877,0.00693580442107325,0.00433726046588409,0.0315256137964912,0.00973853729680974
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.00598281399802904,0.00231873499558537,-0.0105275345893764,-0.00143809340668171,0.0098844432140352
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAPS,Calcyphosin,39929,0.0243136905134035,0.00944202369268804,0.00580732407573491,0.042820056951072,0.01003510541665
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.01007081282555,0.00391836410417782,0.00239081918136146,0.0177508064697385,0.0101778907995835
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0264035891049363,0.010291521836784,0.00623220630483975,0.0465749719050328,0.0103138039695256
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00783347671342612,0.00305393307221614,0.0018477678918825,0.0138191855349698,0.0103270903802645
NMR metabolomics,X23505.Cholesterol in Medium VLDL,METAP1,Methionine aminopeptidase 1,41839,0.00730988074692875,0.00286217413539426,0.001700019441556,0.0129197420523015,0.0106616222659218
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GZMH,Granzyme H,41900,-0.0198508918453287,0.00777691621697755,-0.0350936476306047,-0.00460813606005273,0.0107051266928126
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASE4,Ribonuclease 4,39645,0.00704552143010002,0.00276238882516093,0.00163123933278459,0.0124598035274154,0.0107696812491804
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNN,Tenascin-N,39966,-0.0109337233908674,0.00429140547023219,-0.0193448781125225,-0.00252256866921226,0.0108529242406442
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0120061926952682,0.00472548059111877,0.00274425073667539,0.021268134653861,0.0110756346411853
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.00901691255031764,0.00355591779285897,-0.0159865114243212,-0.00204731367631406,0.0112343960242441
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.00621956890946057,0.00245533970031981,0.00140710309683375,0.0110320347220874,0.011317707602234
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS3,Galectin-3,42196,-0.00738860561033184,0.00292455735456587,-0.013120738025281,-0.00165647319538273,0.0115350285659032
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0170689563026477,0.00675804242537902,0.00382319314890485,0.0303147194563906,0.0115597373558555
NMR metabolomics,X23505.Cholesterol in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00748519404923536,0.00297532665575799,0.00165355380394971,0.013316834294521,0.0118918105915477
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPEP1,Dipeptidase 1,41997,0.0113553143863257,0.00453490513561169,0.00246690032052674,0.0202437284521246,0.0122922703075315
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OPTC,Opticin,42070,0.0111874506509796,0.00448703423460634,0.00239286355115118,0.019982037750808,0.0126686636069818
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DSG3,Desmoglein-3,42196,0.00864162530247688,0.00347090954308551,0.00183864259802928,0.0154446080069245,0.0127958964816419
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00852259198986432,0.00342915067013245,-0.0152437273033239,-0.00180145667640473,0.0129550984696321
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ROBO1,Roundabout homolog 1,42144,-0.00587267935437735,0.00236409065206238,-0.0105062970324196,-0.00123906167633509,0.0129992827974151
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00859524934461213,0.00346145163447009,0.00181080414105076,0.0153796945481735,0.0130377777983371
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINI2,Serpin I2,39930,-0.0142533560187327,0.00574417003374157,-0.0255119292848662,-0.0029947827525992,0.0131025901613055
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP6AP2,Renin receptor,41843,0.00957585294745691,0.00388130265993507,0.00196849973398418,0.0171832061609296,0.0136309340753992
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0108971762069908,0.00441749078796008,0.00223889426258907,0.0195554581513926,0.0136468592999677
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SDK2,Protein sidekick-2,39736,0.00966543064475915,0.0039215615777115,0.00197916995244461,0.0173516913370737,0.0137281958301165
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0338802903743968,0.0137611436340535,-0.0608521318971417,-0.00690844885165194,0.0138302068722412
NMR metabolomics,X23505.Cholesterol in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,39767,-0.00977487025559494,0.00397075898193156,-0.0175575578601808,-0.00199218265100908,0.0138425165996751
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.016430613504733,0.00667725838522757,-0.029518039939779,-0.00334318706968693,0.0138825847484795
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK11,Kallikrein-11,42062,-0.00782333253047591,0.00318118646588685,-0.0140584580036141,-0.00158820705733767,0.0139352521178324
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.00848026773663045,0.00344873961897014,0.00172073808344898,0.0152397973898119,0.0139493576680916
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MUC2,Mucin-2,39966,0.0226342737805591,0.00920885687753572,0.00458491430058911,0.0406836332605291,0.0139907662306556
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNG,Interferon gamma,41913,-0.0277124815709191,0.0112838633782194,-0.0498288537922291,-0.00559610934960918,0.0140643780198874
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPA4,Carboxypeptidase A4,39518,0.0107652948437535,0.00439253347179336,0.00215592923903847,0.0193746604484684,0.014268819261496
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0101489067566,0.00414523616837527,0.0020242438665845,0.0182735696466156,0.0143675203149286
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0106424817910775,0.00434745442995166,-0.0191634924737827,-0.0021214711083722,0.0143814946601026
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CR2,Complement receptor type 2,42217,-0.0112852510501591,0.00461129664890188,-0.0203233924820068,-0.00224710961831144,0.0144054274692814
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP10,Caspase-10,41839,0.0171803410147098,0.00702428311473941,0.00341274610982052,0.030947935919599,0.0144640485503457
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLTP,Phospholipid transfer protein,42267,-0.00910184470497275,0.0037328658262792,-0.01641826172448,-0.00178542768546552,0.0147691928253302
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0142334997058912,0.0058527031542851,-0.02570479788829,-0.00276220152349237,0.015033519390582
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF16,Fibroblast growth factor 16,39657,0.0112636930264063,0.00463195685668519,0.00218505758730337,0.0203423284655093,0.0150424553385071
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLRD1,Natural killer cells antigen CD94,42296,-0.0113116822899241,0.00465937979078601,-0.0204440666798647,-0.00217929789998351,0.0152067527454359
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0142922510710679,0.0058886573375044,-0.0258340194525766,-0.0027504826895593,0.0152368240985867
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0135901198439075,0.00559956337064412,0.002614975637445,0.02456526405037,0.0152373776944675
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX8,Syntaxin-8,42119,0.0114345740096395,0.00471975863769273,0.00218384707976178,0.0206853009395173,0.0154185625927752
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0243682744453148,0.0100689569466702,-0.0441034300607885,-0.00463311882984117,0.0155307113589992
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0110424399571116,0.00457194332371363,0.00208143104263286,0.0200034488715903,0.0157396243977618
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0118690766366508,0.00492782514904345,0.00221053934452568,0.021527613928776,0.0160278528490353
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LPL,Lipoprotein lipase,42145,-0.0114222534744121,0.00474924796630582,-0.0207307794883715,-0.00211372746045271,0.0161828850249085
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CORO6,Coronin-6,39586,-0.00934119958081967,0.00388450422961341,-0.016954827870862,-0.00172757129077738,0.016200678303359
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0107833315396736,0.0044858051849937,0.00199115337708599,0.0195755097022613,0.0162355849123569
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLMP,CXADR-like membrane protein,42262,-0.0052531645705631,0.00218620500930348,-0.00953812638879791,-0.000968202752328288,0.0162802573190116
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0181958331833218,0.00760467251100299,0.00329067506175597,0.0331009913048877,0.0167407249076329
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TLR1,Toll-like receptor 1,39657,-0.00637307156992118,0.00266577061587798,-0.011597981977042,-0.00114816116280033,0.0168326781982002
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ESYT2,Extended synaptotagmin-2,39929,0.0198203510293676,0.00829242837173186,0.00356719142077311,0.036073510637962,0.016856607063472
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.00738089716698047,0.00308840777257421,-0.0134341764012259,-0.00132761793273502,0.0168678797371124
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0246380720976748,0.0103379757735713,0.004375639581475,0.0449005046138745,0.0171765028917407
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00630729557442975,0.00264666926524336,0.00111982381455277,0.0114947673343067,0.0171841766108205
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPEP2,Dipeptidase 2,42070,0.00707996069485251,0.00297428797413624,0.00125035626554548,0.0129095651241595,0.017308222847327
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIF22,Kinesin-like protein KIF22,39575,0.0293889131286471,0.0123633952039197,0.00515665852896454,0.0536211677283297,0.0174668306819554
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,0.007281211754374,0.00307021400856841,0.00126359229757991,0.0132988312111681,0.0177298439054931
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00621119382883762,0.00262398937455769,-0.0113542130029707,-0.00106817465470454,0.0179456595546073
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00806670291290442,0.003414428024033,-0.0147589818400091,-0.00137442398579975,0.0181644168776892
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LARP1,La-related protein 1,39919,0.0146015792691677,0.00618360090296074,0.00248172149936462,0.0267214370389707,0.0182259108073348
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ELN,Elastin,39958,0.00814219412188986,0.00344813527067263,0.0013838489913715,0.0149005392524082,0.0182261791320455
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TREML2,Trem-like transcript 2 protein,42137,0.00802935133646986,0.003403176555999,0.00135912528671182,0.0146995773862279,0.0183201308971147
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAP3,Cytosol aminopeptidase,41913,0.0111808862591327,0.00474346762591472,0.00188368971233984,0.0204780828059255,0.0184320672372816
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0068411424926045,0.00290958617029152,0.00113835359883312,0.0125439313863759,0.0187279763261353
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.00840946856694804,0.00358058715579147,0.00139151774159676,0.0154274193922993,0.0188597858874646
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PALM3,Paralemmin-3,39575,-0.0177092023327478,0.00754581528865234,-0.0324990002985064,-0.00291940436698916,0.0189484952391226
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0274433449185848,0.0117270367359444,-0.0504283369210358,-0.00445835291613374,0.0192918447865048
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F11R,Junctional adhesion molecule A,42137,0.0128582305232343,0.005500861264988,0.00207654244385781,0.0236399186026108,0.0194280034749996
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0141169534160695,0.00605339825197402,0.00225229284220043,0.0259816139899386,0.0197115725221781
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.0152385893227591,0.00654095475158529,-0.0280588606358663,-0.00241831800965197,0.0198387337515575
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CENPF,Centromere protein F,39757,-0.0124983033587789,0.00536748600865973,-0.0230185759357519,-0.00197803078180581,0.0199022341089196
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00689954664556138,0.00298885985465729,0.00104138133043308,0.0127577119606897,0.0209941062966233
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0107885574165738,0.00467378208760681,-0.0199491703082832,-0.00162794452486446,0.0209968267520009
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.0130004828314731,0.00563640343114251,0.00195313210643378,0.0240478335565124,0.0210999672003775
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRG3,Proteoglycan 3,39966,0.0113807382257841,0.00493958909120651,0.00169914360701929,0.0210623328445488,0.0212414449915877
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0147248877081907,0.00641059717084651,0.00216011725333153,0.0272896581630499,0.0216396279019288
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0121605619942165,0.00532793259831169,0.00171781410152558,0.0226033098869074,0.0224802096976983
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPPC,C-type natriuretic peptide,42119,0.0118373987658112,0.00519136447323682,0.00166232439826709,0.0220124731333554,0.0226107621406886
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0380308561162528,0.0166884000746972,0.00532159196984627,0.0707401202626594,0.0226899513620757
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.0149831283662081,0.0065771260341662,0.00209196133924236,0.0278742953931739,0.0227385210967413
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.0134581126942542,0.00591282078878218,0.0018689839482411,0.0250472414402673,0.0228565122228875
NMR metabolomics,X23505.Cholesterol in Medium VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00631691297062681,0.00277841514066079,0.000871219294931659,0.011762606646322,0.0230111219325167
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0142833925529821,0.00629328939569434,-0.0266182397685431,-0.00194854533742123,0.0232460438341429
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IDUA,Alpha-L-iduronidase,42262,-0.0105569546099466,0.00465506162914741,-0.0196808754030755,-0.00143303381681768,0.0233542483062319
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLO1,Lactoylglutathione lyase,41900,-0.0126571041154155,0.00558177716051801,-0.0235973873500308,-0.00171682088080017,0.023371032789544
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRR5,Proline-rich protein 5,39657,0.0106449760615393,0.00469996314596547,0.00143304829544695,0.0198569038276316,0.0235377005244132
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0117732199348386,0.00519845697557026,-0.0219621956069563,-0.00158424426272092,0.0235472512278956
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.00707487339837561,0.00312580214358956,-0.0132014455998111,-0.000948301196940078,0.0236316816266969
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.00853613765017881,0.00377272836529398,0.00114159005420262,0.015930685246155,0.0236771058258438
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,39930,-0.0174633222796762,0.00772804170730767,-0.0326102840259992,-0.00231636053335314,0.0238566456451205
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFRC,Transferrin receptor protein 1,42200,-0.00835678231259388,0.00370407549488315,-0.0156167702825649,-0.00109679434262292,0.0240798871355113
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.007631504920122,0.00338493716268018,-0.0142659817589751,-0.000997028081268845,0.0241776792497433
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0112833785315667,0.00501178126853041,-0.0211064698178863,-0.00146028724524713,0.0243778937204198
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0109499036818471,0.00487538386765959,0.00139415130123426,0.0205056560624599,0.0247227990929015
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,39930,-0.0118783707220812,0.00530475763564893,-0.0222756956879531,-0.00148104575620928,0.0251627554299453
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NINJ1,Ninjurin-1,41843,0.0119995857183562,0.00535989420173335,0.00149419308295882,0.0225049783537535,0.0251872411080515
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0127363380284132,0.00569515960271012,0.00157382520710132,0.023898850849725,0.0253458078049673
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0153611725731779,0.00687539373898251,0.00188540084477221,0.0288369443015836,0.0254847176039864
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAD1,Glutamate decarboxylase 1,39560,0.0058485060839924,0.0026215584514912,0.000710251519069647,0.0109867606489151,0.0257061038666256
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KITLG,Kit ligand,42145,-0.00840150641666679,0.00377148468543442,-0.0157936164001182,-0.00100939643321534,0.0259209590020287
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0118080367128603,0.00530214436395801,-0.022200239666218,-0.00141583375950265,0.0259617051969344
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00606533780306213,0.00272515999737895,-0.0114066513979249,-0.000724024208199399,0.0260522293833859
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00560726508564083,0.00252049811190929,-0.010547441384983,-0.000667088786298609,0.0261233275470816
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA2,Carbonic anhydrase 2,42103,-0.0145143357948437,0.00654921947284473,-0.0273508059616193,-0.00167786562806798,0.0266948782113377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH5,Cadherin-5,42310,-0.00663864183968205,0.00300007542557994,-0.0125187896738187,-0.000758494005545357,0.0269261258135548
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NID2,Nidogen-2,42137,0.0159273843062057,0.0071985122328445,0.00181830032983049,0.0300364682825809,0.0269422804517088
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSO,Cathepsin O,42296,-0.0066860427752278,0.00302188242940725,-0.012608932336866,-0.000763153213589593,0.0269456479309785
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00885376015389105,0.00400423689075899,-0.0167020644597787,-0.00100545584800344,0.0270492540960688
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0102022925542068,0.00463329304155841,0.0011210381927523,0.0192835469156613,0.0276893693511398
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00992386709317309,0.00450820250356034,-0.0187599440001514,-0.00108779018619482,0.0277361251240605
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP1,Interstitial collagenase,41693,-0.0195570187867887,0.00890327750436996,-0.0370074426953539,-0.00210659487822361,0.0280658538981576
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.00826598550735644,0.00376785706169743,0.00088098566642947,0.0156509853482834,0.0282655651552642
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0143824901635615,0.00657280856142135,0.00149978538317565,0.0272651949439473,0.0286771792197014
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.00850982639421495,0.00389673078701628,-0.0161474187367669,-0.00087223405166304,0.0289946286083561
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0182871107999557,0.00837659470783146,0.00186898517260599,0.0347052364273053,0.0290477870555773
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERC2,ERC protein 2,39649,0.01595681645795,0.0073152961160246,0.00161883607054177,0.0302947968453582,0.0291826363107601
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0101017412539211,0.00463658165835622,0.00101404120354291,0.0191894413042993,0.0293747100488755
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA5,Annexin A5,41780,-0.00652985704500116,0.00299822244707828,-0.0124063730412746,-0.000653341048727723,0.0294304464591928
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0114201357395617,0.00525415471164154,-0.0217182789743791,-0.00112199250474427,0.029756682862411
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDCP1,CUB domain-containing protein 1,42016,-0.0120094408165837,0.00552866422309031,-0.0228456226938407,-0.00117325893932668,0.0298569916299617
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPP7,Dipeptidyl peptidase 2,42054,-0.0134780610766011,0.0062121282286479,-0.025653832404751,-0.00130228974845119,0.0300518287130649
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.00919359508122066,0.00424739697739506,-0.017518493156915,-0.000868697005526347,0.0304456041863455
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDT,D-dopachrome decarboxylase,39966,-0.00870380327628892,0.00403966535596271,-0.0166215473739758,-0.000786059178602022,0.0312152511683426
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNGR2,Interferon gamma receptor 2,42016,-0.0111580509008393,0.00521205271226672,-0.0213736742168821,-0.000942427584796544,0.0323067701913058
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00730470209970185,0.00342099691751471,0.000599548141373017,0.0140098560580307,0.0327620679808951
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCC,Netrin receptor DCC,39649,0.00471795664987242,0.00221817845008811,0.000370326887699733,0.00906558641204511,0.0334462551801858
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0159480084155909,0.00750798098947079,0.00123236567622818,0.0306636511549537,0.0336799731664984
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.0112383427934546,0.00529131351656347,0.000867368300990245,0.021609317285919,0.0336982007307124
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPSD1,Tryptase delta,39934,-0.00772504446804458,0.00363719121806343,-0.0148539392554489,-0.000596149680640245,0.0336997782228987
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.00535725545548015,0.00252741238181616,-0.0103109837238398,-0.000403527187120487,0.0340563405698965
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CST7,Cystatin-F,42148,-0.0196785089127251,0.00931688477985926,-0.0379396030812492,-0.00141741474420097,0.0346932115350166
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FABP5,Fatty acid-binding protein 5,42218,0.0138594742634128,0.00656678253558161,0.000988580493672859,0.0267303680331528,0.0348298294774775
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.00805728109466193,0.00381838062757104,0.000573255064622683,0.0155413071247012,0.0348689894661944
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL1A,Interleukin-1 alpha,41913,0.0120586107214679,0.00571847559750486,0.000850398550358344,0.0232668228925774,0.0349881893484333
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.00588688156206925,0.00279367159752028,0.000411285230929509,0.011362477893209,0.035116684159197
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.00887204239991859,0.00421248428521075,0.000615573200905526,0.0171285115989317,0.0352155213012877
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.00700909431914602,0.00333002228521897,-0.0135359379981752,-0.000482250640116834,0.0353290280094613
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.00930496219194682,0.00442297998234545,-0.0179740029573439,-0.000635921426549738,0.0354204564989975
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UROS,Uroporphyrinogen-III synthase,39649,-0.0137834925685868,0.00655924194429215,-0.0266396067793994,-0.00092737835777414,0.0356297722352597
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LMNB1,Lamin-B1,39908,0.012722903487435,0.00607145929648156,0.000822843266331178,0.0246229637085389,0.0361464004709495
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0140350527427817,0.00670097214548908,0.000901147337623077,0.0271689581479403,0.0362397771464581
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00766065642640886,0.00366474373754714,0.000477758700816476,0.0148435541520013,0.0366075370343904
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANG,Angiogenin,42152,0.00676085346825831,0.00323691992813206,0.000416490409119476,0.0131052165273971,0.036756166079397
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DTNB,Dystrobrevin beta,39900,-0.00941523559748689,0.00451364635634051,-0.0182619824559143,-0.000568488739059479,0.0370056267268769
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00627491928382944,0.00301102855549101,-0.0121765352525918,-0.000373303315067063,0.0371812293383846
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0077793686089865,0.00374229932144586,-0.0151142752790204,-0.000444461938952611,0.0376619370500077
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX4,Syntaxin-4,42070,0.0121189296107725,0.0058319786898945,0.000688251378579257,0.0235496078429657,0.0377270206648727
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COPB2,Coatomer subunit beta',39575,0.00889291792695147,0.00428177242102889,0.000500643981734848,0.0172851918721681,0.0378317378763346
NMR metabolomics,X23505.Cholesterol in Medium VLDL,XRCC4,DNA repair protein XRCC4,41839,0.00755368517230384,0.00363715921559158,0.000424853109744348,0.0146825172348633,0.0378384268581594
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0118618411041996,0.00571580636880556,0.000658860621340728,0.0230648215870585,0.0379847945989068
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0111340593326649,0.00536746677822908,-0.0216542942179939,-0.000613824447335935,0.0380689727464393
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFRAL,GDNF family receptor alpha-like,39574,0.0130683745476768,0.00630041426431733,0.000719562589614801,0.0254171865057387,0.0380831862648683
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.0126351723151318,0.00609759744733355,0.00068388131835808,0.0245864633119056,0.0382734967904973
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL32,Interleukin-32,42119,-0.00906645590023667,0.0043855805980515,-0.0176621938724176,-0.000470717928055735,0.0387217642360835
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIAE,Sialate O-acetylesterase,42147,0.0094836896912183,0.00458872894934003,0.000489780950511847,0.0184775984319248,0.0387780263108039
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SWAP70,Switch-associated protein 70,39930,0.00752883784889672,0.00364423491792611,0.000386137409761557,0.0146715382880319,0.0388550844140111
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.00645571232051354,0.00312631106067491,0.000328142641590707,0.0125832819994364,0.0389499308222378
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0104867952906078,0.00508088407026956,-0.0204453280683361,-0.000528262512879435,0.0390437980969763
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.00727434935918043,0.00352479824367662,-0.0141829539167866,-0.000365744801574255,0.0390595153186207
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMOT,Angiomotin,39736,0.00787542761399371,0.00382030847471266,0.000387623003556888,0.0153632322244305,0.0392819709871052
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00357332316384027,0.00173438968626628,-0.00697272694892218,-0.000173919378758358,0.0393911245112907
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0076516061884004,0.0037189012444787,0.000362559749222157,0.0149406526275786,0.0396584606499827
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00396223065420829,0.00192770997727017,-0.00774054220965783,-0.000183919098758748,0.039862376886612
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCN,Decorin,41900,-0.0046700900680297,0.00227348249355481,-0.00912611575539712,-0.000214064380662273,0.0399799955839645
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.00637577410194835,0.00310482025750505,-0.0124612218066583,-0.000290326397238443,0.0400469840412896
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SULT2A1,Bile salt sulfotransferase,42119,-0.0119093555673764,0.0058014065424848,-0.0232801123906467,-0.000538598744106229,0.040107366389457
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0131169685260104,0.00638989592223068,0.000592772518438249,0.0256411645335825,0.0401141872705121
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0154648761487956,0.00753492920761644,-0.0302333373957238,-0.000696414901867335,0.0401520292152631
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00416687575633601,0.00203275799152269,-0.00815108141972049,-0.000182670092951544,0.040401319491826
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMBS,Porphobilinogen deaminase,42262,-0.0081379606958692,0.00397143129791606,-0.0159219660397847,-0.000353955351953724,0.0404689138734316
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MFGE8,Lactadherin,42137,-0.0091696033573914,0.00447554430120998,-0.017941670187763,-0.000397536527019852,0.0404985497334232
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0087331556100631,0.0042759282221264,0.000352336294695348,0.0171139749254309,0.041135376716235
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.00685602638711859,0.00336085402691687,-0.0134433002798757,-0.000268752494361521,0.0413775136261042
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.00822510041586326,0.00405001139070374,-0.0161631227416426,-0.000287078090083935,0.0422864357883982
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.00982649016955781,0.00484174557502616,-0.0193163114966091,-0.000336668842506547,0.0424236403518444
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00536894743769876,0.00265366616534117,0.000167761753630065,0.0105701331217675,0.0430746006443438
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INSR,Insulin receptor,39657,0.00345243169598862,0.00170718647520726,0.0001063462045824,0.00679851718739484,0.0431700939664967
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD200,OX-2 membrane glycoprotein,42119,0.00542045106998779,0.00268311300692329,0.000161549576418134,0.0106793525635574,0.0433813176984767
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDAN1,Codanin-1,39929,0.00438754952670249,0.00217314096975313,0.000128193225986359,0.00864690582741861,0.0435117848677534
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.0101954373799097,0.00505306059854375,0.000291438606764007,0.0200994361530555,0.0436493416204077
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DAND5,DAN domain family member 5,39657,0.0109634953084334,0.00544758365802742,0.000286231338699688,0.0216407592781672,0.0441869486176121
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UPK3A,Uroplakin-3a,39586,0.00969173173499651,0.00481985242397599,0.000244820984003562,0.0191386424859895,0.0443715761115873
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",41900,-0.0166789705600784,0.00829819534881623,-0.0329434334437582,-0.000414507676398553,0.0444564732603929
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.00854440166880432,0.0042533012029164,0.000207931311088183,0.0168808720265205,0.044569265878076
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHBG,Sex hormone-binding globulin,39990,0.00934230963396583,0.00465818066782342,0.000212275525031927,0.0184723437428997,0.0449257034372675
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNW1,Interferon omega-1,39575,0.00704113674998877,0.00351097314485335,0.000159629386076199,0.0139226441139013,0.0449377716843891
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0107236208305225,0.00535280607851446,0.000232120916634142,0.0212151207444108,0.0451619902712559
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.0165660976645451,0.00827403208618856,0.00034899477561549,0.0327832005534747,0.0452854378236086
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EVPL,Envoplakin,39757,0.00664595958334947,0.00332434958327806,0.000130234400124473,0.0131616847665745,0.045613535721498
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNX9,Sorting nexin-9,42145,0.0134002183282805,0.0067149196155144,0.000238975881872324,0.0265614607746888,0.0459986926762861
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00577641720606683,0.00289649250357926,-0.0114535425130822,-9.92918990514857e-05,0.0461459717460934
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0182071338802884,0.00914681989168666,0.00027936689258257,0.0361349008679943,0.046555824059896
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXNL1,Thioredoxin-like protein 1,39570,-0.0201406115638235,0.010119961102887,-0.039975735325482,-0.000305487802164987,0.0465951548414063
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RALY,RNA-binding protein Raly,39919,-0.00949642371532214,0.00477577411581447,-0.0188569409823185,-0.000135906448325769,0.0467851599744563
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.0159399579388819,0.00801844582751408,0.000223804116954288,0.0316561117608095,0.0468461369969363
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSP90B1,Endoplasmin,41774,0.0124376980848277,0.00626173409014687,0.000164699268139829,0.0247106969015156,0.0470204318058878
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPR,Nucleoprotein TPR,39575,-0.00964367793621809,0.00486178255597555,-0.0191727717459302,-0.000114584126506006,0.0473288597451507
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHA1,Ephrin type-A receptor 1,42162,-0.00629423486792615,0.00318395744585173,-0.0125347914617955,-5.36782740567596e-05,0.0480777955217397
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.0106594696335946,0.00539362751132558,-0.0212309795557927,-8.79597113964924e-05,0.0481407068605268
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00614916750815491,0.00311226574043211,4.91266569079725e-05,0.0122492083594019,0.0481997856544108
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.0134599493848066,0.00681906296883641,9.45859658872117e-05,0.0268253128037259,0.0484214734557166
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRSS22,Brain-specific serine protease 4,39657,-0.00680524375038858,0.00345067338057407,-0.0135685635763138,-4.19239244633975e-05,0.0486174256548472
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYH7B,Myosin-7B,39560,-0.00839341797430343,0.00426968134157781,-0.0167619934037959,-2.48425448109175e-05,0.0493448024323574
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GOLM2,Protein GOLM2,42249,0.00440604070477047,0.00224365694840663,8.47308589347825e-06,0.00880360832364747,0.049576287853336
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPM1B,Protein phosphatase 1B,39657,0.012058813677853,0.00614498105168097,1.46508165583311e-05,0.0241029765391477,0.0497428124016223
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0203561123978473,0.0104239907399089,-7.49094523740841e-05,0.0407871342480687,0.0508668628123585
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DLL4,Delta-like protein 4,39638,0.0170894319434701,0.00876055195098794,-8.12498804662713e-05,0.0342601137674064,0.0511149802619317
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB2,Integrin beta-2,42079,-0.0055115656727039,0.0028327813772604,-0.0110638171721343,4.06858267264837e-05,0.0517190585305414
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THBS4,Thrombospondin-4,42189,0.00873108618333459,0.00449040703048417,-7.01115964143843e-05,0.0175322839630836,0.0518694845034461
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IMPACT,Protein IMPACT,39929,0.0104580509825594,0.00539245636612978,-0.000111163495054923,0.0210272654601738,0.0524792246287871
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0058199353743495,0.00301055674709416,-8.07558499550535e-05,0.0117206265986541,0.053235204718445
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL11,Eotaxin,42296,-0.00712906347606291,0.00369115963614041,-0.0143637363628981,0.000105609410772299,0.0534556274143248
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCN5,CCN family member 5,42137,0.00723243836918063,0.00374844166361324,-0.000114507291501312,0.0145793840298626,0.0536956441603837
NMR metabolomics,X23505.Cholesterol in Medium VLDL,QDPR,Dihydropteridine reductase,42081,0.00801702863488568,0.00416011335325071,-0.000136793537485707,0.0161708508072571,0.0539859364675355
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD46,Membrane cofactor protein,42107,-0.00545042331480016,0.00282924039597988,-0.0109957344909207,9.48878613203962e-05,0.0540677049312702
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFIC,Nuclear factor 1 C-type,39934,0.00876534392798637,0.00455020468906085,-0.000153057262572903,0.0176837451185456,0.0540840967429246
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0065744055322159,0.00343762893148483,-0.000163347173494359,0.0133121582379262,0.0558395336750144
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00921071459870184,0.00481631139586636,-0.000229255737196231,0.0186506849345999,0.0558509287711853
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0189691004021787,0.00992978148929969,-0.0384314721212061,0.000493271316848655,0.0561175369248938
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A13,Protein S100-A13,39657,0.00677614226929317,0.00354766092650863,-0.000177273146663758,0.0137295576852501,0.056155070061766
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0110040694794633,0.00576472338515769,-0.000294788355445783,0.0223029273143724,0.0563012161529536
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,39929,-0.00518665955735676,0.00272455216430558,-0.0105267817993957,0.000153462684682164,0.0569779481301906
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0106268069491457,0.00558576487852841,-0.000321292212770019,0.0215749061110614,0.0571300782376368
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSAP,Gamma-secretase-activating protein,41843,0.015768444115127,0.00831202304232374,-0.000523121047827542,0.0320600092780815,0.057841156054516
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0454947596632431,0.0239863091230611,-0.00151840621795655,0.0925079255444428,0.0578933566141784
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRELP,Prolargin,42123,0.00437771077011932,0.00230948983483171,-0.000148889306150844,0.00890431084638948,0.0580433227203325
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.015874169340253,0.00837910676712835,-0.000548879923318514,0.0322972186038246,0.0581812123965982
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEMA3G,Semaphorin-3G,39736,-0.00857579831324819,0.00453740529424145,-0.0174691126899614,0.000317516063465051,0.0587808900264358
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTDH,Protein LYRIC,39657,0.0179202340534524,0.00950048022932086,-0.000700707196016441,0.0365411753029213,0.059288120095731
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.00398686757890966,0.00211947400669844,-0.000167301474219284,0.0081410366320386,0.0599846795080285
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0134619754186172,0.00718041822207183,-0.027535595133878,0.000611644296643586,0.060839510419561
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.00796528624788371,0.00425040339673794,-0.000365504409722646,0.0162960769054901,0.060950839320862
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRYGD,Gamma-crystallin D,39929,0.0182442179769459,0.00974692320588722,-0.000859751506593034,0.0373481874604848,0.0612610595084899
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGT,Angiotensinogen,39990,0.00405044817658755,0.00216489925565867,-0.00019275436450344,0.00829365071767854,0.0613757155087862
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.013810468406722,0.00738900136533522,-0.000671974269335046,0.028292911082779,0.0616409946373234
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.00522776672640853,0.00280314443890149,-0.000266396373838398,0.0107219298266555,0.0622129552847853
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00474523397822707,0.00254464859474885,-0.00973274522393482,0.000242277267480683,0.0622374337713199
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOX2,Transcription factor SOX-2,39915,0.00454515401682856,0.00244236437859271,-0.000241880165213145,0.00933218819887027,0.0627750722559954
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00555957770465306,0.00298801277559536,-0.01141608274482,0.000296927335513846,0.0628226712654965
NMR metabolomics,X23505.Cholesterol in Medium VLDL,JAM3,Junctional adhesion molecule C,39736,0.00943217086855174,0.00507014280216249,-0.000505309023686739,0.0193696507607902,0.0628642984453864
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0210203236191919,0.0113362305165084,-0.00119868819316451,0.0432393354315484,0.0637277688758746
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLSTN1,Calsyntenin-1,41839,0.00926124443368569,0.00499605962934869,-0.00053103243983774,0.0190535213072091,0.0638029253096788
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.016166780080087,0.00872338624935346,-0.000931056968645774,0.0332646171288198,0.0638704993782393
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TP53BP1,TP53-binding protein 1,39657,-0.0158662065579059,0.00856606023421561,-0.0326556846169685,0.000923271501156692,0.064021233298726
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASS1,Argininosuccinate synthase,39575,-0.0142543321748767,0.00769766062024141,-0.0293417469905499,0.000833082640796422,0.0640850401993747
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAG,Myelin-associated glycoprotein,39649,0.00893201873669462,0.0048271437401667,-0.00052918299403211,0.0183932204674214,0.0642864165297743
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCRIB,Protein scribble homolog,39638,0.0161046032778934,0.0087049513311259,-0.000957101331113382,0.0331663078869001,0.0643329177302305
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0138879154569634,0.00751017980459754,-0.000832036960047831,0.0286078678739745,0.0644493647363095
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.009274403420076,0.00502084438841878,-0.000566451581224812,0.0191152584213768,0.0647433523073125
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.00978091837889566,0.00530439655229387,-0.000615698863600326,0.0201775356213916,0.0652157732878648
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL25,Interleukin-25,39510,0.00630176519832288,0.00341988925827652,-0.000401217747899093,0.0130047481445449,0.0654027038390262
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.00925772912200655,0.00503188508920389,-0.0191202238968462,0.000604765652833088,0.0658179230179609
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0149594319991386,0.00814854871903876,-0.00101172349017734,0.0309305874884546,0.0664081748027067
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0054025524348338,0.00294342441915109,-0.000366559426702337,0.0111716642963699,0.0664636658065691
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0104335392957991,0.00568452947502228,-0.000708138475244532,0.0215752170668428,0.066464847008322
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INHBB,Inhibin beta B chain,39736,0.00955210021066708,0.00520563262906809,-0.000650939742306374,0.0197551401636405,0.0665390552101016
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00505952975472522,0.00275754897898405,-0.010464325753534,0.000345266244083528,0.0665582146041365
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0112801875419716,0.00614945062028935,-0.0233331107577387,0.000772735673795516,0.066630338350457
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VEGFD,Vascular endothelial growth factor D,42275,0.0069837914373162,0.00381024652377486,-0.000484291749282519,0.0144518746239149,0.0668395395754147
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0176204463033576,0.00963185585872528,-0.0364988837864592,0.00125799117974393,0.0673677691662297
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.015738111816049,0.00860789209853771,-0.00113335669708491,0.0326095803291829,0.0675261926914047
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRP2BP,LRP2-binding protein,39649,-0.0140897518763749,0.00771011543350837,-0.0292015781260513,0.0010220743733015,0.0676610155534166
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VEGFB,Vascular endothelial growth factor B,39657,-0.00537641448518568,0.00294227136395097,-0.0111432663585296,0.000390437388158226,0.0676815114964543
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PADI2,Protein-arginine deiminase type-2,41913,-0.0102918458687946,0.00563481632341149,-0.0213360858626811,0.000752394125091945,0.0678012669852994
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PZP,Pregnancy zone protein,39979,0.00601251104529309,0.00330380147927526,-0.000462939854086429,0.0124879619446726,0.068804058469859
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MARCO,Macrophage receptor MARCO,42145,0.00463264620897393,0.00255345219884778,-0.000372120100767719,0.00963741251871559,0.069658614021189
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0114913081877097,0.00634599692525614,-0.000946845785792341,0.0239294621612117,0.0701995544273114
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0122911071598476,0.00681567956311817,-0.00106762478386401,0.0256498391035592,0.0713590480002377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MSMB,Beta-microseminoprotein,42103,-0.0124282441135798,0.00689603929073162,-0.0259444811234138,0.00108799289625415,0.0715316275493592
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMBP,Protein AMBP,42239,-0.00358629190704238,0.00199054839027789,-0.00748776675198705,0.000315182937902289,0.0716209506947456
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MSLNL,Mesothelin-like protein,39649,0.00677708460711707,0.00376270541515598,-0.000597818006588656,0.0141519872208228,0.0717111968720982
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.011050008203002,0.00615067091277624,-0.0010053067860394,0.0231053231920435,0.0724292227390143
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00569774592311327,0.00317369863401473,-0.0119181952457821,0.000522703399555592,0.0726277897041145
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.0071348300426384,0.00397870569741618,-0.000663433124297311,0.0149330932095741,0.0729598747644726
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BST2,Bone marrow stromal antigen 2,42249,-0.00900995662933637,0.00503113372867414,-0.0188709787375377,0.000851065478864942,0.0733410908426502
NMR metabolomics,X23505.Cholesterol in Medium VLDL,XG,Glycoprotein Xg,42261,0.00611358869926444,0.00342049385613133,-0.000590579258752979,0.0128177566572819,0.0739045627005214
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.00834957417432016,0.00467682221049292,-0.000816997358245969,0.0175161457068863,0.0742339866664229
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.00714594017282494,0.00400269772860885,-0.000699347375248407,0.0149912277208983,0.0742425369624689
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.0115360419058995,0.00648229169482745,-0.00116924981596234,0.0242413336277613,0.0751604482951652
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.00764684624768231,0.00429760839299703,-0.000776466202591881,0.0160701586979565,0.0752131349441981
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0148075393398868,0.00835046500889774,-0.0311744507573263,0.0015593720775528,0.0762089855197585
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGAL,Integrin alpha-L,39657,0.00772270270707904,0.00435597603124522,-0.000815010314161601,0.0162604157283197,0.0762730777980243
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00425823139020972,0.00240259281461064,-0.00896731330684657,0.000450850526427127,0.0763636090204219
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAT,Catalase,39827,-0.0092130395156561,0.00520203391370525,-0.0194090259865184,0.000982946955206192,0.0765802374946038
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP1,Caspase-1,41839,-0.0120187367909508,0.00679228411515297,-0.0253316136566506,0.001294140074749,0.0768386409287831
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPSG1,Tryptase gamma,39657,0.00461692281156393,0.00261009270853507,-0.000498858897164807,0.00973270452029268,0.0769426162406882
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FUOM,Fucose mutarotase,39736,-0.0113594629796593,0.00642679451548389,-0.0239559802300077,0.00123705427068915,0.077169211158734
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.00888061695216845,0.00503338175714404,-0.000984811291833877,0.0187460451961708,0.0777017054703947
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.00569011857126152,0.0032416558093014,-0.000663526814969228,0.0120437639574923,0.0792286196988095
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.00683713022057542,0.00389813259806952,-0.000803209671640843,0.0144774701127917,0.079466772968462
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0066501745065373,0.00379168937904894,-0.00078153667639862,0.0140818856894732,0.0794784874729474
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,-0.00673878413118252,0.00384485524964704,-0.0142747004204907,0.000797132158125682,0.0796847476920285
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDHR1,Cadherin-related family member 1,41839,-0.00713755949991145,0.00407760292941227,-0.0151296612415595,0.000854542241736589,0.0800672631251274
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0150304793641621,0.00859902611675361,-0.0318845705529991,0.00182361182467503,0.0805045333771865
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.00561735100436291,0.0032139817513914,-0.01191675523709,0.000682053228364225,0.0805235461514982
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK15,Kallikrein-15,39900,0.00908454032289579,0.00521906320854087,-0.00114482356584432,0.0193139042116359,0.0817729080162392
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0122821914593296,0.00705991485446633,-0.0261196245740836,0.00155524165542441,0.081937852355949
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUSD5,Sushi domain-containing protein 5,39695,0.00597047495919201,0.00343202513188558,-0.000756294299303727,0.0126972442176878,0.0819506595444752
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CYB5A,Cytochrome b5,39560,-0.0123172811775097,0.00708705426357201,-0.0262079075341108,0.00157334517909147,0.0822393755398531
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0181586026705525,0.0104725887983224,-0.0386848767152645,0.00236767137415945,0.0829606549606741
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.006460497915099,0.00373317479316647,-0.0137775205097053,0.000856524679507285,0.0835572588546674
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFBR1,TGF-beta receptor type-1,39657,-0.003786230099853,0.0021899335764709,-0.00807849990973597,0.00050603971002997,0.0838504983789931
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0172054823240453,0.0099524667611999,-0.0367123171759971,0.00230135252790654,0.0838783208229626
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LXN,Latexin,41960,-0.0116747274815193,0.00676436857946269,-0.0249328898972662,0.00158343493422758,0.0843857660698368
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LIF,Leukemia inhibitory factor,41839,-0.00850923829529523,0.00493562354505119,-0.0181830604435956,0.00116458385300511,0.0847230204168485
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00823598551317241,0.00478435940066611,-0.00114135891213317,0.017613329938478,0.085193969263726
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOP56,Nucleolar protein 56,39575,-0.0191631499173767,0.0111467437946884,-0.0410107677549661,0.00268446792021258,0.0856115802610629
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0111038412529996,0.00647383656021596,-0.00158487840502364,0.0237925609110229,0.0863382902586896
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DBI,Acyl-CoA-binding protein,42085,0.0131590696748843,0.00768761823708215,-0.00190866206979668,0.0282268014195654,0.0869708004735311
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00558735915854898,0.00327143740407504,-0.000824658153438102,0.0119993764705361,0.087674195545956
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EXTL1,Exostosin-like 1,39575,0.00808599801264736,0.0047362408366891,-0.00119703402726327,0.017369030052558,0.0878018852941385
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.00350704289864051,0.00205501647792129,-0.00753487519536623,0.000520789398085213,0.0879238392457743
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00417278569946289,0.00244604032172523,-0.000621453331118567,0.00896702473004434,0.0880482737581579
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0104867866412848,0.00614797755734161,-0.0015632493711048,0.0225368226536743,0.0880858645748177
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,0.00599923107447014,0.00352068512076141,-0.000901311762222224,0.0128997739111625,0.0884049364690202
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NENF,Neudesin,39919,-0.0188560568311648,0.0111564470139011,-0.040722692978411,0.00301057931608143,0.0910270042287942
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.00704494591116933,0.00417116520766101,-0.00113053789584626,0.0152204297181849,0.0912539257635563
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00703112206926724,0.00416923754928074,-0.00114058352732302,0.0152028276658575,0.0917414793486861
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.00509149857046981,0.00302036245696552,-0.0110114089861222,0.000828411845182615,0.0918717765863239
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.00488035803870808,0.00289672366448123,-0.000797220343675139,0.0105579364210913,0.092057494105616
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00498670664373312,0.00296586397324235,-0.0107998000312881,0.000826386743821884,0.0927143732645496
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL20,Interleukin-20,41913,0.00774751599550482,0.0046106760841897,-0.00128940912950699,0.0167844411205166,0.0929141143097945
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX6,Syntaxin-6,41843,0.0108701591227119,0.00647144125181748,-0.00181386573085032,0.0235541839762742,0.0930369036498429
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0162374648271231,0.00968848232996317,-0.0352268901938509,0.00275196053960475,0.093770041613048
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CENPJ,Centromere protein J,39757,0.0117047957393779,0.00699579766277214,-0.00200696767965553,0.0254165591584113,0.0943320825266005
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.00958204928993039,0.00573097905212321,-0.00165066965223109,0.0208147682320919,0.0945577521735769
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0059068304193315,0.00353293813336938,-0.0128313891607355,0.00101772832207249,0.0945609490780739
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,0.00453513346695546,0.00271273907793137,-0.000781835125790032,0.00985210205970096,0.0945932060154837
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.00476811735187002,0.00285402854897635,-0.0103620133078637,0.000825778604123617,0.0948159890351354
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB5,Integrin beta-5,42181,0.00631090442650891,0.00379458912619812,-0.00112649026083941,0.0137482991138572,0.0963089934280125
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTN4,Contactin-4,42137,-0.00385610321477882,0.00232093049369157,-0.0084051269824143,0.000692920552856653,0.0966468428652208
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADIPOQ,Adiponectin,39979,0.0113833550447001,0.00685819360561556,-0.00205870442230636,0.0248254145117066,0.0969785723723869
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRK1,Protein BRICK1,41839,0.00742297723532567,0.00447792719049704,-0.00135376005804852,0.0161997145286999,0.0974054545355776
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00779318360051637,0.00471407143680604,-0.0170327636166562,0.00144639641562347,0.0983237251605456
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.00720809257869737,0.0043782216314678,-0.0157894069763742,0.00137322181897951,0.0997147019409833
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGB7,Integrin beta-7,42262,-0.00749986035579571,0.00455731037400574,-0.016432188688847,0.00143246797725555,0.0998533028909177
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.00642031505770973,0.00390292886285448,-0.00122942551348505,0.0140700556289045,0.0999976571172169
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEMA6C,Semaphorin-6C,39657,0.00420867860805995,0.00257082084130772,-0.000830130240903187,0.00924748745702308,0.101639024880386
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00509175320464433,0.00311340423213266,-0.0111940254996243,0.00101051909033568,0.101987521829249
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CBX2,Chromobox protein homolog 2,39575,0.00642371931272784,0.00392791682367434,-0.00127499766167386,0.0141224362871295,0.101993678414237
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0120977997450064,0.00743049186187262,-0.0266615637942768,0.00246596430426391,0.103525257965594
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0107416715071247,0.00660614429157973,-0.0022063713043716,0.0236897143186209,0.103974851945762
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00749772019734202,0.00461268048477261,-0.00154313355281229,0.0165385739474963,0.104093635520223
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPB41L5,Band 4.1-like protein 5,39649,-0.0100150802739044,0.00617087365524392,-0.0221099926381824,0.00207983209037371,0.10462651335927
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0140851933137429,0.00870421759806787,-0.0029750731784701,0.031145459805956,0.105647322802408
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CILP,Cartilage intermediate layer protein 1,39966,-0.00886366772060637,0.0054859369525195,-0.0196161041475446,0.00188876870633185,0.106185392529746
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00987237525504167,0.00611237806360662,-0.0218526362597106,0.0021078857496273,0.106307631033838
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL18R1,Interleukin-18 receptor 1,42296,-0.00526757047213554,0.00326203235179904,-0.0116611538816617,0.00112601293739058,0.106374349973587
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOX9,Transcription factor SOX-9,39649,0.00442193751162486,0.00274219838861291,-0.000952771330056439,0.00979664635330617,0.106870432453802
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGM2,Phosphoglucomutase-2,39649,0.00971107477084628,0.00602308012118705,-0.00209416226668035,0.0215163118083729,0.10692296988491
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL16,C-C motif chemokine 16,42310,-0.00816208994423956,0.00506459891187465,-0.0180887038115139,0.00176452392303475,0.107072788760184
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DLGAP5,Disks large-associated protein 5,39934,0.00791929173467457,0.0049157177808294,-0.00171551511575106,0.0175540985851002,0.107204447154866
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH2,Cadherin-2,42145,-0.00561054087981737,0.00348556109328917,-0.0124422406226641,0.00122115886302941,0.10749712161147
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,42100,0.00275512911972419,0.00171871565377984,-0.000613553561684293,0.00612381180113268,0.108954461216884
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.00460332277531141,0.00287367873318369,-0.0102357330923514,0.00102908754172861,0.109207413725083
NMR metabolomics,X23505.Cholesterol in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.0093536905408247,0.00585228143100267,-0.00211678106394052,0.0208241621455899,0.110005467138802
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.00574597820628538,0.00359975383422177,-0.01280149572136,0.00130953930878928,0.110469768534626
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0160914724869523,0.0100826992456831,-0.00367061803458653,0.0358535630084912,0.110523781614377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPRING1,SREBP regulating gene protein,39560,-0.00985801142495145,0.00618009365615042,-0.0219709949910063,0.00225497214110337,0.110713497697003
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLB1,Beta-galactosidase,42016,0.00676654095095363,0.00425574541128319,-0.00157472005516141,0.0151078019570687,0.111863359785724
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.00689424634788503,0.00434636020047176,-0.00162461964503961,0.0154131123408097,0.112714812177806
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0183538552790212,0.0116017866796088,-0.0410933571710544,0.00438564661301197,0.113676606126575
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNGR1,Interferon gamma receptor 1,42185,-0.00337409861440345,0.00213572171815784,-0.00756011318199282,0.000811915953185919,0.114166792490312
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.00475774615719921,0.00301475124379844,-0.00115116628064574,0.0106666585950441,0.114558504456525
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NADK,NAD kinase,42145,-0.00849521353835344,0.00540177857099925,-0.019082699537512,0.00209227246080509,0.115818673460474
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,-0.00481948862986305,0.00306462760795719,-0.0108261587414591,0.00118718148173304,0.115830646857723
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZNF174,Zinc finger protein 174,39657,0.00576066115900486,0.00366339451871881,-0.001419592097684,0.0129409144156937,0.11586494158035
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKCQ,Protein kinase C theta type,41913,0.0066455582583402,0.00422680384707421,-0.00163897728192525,0.0149300937986056,0.11591821730016
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.00632012645956647,0.00402305334897318,-0.00156505810442096,0.0142053110235539,0.116211797369214
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINB8,Serpin B8,42296,-0.00906202702370282,0.00577393411425309,-0.0203789378876389,0.00225488384023323,0.116561136060716
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00924602784782179,0.00591428686247147,-0.00234597440262229,0.0208380300982659,0.11800181520343
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00969311166942871,0.00621272777064906,-0.0218700580999009,0.00248383476104346,0.11874097350194
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBP1,Retinol-binding protein 1,39649,-0.0108523307523324,0.0069700232074485,-0.0245135762389314,0.00280891473426667,0.119498968926304
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WDR46,WD repeat-containing protein 46,39919,0.00564940507184733,0.00363672935521801,-0.00147858446437998,0.0127773946080746,0.12034835960792
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL36G,Interleukin-36 gamma,39624,0.0103885357393872,0.00669543621481255,-0.00273451924164539,0.0235115907204198,0.120790355581984
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.00964639732674017,0.00624184429456919,-0.0218804121440958,0.00258761749061545,0.122267886814657
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPTX2,Neuronal pentraxin-2,39966,0.00523885216008334,0.00339861414314086,-0.00142243156047275,0.0119001358806394,0.123230963398942
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.00347321090470804,0.00225684964345208,-0.00789663620587411,0.000950214396458033,0.123836103613184
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,0.00594946546527604,0.00386780621395153,-0.00163143471406897,0.013530365644621,0.124028173531947
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00651582199133946,0.00423744540154169,-0.0148212149783612,0.00178957099568225,0.124156243880868
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPM,Carboxypeptidase M,42195,-0.00511710609899669,0.00335469868400733,-0.0116923155196511,0.00145810332165768,0.12719386129892
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.00795381601605333,0.00522402538392997,-0.00228527373644941,0.0181929057685561,0.127900863517416
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYL6B,Myosin light chain 6B,39649,-0.0137634318595657,0.00905516175748181,-0.0315115489042301,0.00398468518509865,0.12855108089278
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNLZ,DNL-type zinc finger protein,39586,0.0127713035186183,0.00840466046261385,-0.00370183098810485,0.0292444380253414,0.128652838481037
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00413590805044773,0.0027228495270178,-0.00947269312340261,0.00120087702250715,0.128800111104936
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDK1,Cyclin-dependent kinase 1,39560,-0.00551049434061524,0.0036323423923821,-0.0126298854296842,0.00160889674845367,0.129279474493062
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FBN2,Fibrillin-2,39649,-0.00899406993061875,0.00596157645833337,-0.0206787597889522,0.00269061992771465,0.131410940245816
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00391326456406427,0.00259626559464052,-0.00900194512955968,0.00117541600143114,0.131771142151782
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0106582551791037,0.00707185212530834,-0.00320257498650066,0.024519085344708,0.13180323937846
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATXN10,Ataxin-10,41839,-0.0108950816103112,0.00723148205431714,-0.0250687864367728,0.00327862321615036,0.131932439371505
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EFNB2,Ephrin-B2,39649,-0.00862392044772774,0.00574060487621213,-0.0198755060051035,0.00262766510964804,0.133056782173044
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLAU,Urokinase-type plasminogen activator,42137,0.00422709133228021,0.00282022325249479,-0.00130054624260957,0.00975472890716999,0.133935895104398
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00529159945327002,0.00353127994031603,-0.0122129081362894,0.0016297092297494,0.134033009854484
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00416176955271004,0.00279090385975341,-0.00963194111782673,0.00130840201240665,0.13593930757301
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,42119,0.00772533072348741,0.00518287848507913,-0.00243311110726769,0.0178837725542425,0.13610345645697
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADA,Adenosine deaminase,42296,-0.0052088267768508,0.00350748391141461,-0.0120834952432234,0.00166584168952185,0.137550740379546
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEO1,Neogenin,39934,0.00333049706794757,0.00224732084024302,-0.00107425177892875,0.00773524591482389,0.138371934256421
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNX5,Sorting nexin-5,39638,0.00437501058924081,0.00296022376870681,-0.00142702799742454,0.0101770491759062,0.139454408018357
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0083476566869737,0.00565800363927218,-0.0194373438199472,0.00274203044599977,0.14013639500762
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.00997113608647924,0.00676320866693161,-0.0032847529007067,0.0232270250736652,0.140424044401052
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CBLN1,Cerebellin-1,39586,0.0135791721450959,0.00921940552693115,-0.00449086268768916,0.031649206977881,0.140809290587027
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPA33,Cell surface A33 antigen,42070,-0.0194212605852714,0.0132244653542866,-0.0453412126796732,0.00649869150913034,0.141968549802295
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0108500606082992,0.00739858334092939,-0.00365116273992245,0.0253512839565208,0.142538461664909
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.00881993415955576,0.00602408510736233,-0.0206271409699859,0.0029872726508744,0.143187034892408
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EGLN1,Egl nine homolog 1,42119,-0.00803433364142345,0.00551480722476026,-0.0188433558019536,0.00277468851910666,0.145176673254047
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.00992443986239207,0.00681371385899713,-0.00343043930124229,0.0232793190260264,0.145271821434344
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00485486489411806,0.00333582008224633,-0.00168334246708476,0.0113930722553209,0.145589109992701
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZNF830,Zinc finger protein 830,39919,-0.0112101823096895,0.00770405951926418,-0.0263101389674473,0.00388977434806825,0.145669119800827
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOLR3,Folate receptor gamma,42132,-0.0275867237654784,0.0189624390428158,-0.0647531042893974,0.00957965675844068,0.145745387868724
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLINT1,Clathrin interactor 1,39560,0.00722896857455658,0.00497535870406114,-0.00252273448540326,0.0169806716345164,0.146265086062399
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00472613800666963,0.00326406827273646,-0.0111237118212331,0.00167143580789383,0.14766556787925
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,39649,0.00585926747413275,0.00404810405566732,-0.00207501647497519,0.0137935514232407,0.14781041603542
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,-0.00831507360467447,0.00575471178699851,-0.0195943087071916,0.00296416149784261,0.148509238263889
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.00455826713746161,0.00315692160677337,-0.0107458334867374,0.0016292992118142,0.148796689068481
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHIT1,Chitotriosidase-1,42207,-0.0222761564701947,0.0154424450351039,-0.0525433487389985,0.00799103579860901,0.149176548235321
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0101184716097815,0.00701572266212043,-0.00363234480797456,0.0238692880275375,0.149258096980119
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EZR,Ezrin,42249,0.00345691455931047,0.00239777159440601,-0.00124271776572531,0.00815654688434625,0.1494044048431
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.00590161737724012,0.00409532306235766,-0.00212521582498091,0.0139284505794611,0.149590615793604
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00376742502283836,0.00261598390497209,-0.00135990343090694,0.00889475347658366,0.149851781194572
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMSB10,Thymosin beta-10,42137,0.0108064503194645,0.00750383824214465,-0.00390107263513904,0.025513973274068,0.149855718142223
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLASP1,CLIP-associating protein 1,39560,0.0107324094703761,0.00748087017169852,-0.00393009606615303,0.0253949150069052,0.151416188630048
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OPLAH,5-oxoprolinase,39638,0.00989715524911106,0.00690062056418315,-0.00362806105668792,0.02342237155491,0.151531733544823
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0039369834017771,0.00274512837945729,-0.00931743502551339,0.00144346822195919,0.151546567157163
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL4,Interleukin-4,41913,0.0133370211713449,0.00932777203688088,-0.00494541202094158,0.0316194543636315,0.152792579705033
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NLGN1,Neuroligin-1,39649,0.00952206404046525,0.00666581728068139,-0.00354293782967027,0.0225870659106008,0.153178675325402
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.00694334949085201,0.00486091817827042,-0.00258405013855802,0.016470749120262,0.153204227087152
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.00438111477203336,0.00307101775119517,-0.0104003095643759,0.00163808002030916,0.153722701575783
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,42296,-0.00347692772351927,0.00243768070312853,-0.0082547819016512,0.00130092645461265,0.153797013968351
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0110474856807896,0.00774951080925059,-0.00414155550534156,0.0262365268669208,0.154015490250696
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GH2,Growth hormone variant,41843,0.0227827968790395,0.015994206600728,-0.0085658480583875,0.0541314418164664,0.154342538427321
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00583439903712149,0.00410947420798673,-0.00222017041053249,0.0138889684847755,0.155705933150675
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMOX1,Heme oxygenase 1,42007,-0.00688322987333368,0.00485855950915509,-0.0164060065112776,0.00263954676461028,0.156587352936509
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPRR1B,Cornifin-B,39757,-0.0121803615832212,0.00860239067483851,-0.0290410473059047,0.00468032413946224,0.156824645458954
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.00926364919445797,0.00655408160767683,-0.00358235075658863,0.0221096491455046,0.157560607381545
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.00525818709464297,0.00372656500227241,-0.0125622544990969,0.00204588030981095,0.158272623839659
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAA4,Serum amyloid A-4 protein,39979,-0.0046234996993166,0.00328028156721774,-0.0110528515710634,0.00180585217243016,0.158719851836515
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.00727249209621968,0.00516627211439867,-0.00285340124800172,0.0173983854404411,0.159252248236348
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MELTF,Melanotransferrin,39958,0.00420266963400226,0.0029861190944939,-0.00165012379120579,0.0100554630592103,0.159335618458825
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCDH12,Protocadherin-12,39934,-0.00356376262449495,0.00253658697895857,-0.00853547310325374,0.00140794785426385,0.160065341154042
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00823386395929645,0.00586095724974364,-0.019721340168794,0.00325361225020109,0.160088997913074
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.00623806097069802,0.00444511122028177,-0.00247435702105424,0.0149504789624503,0.160538978444731
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00620656650158904,0.00442395236168125,-0.00246438012730622,0.0148775131304843,0.16065637747502
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCN1,Transcobalamin-1,39806,-0.00497452800265808,0.0035470646240434,-0.0119267746657832,0.00197771866046699,0.160813053560997
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD274,Programmed cell death 1 ligand 1,42016,-0.00466804267959942,0.00333228418966437,-0.0111993196913416,0.00186323433214275,0.161280951655346
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ELOB,Elongin-B,39575,0.00546810067816553,0.00390375735581549,-0.00218326373923283,0.0131194650955639,0.161323817714863
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00494455982388847,0.00353146495186118,-0.0118662311295364,0.00197711148175944,0.161497485455465
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAX,Apoptosis regulator BAX,41814,-0.0126422326202403,0.00904606811631851,-0.0303725261282245,0.005088060887744,0.162275021772928
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACYP1,Acylphosphatase-1,39701,0.00906163310550914,0.0064871228948294,-0.00365312776835648,0.0217763939793748,0.162482178543136
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.0144372099108023,0.0103415493692882,-0.0347066466746071,0.0058322268530025,0.162729996945773
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DENR,Density-regulated protein,39657,0.00799640883497437,0.00573002270855427,-0.00323443567379201,0.0192272533437407,0.162884611762161
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.00341774360284086,0.0024502706125825,-0.00138478679782084,0.00822027400350256,0.163090911662909
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.00379371443044905,0.00272269228365821,-0.00154276244552103,0.00913019130641914,0.163536298596905
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPAG1,Sperm-associated antigen 1,39934,0.00809751608047385,0.00581405886255109,-0.00329803929012629,0.019493071451074,0.163723470892881
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.00476225183339838,0.00342086983598926,-0.00194265304514057,0.0114671567119373,0.163914649365653
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP7,Matrilysin,41881,-0.00713250098311816,0.00512658127370201,-0.0171806002795741,0.00291559831333777,0.164164373416318
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00418886041219601,0.00301577581871759,-0.0100997810168825,0.00172206019249047,0.164866168211918
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMS,Spermine synthase,39586,0.00888119207760748,0.00639464917227194,-0.00365232030004551,0.0214147044552605,0.164907302264346
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CABP2,Calcium-binding protein 2,39649,0.0089770754385568,0.00649349765055971,-0.00375017995654022,0.0217043308336538,0.166854917675898
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL11,C-X-C motif chemokine 11,42249,-0.0106357977840059,0.00770251790560216,-0.0257327328789862,0.00446113731097432,0.16735664133612
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.00909907874839134,0.00659049838541519,-0.00381829808702243,0.0220164555838051,0.167414243271762
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0133791692665947,0.00971966418284098,-0.00567137253177358,0.0324297110649631,0.168693328515508
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HK2,Hexokinase-2,41900,0.00371133252125699,0.00269796910367233,-0.00157668692194077,0.00899935196445474,0.168967958243608
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SOD3,Extracellular superoxide dismutase,39990,0.0082969041536717,0.00603868439116662,-0.00353891725301487,0.0201327255603583,0.169481479893851
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00573510586821323,0.00417627479282806,-0.00245039272572977,0.0139206044621562,0.169699769235501
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00499075107085725,0.00364263926470127,-0.0121303240296717,0.00214882188795724,0.170686009693762
NMR metabolomics,X23505.Cholesterol in Medium VLDL,JUN,Transcription factor AP-1,41913,-0.0065365123827467,0.00477131528568078,-0.015888290342681,0.00281526557718763,0.170722406908133
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00407237969786383,0.0029831349339243,-0.0017745647726278,0.00991932416835547,0.172234045960353
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.00868604464173461,0.00638214652164634,-0.00382296254069221,0.0211950518241614,0.173543569536346
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCN1,Ficolin-1,39978,-0.00754163792888169,0.00554516734372479,-0.0184101659225823,0.00332689006481889,0.173844866698946
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.011373456645114,0.00836515440936679,-0.00502224599724493,0.0277691592874729,0.173971841316575
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00532288471556949,0.00392341961704851,-0.0130127871649846,0.0023670177338456,0.174905515220653
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.00725575243232776,0.00535261567195773,-0.0177468791493649,0.00323537428470938,0.175269527257974
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00397109882005967,0.00293239183311592,-0.00177638917284754,0.00971858681296688,0.175694401889646
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SORD,Sorbitol dehydrogenase,42204,0.00917191798176194,0.00679279581969144,-0.00414196182483328,0.0224857977883572,0.176960843478947
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL7,C-C motif chemokine 7,42119,0.00748251308633269,0.00554398529631286,-0.00338369809444053,0.0183487242671059,0.17714663214705
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATXN3,Ataxin-3,39929,0.00819584808181918,0.00607289535976945,-0.00370702682332895,0.0200987229869673,0.177178240517141
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP1B4,Protein ATP1B4,39560,-0.00561233235025254,0.00416961989302643,-0.0137847873405843,0.00256012264007927,0.178328502193229
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.00711474469294435,0.00528626846464276,-0.0174758308836441,0.00324634149775545,0.178364411435064
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAXX,Protein PAXX,39736,0.00620970734701001,0.00461419180697074,-0.00283410859465264,0.0152535232886727,0.178399456006507
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FBLN2,Fibulin-2,39966,-0.00429320310031537,0.00319020717667731,-0.0105460091666029,0.00195960296597214,0.178411839609215
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00863692625492571,0.00641905844782573,-0.00394442830281272,0.0212182808126641,0.17848747784566
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.00358520189963421,0.00267381012055987,-0.00165546593666313,0.00882586973593155,0.179993879656648
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSC,Dipeptidyl peptidase 1,42123,-0.00587304076726694,0.00438157218986304,-0.0144609222593985,0.00271484072486462,0.180139232910544
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PALLD,Palladin,39657,0.00508943585335152,0.00379845038762228,-0.00235552690638815,0.0125343986130912,0.180314622795163
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF3,Fibroblast growth factor 3,39657,0.0039380260414242,0.00295087275462693,-0.00184568455764459,0.00972173664049298,0.182057943718713
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNC,Tenascin,42217,0.00636281715321697,0.00477367904342715,-0.00299359377190024,0.0157192280783342,0.182588273720579
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CA1,Carbonic anhydrase 1,41890,-0.00742163026267904,0.00556883755248607,-0.0183365518655517,0.00349329134019367,0.182650735882395
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPC1,Glypican-1,42262,0.00388271124681099,0.00291953859395399,-0.00183958439733884,0.00960500689096081,0.183571519120237
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.00757309228860261,0.00569860373360643,-0.00359617102926599,0.0187423556064712,0.183890954371084
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.00363008382197988,0.00273867549848546,-0.00173772015505161,0.00899788779901138,0.185031939099304
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NLGN2,Neuroligin-2,39586,-0.00616074704289985,0.00465203559497687,-0.0152787368090545,0.00295724272325482,0.18542696243193
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HEPACAM2,HEPACAM family member 2,39929,0.00575085929184249,0.00434357117750089,-0.00276254021605925,0.0142642587997442,0.185531970511869
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.00824730227514726,0.00624326296638099,-0.00398949313895948,0.020484097689254,0.186526764863247
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADD1,Alpha-adducin,39736,0.00917550195960069,0.0069522814752994,-0.00445096973198614,0.0228019736511875,0.186934654359283
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0050868501777098,0.0038553442321879,-0.00246962451737849,0.0126433248727981,0.187048211401933
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.0067536406797047,0.00511975389133919,-0.00328107694732011,0.0167883583067295,0.187146719197779
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTRB1,Chymotrypsinogen B,42137,-0.0076000246235692,0.00576774114251295,-0.0189047972628946,0.00370474801575618,0.18763381896718
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0120495016440081,0.00914688029496171,-0.00587838373411687,0.0299773870221331,0.187753974768228
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.00579713224267509,0.00440835797628903,-0.0144375138762016,0.00284324939085141,0.188525731467871
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSNAX,Translin-associated protein X,39575,0.0051455128784228,0.00391296604160449,-0.00252390056312201,0.0128149263199676,0.188540595089459
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00367784260726517,0.00279904119484676,-0.00916396334916483,0.00180827813463448,0.188880181865087
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00682173428388098,0.00519877877662434,-0.0170113406860647,0.00336787211830274,0.189486840202054
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.00533460455078928,0.00406603757087191,-0.0133040381896982,0.00263482908811967,0.189545460558575
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00649769579102763,0.0049538773229914,-0.0162072953440908,0.00321190376203551,0.18966960238637
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UNG,Uracil-DNA glycosylase,39919,0.0045827410644784,0.00349620708879922,-0.00226982482956807,0.0114353069585249,0.189960363495297
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PADI4,Protein-arginine deiminase type-4,41814,-0.00942168648541618,0.00720353097898199,-0.0235406072042209,0.00469723423338851,0.190921114053041
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GNLY,Granulysin,42137,0.00696823462834569,0.00532810876113387,-0.0034748585434767,0.0174113278001681,0.190954831183509
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD177,CD177 antigen,42123,-0.0165274413912504,0.0127160964290408,-0.0414509903921703,0.00839610760966956,0.193717043887913
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.00894985480165513,0.00689738645307217,-0.0224687322496766,0.00456902264636632,0.194461730371759
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DUOX2,Dual oxidase 2,41900,0.00900757154506636,0.00694692019144881,-0.0046083920301733,0.022623535120306,0.194781693552584
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0046614547611523,0.00361390786326937,-0.0117447141731603,0.00242180465085567,0.197119425873624
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.00480650342943263,0.00372656532980131,-0.0121105714758432,0.00249756461697794,0.19714899750381
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.00798803577584842,0.00620621026195631,-0.00417613633758595,0.0201522078892828,0.198085112198784
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00501482833657436,0.00389720791727176,-0.00262369918127828,0.012653355854427,0.198199986708998
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00751266628729574,0.00585564956223755,-0.00396440685468986,0.0189897394292813,0.19952707226649
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.0106178413741625,0.0082823109034152,-0.0268511707448563,0.00561548799653127,0.199868149737293
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AHCY,Adenosylhomocysteinase,42145,0.00849417039388013,0.00664642259413552,-0.00453281789062548,0.0215211586783857,0.201269082024052
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00485087384019945,0.00380279743390739,-0.0123043568106579,0.00260260913025904,0.202121586863806
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PFDN6,Prefoldin subunit 6,39649,0.00818607000167785,0.0064352724238963,-0.00442706394915889,0.0207992039525146,0.203377614892148
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEMA4C,Semaphorin-4C,42070,0.0034991536471228,0.00275368404992657,-0.00189806709073327,0.00889637438497887,0.203851224831281
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.00508077986939435,0.00400641108941635,-0.0129333456046504,0.0027717858658617,0.204761574372617
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAD2,Glutamate decarboxylase 2,39657,0.00571984408656365,0.00451341220113994,-0.00312644382767063,0.0145661320007979,0.2050749834125
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00808609983823665,0.00639288407923446,-0.0206161526335362,0.00444395295706289,0.205948392518633
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.00364014400295546,0.00288457869353063,-0.00201363023636458,0.00929391824227551,0.206999455731247
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEZ6,Seizure protein 6 homolog,39649,0.00391475170173905,0.00310738145464114,-0.00217571594935758,0.0100052193528357,0.207759705115
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FSHB,Follitropin subunit beta,39638,-0.00513165012909848,0.0040756692481847,-0.0131199618555405,0.00285666159734353,0.208023057506504
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB44,Ras-related protein Rab-44,39919,-0.00556529672851765,0.00445478468769291,-0.0142966747163958,0.00316608125936045,0.211586600192099
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.0051358206465663,0.004115036194187,-0.00292965029404023,0.0132012915871728,0.21203492145624
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00404783288776047,0.00324792000904228,-0.0023180903299624,0.0104137561054833,0.212686507818707
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,42281,-0.00641039634523217,0.00514405206715617,-0.0164927383968583,0.00367194570639392,0.212720975164014
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COPE,Coatomer subunit epsilon,41839,0.00569113757844122,0.00457381605262465,-0.00327354188470308,0.0146558170415855,0.213416165214771
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPHB6,Ephrin type-B receptor 6,41997,-0.00402679885275507,0.00323666564796059,-0.0103706635227578,0.00231706581724768,0.21347735117381
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0105540652443048,0.00850101164770756,-0.0272160480738116,0.00610791758520205,0.214444878439307
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.00356535395880679,0.00287677892159233,-0.00207313272751417,0.00920384064512775,0.21523562427331
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0088121991241594,0.00711120368386615,-0.022750158344537,0.00512576009621825,0.2152973678733
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTSL,Cathepsin L1,42145,-0.00299582606675203,0.00241839577917582,-0.00773588179393663,0.00174422966043257,0.215453696167343
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.00385733075895542,0.00311694560150087,-0.00996654413789712,0.00225188261998628,0.215914827447152
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP3,Stromelysin-1,42137,-0.00606720640274881,0.00490713292889461,-0.0156851869433822,0.00355077413788463,0.216329304372589
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MSLN,Mesothelin,42048,-0.00710413645266522,0.00575139583246974,-0.0183768722843059,0.00416859937897548,0.216776861208544
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0048505345352657,0.0039396445204993,-0.0125722377954443,0.00287116872491293,0.218269457053257
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.00404286184228839,0.00328739643960913,-0.0104861588639223,0.0024004351793455,0.218790895775315
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TLR2,Toll-like receptor 2,39757,-0.00283350479807939,0.00230458088262716,-0.00735048332802862,0.00168347373186985,0.218906650377141
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VCAN,Versican core protein,42249,0.00364813593147796,0.00296886566511859,-0.00217084077215447,0.00946711263511039,0.21916876976263
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.00874553853013013,0.00712124644925895,-0.00521210451041741,0.0227031815706777,0.219438957768582
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.00458912916404002,0.00374040751404755,-0.00274206956349318,0.0119203278915732,0.219884069295876
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPT1,Translationally-controlled tumor protein,41913,0.00772960020370267,0.00633175084836952,-0.00468063145910158,0.0201398318665069,0.222195410749819
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCIN,Adseverin,39586,-0.00895878481546747,0.00734257351976915,-0.023350228914215,0.00543265928328006,0.22244743566705
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00549856786406543,0.0045083451139666,-0.01433492428744,0.00333778855930911,0.222626582688682
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TLR3,Toll-like receptor 3,42296,0.00735783114107372,0.00603898019688816,-0.00447857004482708,0.0191942323269745,0.223096912417278
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARG1,Arginase-1,42015,-0.00607203095149428,0.00499676738408325,-0.0158656950242975,0.00372163312130889,0.224314318348608
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,42070,-0.00698291503269121,0.00574899409937503,-0.0182509434674663,0.00428511340208384,0.22452758246396
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,0.00437927790814916,0.00360840703144979,-0.00269319987349242,0.0114517556897907,0.224909682216016
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.0097977474697786,0.00807497108004365,-0.00602919584710694,0.0256246907866641,0.225018466443993
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFRA2,GDNF family receptor alpha-2,42070,-0.0024909023718992,0.00206441209861319,-0.00653715008518104,0.00155534534138265,0.227610639377089
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD164,Sialomucin core protein 24,42137,0.00321703778048594,0.00266720344139138,-0.00201068096464116,0.00844475652561304,0.227782133129755
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSPAN7,Tetraspanin-7,39586,-0.0116677874513327,0.00970787211541099,-0.0306952167975383,0.00735964189487279,0.229432334166251
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHGB,Secretogranin-1,42210,-0.00499856370270435,0.004172356480003,-0.0131763824035102,0.00317925499810154,0.230930355134754
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.00587137769854449,0.00491362317002207,-0.00375932371469877,0.0155020791117877,0.23214400761364
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCP2,Non-specific lipid-transfer protein,41843,-0.00874820889990902,0.00732373363728426,-0.0231027268289862,0.00560630902916814,0.232303349886642
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.00749760977143373,0.00627819056893703,-0.00480764374368285,0.0198028632865503,0.232413010574369
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.00797400862457049,0.00669248149482448,-0.00514325510528549,0.0210912723544265,0.233487992187552
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LEPR,Leptin receptor,42145,-0.00368397543176314,0.00310638758204588,-0.00977249509257306,0.00240454422904678,0.235668559856065
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00424690933087581,0.00359391070583939,-0.0027971556525694,0.011290974314321,0.237351841893712
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,-0.00973516163977631,0.00826728515198627,-0.0259390405376694,0.00646871725811679,0.238995675626267
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HIP1,Huntingtin-interacting protein 1,39575,-0.00385602791681024,0.00327863045386671,-0.010282143606389,0.00257008777276852,0.239576694138656
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.00812813432627297,0.0069221957996839,-0.00543936944110748,0.0216956380936534,0.240329998439354
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.00615566557009247,0.00524449540160913,-0.00412354541706143,0.0164348765572464,0.240525154465864
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRTAP,Cartilage-associated protein,39649,0.00572276102508231,0.00489525917632136,-0.00387194696050756,0.0153174690106722,0.242412140226902
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0142571182446126,0.0122128976602852,-0.00968016116954648,0.0381943976587717,0.243077110668965
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.00462702317382977,0.00396433700864627,-0.0123971237107765,0.00314307736311693,0.243170176038424
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00896343952003039,0.00768201243991359,-0.024020183902261,0.00609330486220024,0.243312989230425
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,-0.00457421308939955,0.00393049323941588,-0.0122779798386547,0.00312955365985556,0.244535836751408
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00399935170198834,0.00344195139106959,-0.00274687302450807,0.0107455764284847,0.245283819215726
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00465943015975656,0.00401177922598585,-0.0125225174426888,0.0032036571231757,0.245489353533446
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYO6,Unconventional myosin-VI,39934,0.00431729939125,0.00372271352615834,-0.00297921912002035,0.0116138179025203,0.246187904212494
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHD,SH2 domain-containing adapter protein D,39554,-0.00950112100369687,0.00820686672040234,-0.0255865797756855,0.00658433776829172,0.247010163997251
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0040263534871649,0.00347872126729865,-0.00279194019674045,0.0108446471710702,0.247119592308718
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA2,Annexin A2,39492,-0.0081089175132241,0.00700787078854274,-0.0218443442587679,0.00562650923231967,0.247250456720637
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00391338980332179,0.00338567252416097,-0.0105493079506773,0.00272252834403371,0.247760402655855
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0104114652355597,0.00902472559601274,-0.00727699693262522,0.0280999274037447,0.248659785044199
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.00794368835626565,0.00688877051248225,-0.0214456785607309,0.00555830184819955,0.248879325697021
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL17RA,Interleukin-17 receptor A,42137,-0.00504540940121062,0.00438192231867912,-0.0136339771458217,0.00354315834340045,0.249582039679288
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.00511846449758702,0.00444661084895378,-0.0138338217615364,0.00359689276636239,0.249714236250589
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGR,Progesterone receptor,39657,0.0114477027710901,0.00998408490327588,-0.0081211036393306,0.0310165091815108,0.251573816484791
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.00491317410186101,0.00428990812161186,-0.00349504581649823,0.0133213940202202,0.252111169435575
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FUS,RNA-binding protein FUS,41831,0.00448010784289189,0.00391742710385917,-0.00319804928067208,0.0121582649664559,0.252795614814486
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FMNL1,Formin-like protein 1,41839,-0.00711024878679609,0.00622847194080478,-0.0193180537907735,0.00509755621718127,0.25365264119048
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DMD,Dystrophin,39638,0.00583703126193019,0.00511316547357624,-0.00418477306627923,0.0158588355901396,0.253657974845352
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00362158978285983,0.00317826901452321,-0.00985099705132532,0.00260781748560567,0.254521542135649
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.00802028010856606,0.00703948355613435,-0.0218176678785894,0.00577710766145726,0.254591251348367
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0022009400777995,0.0019334949801928,-0.00158871008337837,0.00599059023897738,0.255006251868374
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00310089937754696,0.00272841092312688,-0.00224678603178173,0.00844858478687565,0.255758165018943
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NTF3,Neurotrophin-3,42119,-0.0038535865270916,0.00339672823209814,-0.010511173862004,0.00280400080782076,0.256605192959391
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.00597154622207017,0.00528046407685614,-0.00437816336856785,0.0163212558127082,0.258131902912816
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LPA,Apolipoprotein(a),39775,-0.0204980434527051,0.0181561578834965,-0.0560841129043583,0.0150880259989481,0.258928081542824
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.00428999987855981,0.00380887395773446,-0.00317539307859973,0.0117553928357194,0.260055227345311
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.00351723456692314,0.00312487581655941,-0.00964199116737957,0.0026075220335333,0.260375729535026
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00284653131840823,0.00252990774516289,-0.00211208786211104,0.0078051504989275,0.260549174616836
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,0.00538952902978635,0.00479219679705493,-0.00400317669244131,0.014782234752014,0.260758681715454
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.00770970446028616,0.00685897244142546,-0.00573388152490774,0.0211532904454801,0.261023873752429
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA11,Serpin A11,42310,-0.00463453380753559,0.00412575794103412,-0.0127210193719625,0.00345195175689129,0.261322579012672
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.00455674575312373,0.00407559207436473,-0.00343141471263113,0.0125449062188786,0.263562638044132
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HDAC8,Histone deacetylase 8,39657,0.00670249968041305,0.00599822268879178,-0.00505401678961885,0.0184590161504449,0.263841511561153
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DKK3,Dickkopf-related protein 3,42310,-0.00325194589474969,0.00291197310751564,-0.00895941318548034,0.00245552139598096,0.264120814247584
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A12,Protein S100-A12,41910,0.00810295982079489,0.00725903670702951,-0.00612475212498295,0.0223306717665727,0.264331745953824
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.00535046380414143,0.00481258146328757,-0.0147831234721851,0.0040821958639022,0.266259013674833
NMR metabolomics,X23505.Cholesterol in Medium VLDL,REST,RE1-silencing transcription factor,39560,0.00378832345674844,0.00340812231963801,-0.00289159628974206,0.0104682432032389,0.266352896073998
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL3,C-C motif chemokine 3,42119,-0.00647149995166604,0.00585517560399099,-0.0179476441354884,0.0050046442321563,0.269065980758194
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0063862565075103,0.00578223129740869,-0.0177194298504313,0.00494691683541074,0.269416835443233
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.00680205622396252,0.0061940620992122,-0.00533830549049339,0.0189424179384184,0.272159617115845
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00395687608348561,0.00361644182849136,-0.00313134990035746,0.0110451020673287,0.27391954749336
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TALDO1,Transaldolase,39948,0.00479012656756655,0.0043905212987896,-0.00381529517806107,0.0133955483131942,0.275289248666984
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSAP,Prosaposin,39886,-0.00309308456492364,0.0028359647965827,-0.00865157556622574,0.00246540643637846,0.275444063809642
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.00777015912881293,0.0071304381352887,-0.00620549961635292,0.0217458178739788,0.27585758166164
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.00441079741290233,0.00404940444746169,-0.00352603530412259,0.0123476301299272,0.276064892068836
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.00824706518149714,0.00757488167257165,-0.0230938332597376,0.00659970289674329,0.276293165420241
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENG,Endoglin,42310,-0.00184677933328928,0.0017067849902894,-0.00519207791425651,0.00149851924767795,0.279261672649879
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00358376890327077,0.00332783347942066,-0.00293878471639372,0.0101063225229353,0.281545285752633
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0052171750397927,0.00487020463547762,-0.00432842604574343,0.0147627761253288,0.28408276910576
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00705090621539787,0.00658227404486229,-0.00585035091253221,0.019952163343328,0.284104650428736
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLSPN,Claspin,41820,0.00374965519430322,0.0035044863024001,-0.00311913795840097,0.0106184483470074,0.284657486801926
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.003531439858887,0.00330890293107256,-0.0100168896037892,0.00295400988601523,0.285880609921193
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.0113685245988185,0.0106611189958992,-0.032264317830781,0.00952726863314398,0.286286410497826
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RGMB,RGM domain family member B,42249,0.00294225527677634,0.0027665463145062,-0.0024801754996558,0.00836468605320848,0.287568629208805
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.00503459819699058,0.00474323132601572,-0.0143313315959814,0.00426213520200023,0.288518087022882
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00520631889292034,0.00492482700123807,-0.00444634202950627,0.014858979815347,0.290462879717777
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL31,Interleukin-31,39657,0.00584120997125424,0.0055387824876672,-0.00501480370457347,0.016697223647082,0.291630524375235
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00512515014970839,0.0048614515844416,-0.00440329495579714,0.0146535952552139,0.291794971178031
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00355521587183408,0.00337328291074596,-0.003056418633228,0.0101668503768962,0.291936392739859
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HRAS,GTPase Hras,39750,0.0103938396531853,0.00986745967854441,-0.0089463813167618,0.0297340606231323,0.292205711486788
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.00504130871506941,0.00478801365377061,-0.0144258154764598,0.00434319804632098,0.292408405182683
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCN3B,Sodium channel subunit beta-3,39586,0.00486121689810281,0.00463587248066068,-0.00422509316399212,0.0139475269601978,0.294381250000891
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.00241453269037858,0.00230584620171405,-0.00210492586498097,0.00693399124573812,0.295055693222314
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STC2,Stanniocalcin-2,42113,-0.00247321764056277,0.00236942059663841,-0.00711728200997406,0.00217084672884852,0.296593396788132
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00556321868013745,0.00533147286157487,-0.00488646812854929,0.0160129054888242,0.296750876461484
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYH4,Myosin-4,39575,0.00474975562549955,0.00456004585941756,-0.00418793425895887,0.013687445509958,0.297618906540093
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00490679098605334,0.00471491444626137,-0.0141480233007256,0.00433444132861895,0.298039744531515
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD244,Natural killer cell receptor 2B4,42296,0.00282418663039932,0.00271885581201842,-0.00250477076115677,0.00815314402195542,0.298943608988628
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.00516076727319049,0.00500426450440897,-0.0149691257018321,0.00464759115545109,0.302434976431098
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00788868238175705,0.00766145191799047,-0.00712776337750427,0.0229051281410184,0.303192680270109
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.00973689284534791,0.00947572081898787,-0.0283093056505641,0.00883551995986832,0.304178474106185
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ISM2,Isthmin-2,39966,0.00442733635881796,0.00430995631734282,-0.00402017802317396,0.0128748507408099,0.304331858005607
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNX18,Sorting nexin-18,39930,-0.00446263352791205,0.00434815416559231,-0.012985015692473,0.00405974863664887,0.304758788536303
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.00685533985667802,0.00668322697810072,-0.0199544647337554,0.0062437850203994,0.305030499672645
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARSA,Arylsulfatase A,42137,-0.00456683419150245,0.00445507111034489,-0.0132987735677784,0.00416510518477354,0.305340592355741
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOSB,Protein fosB,41839,0.00388672094063288,0.00379247445041421,-0.00354652898217898,0.0113199708634447,0.305452259509359
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RALB,Ras-related protein Ral-B,39657,0.00302757566230205,0.0029543614741675,-0.00276297282706626,0.00881812415167035,0.305488607730527
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL3,Interleukin-3,39560,0.00624819057704754,0.00609746705525771,-0.00570284485125758,0.0181992260053527,0.305518393104709
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IKZF2,Zinc finger protein Helios,41843,0.00898548153416705,0.00877118296794468,-0.00820603708300453,0.0261770001513386,0.305649930784652
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00559664818804944,0.0054797635120573,-0.0163369846716818,0.00514368829558287,0.307120546340209
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGLON5,IgLON family member 5,39560,-0.00940929751729642,0.00922471597622437,-0.0274897408306962,0.00867114579610335,0.30774649083086
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACTN4,Alpha-actinin-4,41913,0.0031778306941381,0.00311777730837052,-0.00293301283026812,0.00928867421854433,0.308097309924487
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00390215483808368,0.00385810381095314,-0.0114640383075518,0.00365972863138447,0.311838806294377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACRV1,Acrosomal protein SP-10,39657,-0.0107060012913772,0.0105895056926764,-0.0314614324490229,0.0100494298662686,0.312038053828599
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RILP,Rab-interacting lysosomal protein,42224,0.00585358718498042,0.0057904226389294,-0.0054956411873212,0.017202815557282,0.312078201441206
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ING1,Inhibitor of growth protein 1,41820,0.0047245443361916,0.00469684712379486,-0.00448127602644633,0.0139303646988295,0.314483539914156
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GZMB,Granzyme B,42119,0.0067290255285601,0.0066937165998791,-0.00639065900720294,0.0198487100643231,0.314782472734625
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRSF1,G-rich sequence factor 1,39486,-0.00832174235363821,0.00828387430892613,-0.0245581359991334,0.00791465129185701,0.315125653008696
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TP73,Tumor protein p73,39649,0.0034134611239009,0.00340076541485783,-0.00325203908922044,0.0100789613370222,0.315529214846827
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASQ2,Calsequestrin-2,39575,0.00475084832599603,0.00473544885740921,-0.00453063143452602,0.0140323280865181,0.315761429253261
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00388404452623733,0.00389034658142867,-0.00374103477336287,0.0115091238258375,0.318113024098549
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GFRA3,GDNF family receptor alpha-3,41989,-0.0027350077608404,0.00274728776772853,-0.00811969178558831,0.00264967626390752,0.319496486606218
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAPN3,Calpain-3,39919,-0.00384276234947111,0.00387265811079048,-0.0114331722466204,0.00374764754767823,0.321082022056458
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTF,Ciliary neurotrophic factor,39586,0.00340877772939068,0.00343845890728087,-0.00333060172887983,0.0101481571876612,0.321527810619141
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00583488378769357,0.00588657431079112,-0.00570280186145703,0.0173725694368442,0.321599885903339
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NXPE4,NXPE family member 4,39575,-0.00315471016046291,0.00318407839929646,-0.00939550382308397,0.00308608350215815,0.321816552752011
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.00553091511031468,0.00558423813194946,-0.00541419162830627,0.0164760218489356,0.321975487603646
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.0072094439455785,0.00729100100508429,-0.0214998059155437,0.0070809180243867,0.32277559141632
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.00664333786060966,0.00672872686479109,-0.00654496679438088,0.0198316425156002,0.323508839571967
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EP300,Histone acetyltransferase p300,39657,0.00302749187504488,0.0030675297929679,-0.00298486651917221,0.00903985026926197,0.323689810282909
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.00742196029273061,0.0075288135626856,-0.00733451429013318,0.0221784348755944,0.32424933283351
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.00412124382791474,0.00419577971805998,-0.00410248441948283,0.0123449720753123,0.326001170326595
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CES1,Liver carboxylesterase 1,42163,0.00822928145440031,0.00838294573716502,-0.00820129219044312,0.0246598550992437,0.326280247081974
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCLRE1C,Protein artemis,39560,0.00297311245273711,0.00303106250704749,-0.00296777006107598,0.0089139949665502,0.326672944160503
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.00794986682695182,0.00812502749900388,-0.0238749207249994,0.00797518707109579,0.327877441207815
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.000795304224036098,0.000813220436403553,-0.00238921627938706,0.000798607831314866,0.328110881946397
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX7,Syntaxin-7,39657,-0.00478117006651885,0.00489026899015876,-0.01436609728723,0.00480375715419232,0.328248757854196
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00357201169109797,0.00365852455853833,-0.0107427198258331,0.00359869644363716,0.328907268870636
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFNL2,Interferon lambda-2,39586,-0.00567480052365781,0.00582485264497199,-0.0170915117078029,0.0057419106604873,0.329959172370712
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TNPO1,Transportin-1,39757,0.00343673503584784,0.00353280091712255,-0.00348755476171236,0.010361024833408,0.330670101379105
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00328775715394782,0.00338003061968994,-0.00333710286064445,0.0099126171685401,0.330722981896421
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PMCH,Pro-MCH,39575,-0.00796930455561005,0.00821230181250226,-0.0240654161081145,0.00812680699689438,0.331863263000198
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD99,CD99 antigen,42137,-0.00190963449872952,0.00196832640650082,-0.00576755425547113,0.0019482852580121,0.331973203967071
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLSTN3,Calsyntenin-3,39929,0.00291839049622383,0.00300841258891531,-0.00297809817805017,0.00881487917049783,0.332029048059112
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.00532577881976208,0.00550716005771712,-0.00546825489336347,0.0161198125328876,0.333529082463765
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.00528403531479846,0.00547767528209646,-0.00545220823811059,0.0160202788677075,0.334738145777082
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM171B,Protein FAM171B,39919,0.00253984094460161,0.00263574775974979,-0.00262622466450798,0.00770590655371119,0.335260545998304
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAFB2,Scaffold attachment factor B2,39934,-0.00260915547588881,0.00271087206504183,-0.0079224647233708,0.00270415377159319,0.335829943051389
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.0034889613489902,0.00362672374949323,-0.00361941720001654,0.0105973398979969,0.336063443454424
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL21R,Interleukin-21 receptor,39657,-0.00518782536754169,0.00539394939150441,-0.0157599661748903,0.00538431543980695,0.336178110661167
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.00750720888913027,0.00783055633636584,-0.00784068153014676,0.0228550993084073,0.337727387654449
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0064071189778615,0.00669573403406506,-0.019530757684629,0.00671651972890602,0.338641017617336
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIMAP8,GTPase IMAP family member 8,39560,-0.00477225721383072,0.00499253562578525,-0.0145576270403698,0.00501311261270836,0.339154730676868
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00660108247851268,0.00692330987700797,-0.00696860488042293,0.0201707698374483,0.340375149532659
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.00337108382884777,0.00354515588399418,-0.0103195893614764,0.00357742170378082,0.341672720625049
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00337728696150116,0.003558648198061,-0.00359766350669839,0.0103522374297007,0.342622955044304
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C19orf12,Protein C19orf12,41839,0.00624209929272216,0.00657908840658981,-0.00665291398419387,0.0191371125696382,0.342750468705834
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.00679508436431169,0.00718620721586084,-0.00728988177877556,0.0208800505073989,0.344386525205377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.00492766175753354,0.00521566154357875,-0.00529503486788081,0.0151503583829479,0.344790416164036
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPY30,Protein dpy-30 homolog,42216,0.00560349144552765,0.00593499385309289,-0.00602909650653442,0.0172360793975897,0.345112595227685
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00942694258857465,0.0100031364264205,-0.0290330899843589,0.0101792048072095,0.346008979264867
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0017864569242902,0.00190160222294121,-0.00551359728125497,0.00194068343267457,0.347517285980866
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL19,C-C motif chemokine 19,42249,0.0104466175953353,0.0111417932543059,-0.0113912971831043,0.0322845323737748,0.348463268194315
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIMAP7,GTPase IMAP family member 7,39736,0.00300348023235078,0.00320811693821521,-0.00328442896655104,0.0092913894312526,0.349183921365457
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00556293872377741,0.00595339553628468,-0.00610571652734056,0.0172315939748954,0.35010719697836
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.00971523374865228,0.0104286408906441,-0.0107249023970101,0.0301553698943147,0.35156436459126
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0036549224544902,0.0039373961812038,-0.00406237406066925,0.0113722189696496,0.353293447309606
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSLP,Thymic stromal lymphopoietin,41900,-0.00552071966778218,0.00595261113767777,-0.0171878374976306,0.00614639816206625,0.353712345162696
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RTKN2,Rhotekin-2,39575,0.00467894264557355,0.0050677598679085,-0.00525386669552711,0.0146117519866742,0.355883525900656
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.00476024981288176,0.0051619000687982,-0.00535707432196271,0.0148775739477262,0.356449417976276
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.00694731876542052,0.00753528415300395,-0.00782183817446722,0.0217164757053082,0.356562967328821
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LSP1,Lymphocyte-specific protein 1,42119,-0.003675225718904,0.00399480556920877,-0.0115050446345532,0.00415459319674519,0.357588573408849
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.00419924663494581,0.00457011905047029,-0.00475818670397595,0.0131566799738676,0.358191237489447
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BRD2,Bromodomain-containing protein 2,39586,-0.00318962426947754,0.00348603417768865,-0.0100222512577473,0.00364300271879222,0.360226320035978
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.00717064885766724,0.00786425975397729,-0.00824330026012825,0.0225845979754627,0.361892817135349
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00402644293924554,0.00442142665819321,-0.0126924391893042,0.00463955331081315,0.362491056314678
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.00417610248000775,0.00459453763923416,-0.0131813962529067,0.0048291912928912,0.36340825554375
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OMP,Olfactory marker protein,39586,-0.00430033140469751,0.00477143239215216,-0.0136523388933157,0.00505167608392073,0.367466483605841
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.00260546659581677,0.00289289534910647,-0.00306460828843192,0.00827554148006546,0.367794427299475
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00391039134575168,0.00434416824800502,-0.0124249611118415,0.00460417842033816,0.368061641325157
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAG,S-arrestin,39586,-0.00464572072832996,0.00520307323379715,-0.0148437442665724,0.00555230280991246,0.3719409240409
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATXN2,Ataxin-2,39586,0.00936284862072599,0.0105483821763665,-0.0113119804449524,0.0300376776864043,0.374770049163377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FZD8,Frizzled-8,39586,-0.00380146146369186,0.00428539305345706,-0.0122008318484677,0.00459790892108399,0.375058390990792
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00422101186272947,0.00481388018194261,-0.013656217019337,0.00521419329387805,0.380591707469164
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.00484806406097241,0.00553378369619626,-0.0156942801055171,0.00599815198357227,0.381002482870118
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00380035796406427,0.00437486803128286,-0.0123750993053787,0.00477438337725014,0.385040901446505
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.00564361176660284,0.00649949226847832,-0.00709539307961467,0.0183826166128203,0.385236844965661
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.00391804668851176,0.00451917030322959,-0.00493952710581824,0.0127756204828418,0.38596939463192
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TLR4,Toll-like receptor 4,39657,0.00244985625645118,0.00282822175134482,-0.00309345837618468,0.00799317088908703,0.386389483907946
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NMI,N-myc-interactor,39875,0.00623378283466191,0.00723130085155015,-0.00793956683437638,0.0204071325037002,0.388675298901267
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00419918654360409,0.0048762479852191,-0.0137566325946335,0.00535825950742534,0.389173615596894
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.00451170055628039,0.00523998541147563,-0.00575867085021184,0.0147820719627726,0.389245610022376
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SKIV2L,Helicase SKI2W,39575,-0.00338853897438475,0.00393838010754991,-0.0111077639851826,0.00433068603641307,0.389593434588491
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH23,Cadherin-23,39929,-0.00228347399129814,0.00266062461322392,-0.00749829823321702,0.00293135025062074,0.390774058715709
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00239116573561827,0.00278834051833222,-0.00785631315154942,0.00307398168031288,0.391154762444122
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.00572714543099583,0.00669790124443901,-0.00740074100810462,0.0188550318700963,0.392532994725483
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,39575,0.00269375392037626,0.00315663411051918,-0.00349324893624133,0.00888075677699385,0.393476803531166
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLAMF6,SLAM family member 6,41843,0.00324589887695652,0.0038141634000248,-0.00422986138709209,0.0107216591410051,0.394778065999832
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALB1,Calbindin,42070,-0.00380467135570082,0.0044747904604229,-0.0125752606581297,0.00496591794672806,0.395203610148229
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00586080264392461,0.00691532460950197,-0.0194148388785485,0.00769323359069926,0.396729728485223
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.00581489086659744,0.00688999525534548,-0.0193192815670746,0.00768949983387971,0.398709167176527
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0104694301141759,0.012460533079065,-0.0139532147207915,0.0348920749491433,0.400807367972522
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHH,Sonic hedgehog protein,39657,-0.00356073285613368,0.00425016558574046,-0.011891057404185,0.00476959169191762,0.402168531704831
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.0045179324023131,0.0053935856645897,-0.00605349550028272,0.0150893603049089,0.40224605030445
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.00333594995602913,0.00399489750652073,-0.00449404915675151,0.0111659490688098,0.403705643334198
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00626584872448979,0.00750423143235599,-0.00844244488292795,0.0209741423319075,0.403749175914667
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0049260461853227,0.00591063860883455,-0.0165108978586384,0.00665880548799302,0.404622509142769
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DGCR6,Protein DGCR6,39586,-0.0034653434522007,0.00416675449578363,-0.0116321822639366,0.00470149535953522,0.405616195259132
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.00296311204449333,0.00356505495092064,-0.00402439565931113,0.00995061974829779,0.405901248075987
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KHDC3L,KH domain-containing protein 3,39560,0.00554143034606055,0.00668116037101705,-0.00755364398113287,0.018636504673254,0.406889735977052
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,39638,-0.00339178403638805,0.00409806674851619,-0.0114239948634798,0.00464042679070368,0.407883997038931
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD2AP,CD2-associated protein,42145,0.00515787639555282,0.00623297408949044,-0.00705875281984845,0.0173745056109541,0.407960089341603
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TBR1,T-box brain protein 1,39649,0.0039260851573262,0.00476088408826391,-0.00540524765567106,0.0132574179703235,0.409585492660134
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.00353435087426792,0.00429239771317858,-0.00487874864356209,0.0119474503920979,0.410299597562824
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRP2,Neuropilin-2,42137,0.00228071789214063,0.00277737976842686,-0.00316294645397601,0.00772438223825727,0.411560427861358
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HDAC9,Histone deacetylase 9,39586,-0.00544438882207779,0.0066392738820248,-0.0184573656308464,0.00756858798669081,0.412218078613903
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00493700811245796,0.00602871432206865,-0.00687927195879659,0.0167532881837125,0.41285234109631
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL24,Interleukin-24,41913,-0.00389151487748981,0.00476582371139839,-0.0132325293518306,0.00544949959685104,0.414202465296052
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0041704335948761,0.00513360101156945,-0.00589142438780001,0.0142322915775522,0.416591085205509
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TOP1,DNA topoisomerase 1,39930,0.00974133178513233,0.0119912614863979,-0.0137615407282076,0.0332442042984723,0.41659686839649
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,0.00385568556975467,0.00475159157681747,-0.00545743392080757,0.0131688050603169,0.41712108371937
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00177239292196532,0.00218581761007506,-0.00605659543771245,0.0025118095937818,0.417463301423364
NMR metabolomics,X23505.Cholesterol in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.00463239733451317,0.00571597031671815,-0.00657090448625439,0.0158356991552807,0.417710200742765
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TXN,Thioredoxin,39854,0.00345706598331513,0.00427821787594638,-0.00492824105353977,0.01184237302017,0.419071878586068
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAPT,Microtubule-associated protein tau,41839,0.00419355668553847,0.00520944120498918,-0.00601694807624032,0.0144040614473173,0.420838952939315
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00287975307257453,0.0035956124663472,-0.00416764736146599,0.00992715350661505,0.423202423432914
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00311333699486273,0.0038887839107515,-0.0107353534599357,0.00450867947021022,0.42338408956111
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FZD10,Frizzled-10,39649,-0.00473477854668606,0.00591961485254028,-0.016337223657665,0.00686766656429288,0.423817390928419
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.00326861546893829,0.00409211258709873,-0.00475192520177521,0.0112891561396518,0.424446677180494
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KHK,Ketohexokinase,39638,-0.00500252748039171,0.00626544096593311,-0.0172827917736206,0.00727773681283719,0.424637117470099
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00286684509288286,0.00359369399675708,-0.00991048532652674,0.00417679514076102,0.425036821893052
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.00184436602277697,0.00231382606507852,-0.00269073306477693,0.00637946511033088,0.425403059781544
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.00364740657951714,0.0045785431574676,-0.0126213511681536,0.00532653800911935,0.425682705878671
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.00287477225971687,0.0036099649317906,-0.00995030352602645,0.0042007590065927,0.425849101661849
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GUK1,Guanylate kinase,39575,-0.00317750269661419,0.00400560393681305,-0.0110284864127678,0.00467348101953938,0.42764098699388
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC1A4,Neutral amino acid transporter A,39649,-0.00399526298948677,0.00504183246518495,-0.0138772546212493,0.00588672864227574,0.428131203851756
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0051842918834521,0.00654334598535043,-0.00764066624783474,0.018009250014739,0.428202455880065
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.00219849605223067,0.00280035058244842,-0.00768718319382958,0.00329019108936824,0.432421070715313
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ESPL1,Separin,39560,0.00415577138108996,0.00531378920379425,-0.00625925545834678,0.0145707982205267,0.43418853337164
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0025953261893128,0.00335989069140175,-0.00918071194446023,0.00399005956583462,0.439867830283764
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.0021541088173175,0.00279942483948967,-0.00764098150271724,0.00333276386808225,0.441623295277061
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00367485997538825,0.00481282142944736,-0.00575827002632858,0.0131079899771051,0.445144983692995
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,42145,-0.00347254504317151,0.00454977561537008,-0.0123901052492969,0.00544501516295386,0.445336937951738
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.00693200769472151,0.00912651311147053,-0.0109559580037607,0.0248199733932037,0.447542124159926
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRYBB2,Beta-crystallin B2,39929,-0.00527550400565543,0.00695336591326555,-0.0189041011956559,0.00835309318434505,0.448049086570284
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ESR1,Estrogen receptor,39657,0.00431540131528006,0.00569418521107594,-0.00684520169842879,0.0154760043289889,0.448550307315572
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCG3,Secretogranin-3,42144,-0.00248765179884448,0.00328546595064023,-0.00892716506209933,0.00395186146441037,0.448962004830811
NMR metabolomics,X23505.Cholesterol in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.00657132162183669,0.00868774083759579,-0.0104566504198511,0.0235992936635244,0.449431545553647
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LMOD2,Leiomodin-2,39586,-0.00462465997816977,0.00611901193194923,-0.0166179233647903,0.00736860340845072,0.4497940663798
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00397646907862708,0.00533223587691213,-0.0144276513973748,0.00647471324012068,0.455839127508253
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.00440736446245701,0.00591219331473446,-0.00718053443442253,0.0159952633593365,0.456002924380595
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LTA,Lymphotoxin-alpha,42119,-0.0029301475097373,0.00395068925401261,-0.010673498447602,0.00481320342812742,0.458294077640053
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0033963707786645,0.00458133585547703,-0.00558304749807048,0.0123757890553995,0.458496971201084
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCGB2A2,Mammaglobin-A,39575,-0.00229728295620675,0.00309886633075141,-0.00837106096447951,0.003776495052066,0.458509163709907
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CYTH3,Cytohesin-3,39560,-0.00536781174844264,0.00727777989807,-0.0196322603486598,0.00889663685177455,0.460796623614796
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SSB,Lupus La protein,41839,-0.00426943469562037,0.00580473925850399,-0.0156467236422882,0.00710785425104745,0.462042933538676
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX3,Syntaxin-3,39929,-0.00277255550014107,0.00379162972347876,-0.0102041497581594,0.0046590387578773,0.464653464394802
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.00467856818066175,0.00639837241032035,-0.0172193781048896,0.00786224174356613,0.464662090680224
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.00365563753249222,0.00502114762562279,-0.00618581181372845,0.0134970868787129,0.466599385343849
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.00454720229615278,0.00624596002503125,-0.00769487935290847,0.016789283945214,0.46661497543334
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0042977422305185,0.0059090172420286,-0.0158794160248946,0.00728393156385755,0.46704537437507
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.00577854387225668,0.00794604394782313,-0.02135279000999,0.00979570226547664,0.467105049465782
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MKI67,Proliferation marker protein Ki-67,39657,-0.00294461109950392,0.00405491560481284,-0.0108922456849371,0.00500302348592924,0.467741914822535
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CX3CL1,Fractalkine,42016,-0.00239196721587737,0.00329973693394344,-0.00885945160640651,0.00407551717465177,0.468528270648241
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,-0.00338104083034538,0.00466638662558247,-0.012527158616487,0.00576507695579627,0.468739194304484
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.00251368622452901,0.00349126652750474,-0.0093565686184383,0.00432919616938027,0.471544390043384
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EVI2B,Protein EVI2B,39560,0.00285790776149789,0.0039784154819418,-0.00493978658310805,0.0106556021061038,0.472554806417657
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.00269388406519006,0.0037663791607852,-0.0100759872203291,0.00468821908994892,0.474470460164709
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00491041342260066,0.00686669873008073,-0.00854831608835756,0.0183691429335589,0.47455887338865
NMR metabolomics,X23505.Cholesterol in Medium VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00358623807411111,0.0050159959818682,-0.0134175901985728,0.00624511405035057,0.474648793275977
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.00316500377126763,0.00442754108509953,-0.00551297675552744,0.0118429842980627,0.474720271304983
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.0018916342854218,0.00265539160643641,-0.00331293326319356,0.00709620183403716,0.476247828936161
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL11,Interleukin-11,41913,0.00427965338749866,0.00602104333197852,-0.00752159154317923,0.0160808983181766,0.477231359376895
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00155010274923541,0.00219459805816578,-0.00275130944476952,0.00585151494324035,0.479997287841258
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00477759985079576,0.00679512949075741,-0.00854085395108875,0.0180960536526803,0.482013473735963
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL33,Interleukin-33,41913,-0.00273617251371809,0.00389857951905471,-0.0103773883710653,0.00490504334362913,0.482792264976132
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00375868368594493,0.00535658907726944,-0.014257598277393,0.00674023090550316,0.482885197686955
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.00351029827824842,0.00501202911376055,-0.00631327878472225,0.0133338753412191,0.483708092562081
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH4,Cadherin-4,39586,0.00322416816270105,0.00462937604290096,-0.00584940888138483,0.0122977452067869,0.486156490739406
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX5,Syntaxin-5,39657,0.00275828274084714,0.00396291150756987,-0.00500902381398981,0.0105255892956841,0.486428236179837
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSNL1,Visinin-like protein 1,39929,-0.00267902959512802,0.00385614414638101,-0.0102370721220348,0.00487901293177876,0.487230550787716
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.00827291531192927,0.0119312224501179,-0.0151122806903019,0.0316581113141604,0.488082994847736
NMR metabolomics,X23505.Cholesterol in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.00235347640656698,0.00340449749236916,-0.00902629149161053,0.00431933867847658,0.489398672757165
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STX1B,Syntaxin-1B,39649,-0.00275333803815144,0.00398482436085005,-0.0105635937854175,0.00505691770911465,0.489607749373729
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTNNA1,Catenin alpha-1,39586,-0.00231831970182531,0.00336532184352332,-0.00891435051513102,0.0042777111114804,0.49091019404949
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00369721462956018,0.00536890919708718,-0.0142202766558511,0.00682584739673069,0.491068053014946
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.00212500918274875,0.00309302937388712,-0.0081873467555675,0.00393732839007,0.492076129719466
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00277347441868886,0.00403883282440817,-0.00514263791715116,0.0106895867545289,0.49228461624185
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.00575023179568009,0.00841023248881843,-0.0222342874737642,0.010733823882404,0.494166902415953
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL2,C-C motif chemokine 2,41992,0.00348161352474663,0.00512127275331562,-0.00655608107175198,0.0135193081212452,0.496621551148694
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARTN,Artemin,41913,0.00303494256791747,0.00446761380060621,-0.0057215804812707,0.0117914656171056,0.496946488775196
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00315950565984203,0.00466972079399124,-0.0059931470963808,0.0123121584160649,0.498675327400148
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RUVBL1,RuvB-like 1,41843,-0.00655668558998659,0.00976583564124432,-0.0256977234468254,0.0125843522668523,0.501983746079146
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THOP1,Thimet oligopeptidase,42081,0.0020578924202903,0.00309461579728706,-0.00400755454239234,0.00812333938297293,0.506067466631343
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLIT2,Slit homolog 2 protein,41839,-0.00338560694476619,0.00509125083366674,-0.013364458578753,0.00659324468922062,0.506071480966608
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0029343554460263,0.00441534196684898,-0.0057197148089977,0.0115884257010503,0.506331940087381
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.00445663146829092,0.00671364183724175,-0.0087021065327029,0.0176153694692847,0.506818476390411
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00317316339907965,0.00478578304181174,-0.0125532981610307,0.00620697136287136,0.5073191540766
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00428780441194457,0.00646839209503403,-0.00839024409432212,0.0169658529182113,0.507417688899458
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0047000599710145,0.0071308707670171,-0.00927644673233902,0.018676566674368,0.509835879461117
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PREB,Prolactin regulatory element-binding protein,41913,-0.00184549930723956,0.00280257585356611,-0.00733854798022915,0.00364754936575002,0.510227572277227
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RGS8,Regulator of G-protein signaling 8,41913,0.00415598355473293,0.0063154653010653,-0.00822232843535505,0.0165342955448209,0.51050806072499
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.00395480749563445,0.00601869734836806,-0.00784183930716695,0.0157514542984358,0.511136194034294
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00199099178007693,0.00303199811665226,-0.00395172452856151,0.00793370808871536,0.511413368602951
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGMN,Legumain,42185,0.00235128572743752,0.00358537837990702,-0.00467605589718025,0.00937862735205528,0.511964894061925
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TEF,Thyrotroph embryonic factor,39575,0.00279121433461352,0.00426222226726307,-0.0055627413092221,0.0111451699784491,0.512563241684239
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.00545576494628891,0.00833739560828105,-0.0217970603385198,0.010885530445942,0.51288538178448
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.00286087410803041,0.00439440505373483,-0.00575215979728985,0.0114739080133507,0.515043015463449
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00356284059224474,0.00547701277138975,-0.00717210443967916,0.0142977856241686,0.515377743143976
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPHS2,Podocin,39657,0.00658334958825038,0.010151569499095,-0.0133137266299758,0.0264804258064766,0.516671462614393
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYOM1,Myomesin-1,39586,-0.00315958156034211,0.00487318267573901,-0.0127110196047906,0.00639185648410635,0.516765043937659
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PMS1,PMS1 protein homolog 1,39649,-0.00316809781366012,0.00490539417738798,-0.0127826704013406,0.00644647477402032,0.518396651511003
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,-0.00234334060882391,0.00363332245043949,-0.00946465261168531,0.00477797139403748,0.518965347221553
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.00384023092882384,0.00596146073091236,-0.00784423210376438,0.0155246939614121,0.519474256023024
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AGRN,Agrin,42185,-0.00227388947670573,0.00353891870930377,-0.00921017014694113,0.00466239119352966,0.520534817794583
NMR metabolomics,X23505.Cholesterol in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.00345591074326961,0.00539105672734364,-0.0140223819288631,0.00711056044232392,0.521506587940829
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00360087305862065,0.00562969198874413,-0.00743332323931784,0.0146350693565591,0.522432550833963
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00315320075225525,0.00494843034309975,-0.0128521242247308,0.00654572272022026,0.523999750518407
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00414381878190806,0.00650375544624298,-0.0168911794565443,0.00860354189272819,0.524045122901875
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.00348139153634571,0.00550771605530384,-0.00731373193204982,0.0142765150047412,0.527336645205893
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.00360421962631886,0.00570548972023261,-0.00757854022533706,0.0147869794779748,0.527589009646121
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.00545384404551428,0.00864063731819227,-0.0223894931891711,0.0114818050981426,0.527932046662904
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NBN,Nibrin,41913,0.00338717228508632,0.00537108627319263,-0.00714015681037124,0.0139145013805439,0.52829279833421
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00297686789087945,0.00472705296161749,-0.00628815591389083,0.0122418916956497,0.528868110981936
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.00357566085880216,0.00569404130527936,-0.00758466009954538,0.0147359818171497,0.530037145775447
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00348672536494745,0.00555441630903291,-0.0143733813306519,0.00739993060075704,0.530187788050711
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LHB,Lutropin subunit beta,41843,0.0054643585055846,0.00873059218272996,-0.0116476021725661,0.0225763191837353,0.531400272375432
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00291067018386727,0.00466239457405776,-0.00622762318128594,0.0120489635490205,0.532452415091989
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.002510622831158,0.00402724673238407,-0.00538278076431477,0.0104040264266308,0.533025997168558
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,0.00485507671690386,0.00786490317713578,-0.0105601335102823,0.02027028694409,0.537043428730989
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,0.00329241607599816,0.00533680188646477,-0.00716771562147279,0.0137525477734691,0.537295617576741
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00257050879987401,0.00417972282563906,-0.0107627655381266,0.00562174793837855,0.538570539624995
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00385540184258888,0.00632245091434949,-0.0162474056347139,0.00853660194953612,0.542009953280099
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSPAN1,Tetraspanin-1,41900,0.00438179026649987,0.00719935380375315,-0.00972894318885632,0.0184925237218561,0.542775729416004
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00242355463388109,0.00401806626775098,-0.00545185525091083,0.010298964518673,0.546411774650531
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPTX1,Neuronal pentraxin-1,42137,0.00247275888862958,0.00412413462130306,-0.00561054496912441,0.0105560627463836,0.548794557218449
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANK2,Ankyrin-2,39575,0.00416279839895215,0.00695620038495889,-0.00947135435556729,0.0177969511534716,0.549565460256134
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RRP15,RRP15-like protein,39586,0.00541671720500997,0.00907499652625929,-0.0123702759864582,0.0232037103964782,0.550597352681625
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF6,Fibroblast growth factor 6,39657,0.00231917922546921,0.0038927711127641,-0.00531065215554842,0.00994901060648684,0.551344003264387
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTTG1,Securin,39757,0.00246715996271622,0.00414380609024751,-0.0056546999741689,0.0105890198996013,0.551598230061884
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRN1,Neuritin,39934,0.00205453420697186,0.00345976332724521,-0.00472660191442875,0.00883567032837248,0.552633235710681
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00252342102205519,0.00425328030160839,-0.00581300836909726,0.0108598504132076,0.5530004282341
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00215764180612646,0.00364095626049404,-0.00497863246444184,0.00929391607669477,0.553458961002545
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.0036407561510499,0.00615484530117129,-0.0157042529413456,0.00842274063924583,0.554177718142638
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MTR,Methionine synthase,39575,0.00379221512515936,0.00650142573990593,-0.00895057932505626,0.016535009575375,0.559710233356917
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.00180321847688471,0.00310079969636546,-0.00427434892799159,0.00788078588176102,0.56089289375908
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,39586,0.00480071967966483,0.00828394625568922,-0.011435814981486,0.0210372543408157,0.562249656879726
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.00234804403499536,0.00405636452876122,-0.0102985185113674,0.00560243044137664,0.562697061070982
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0017248199221521,0.00298502937455368,-0.00757547749627731,0.00412583765197312,0.563392943554601
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00186333644065389,0.00322656202500595,-0.00446072512835778,0.00818739800966556,0.563614228276167
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00276951529947643,0.00483115560075899,-0.012238580276964,0.00669954967801119,0.566477544499847
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTGES2,Prostaglandin E synthase 2,39579,-0.00318576839298126,0.00556254048431651,-0.0140883477422416,0.00771681095627909,0.566847213784652
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.0034973330848021,0.00612518267254858,-0.0155026911229973,0.00850802495339312,0.568027515705261
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.00472880317443586,0.00829968648297605,-0.0115385823321972,0.0209961886810689,0.568853926190361
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.00161362612050788,0.00283845633676047,-0.00394974829954264,0.00717700054055841,0.569713772358156
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPPK1,Epiplakin,39638,-0.00415577387215864,0.00736113564271743,-0.0185835997318848,0.0102720519875675,0.572387218571205
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.00204561409651509,0.00363327006380247,-0.00507559522853776,0.00916682342156794,0.573430734731985
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK1,Kallikrein-1,42016,0.00710009309433143,0.0126394193244112,-0.0176731687815145,0.0318733549701773,0.574301176082277
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.00326251183165974,0.00581372662021417,-0.0146574160072795,0.00813239234396002,0.574688270567546
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEPTIN7,Septin-7,39757,0.0029559252935312,0.00529797574201498,-0.00742810716081816,0.0133399577478806,0.576900068619056
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SH3GL3,Endophilin-A3,39690,-0.00472987668528263,0.00848054165123762,-0.0213517383217084,0.0118919849511431,0.577038078307795
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.00234676460129143,0.00421178550270309,-0.00590833498400663,0.0106018641865895,0.577407014983544
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.00364872076405359,0.00656553369063371,-0.00921972526958847,0.0165171667976957,0.578400865816701
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PKD1,Polycystin-1,39958,-0.00149945649699905,0.00270067900829343,-0.00679278735325417,0.00379387435925607,0.578758797317705
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPL,Periplakin,39657,0.00178398824951769,0.00321733167075551,-0.00452198182516311,0.00808995832419849,0.579252633488228
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.00140979113290464,0.00254283876826553,-0.00639375511870508,0.0035741728528958,0.579303265943571
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00229426999284669,0.00414329686073199,-0.00582659185418801,0.0104151318398814,0.579774197049095
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00504341112051877,0.00911309339495875,-0.0229050741746379,0.0128182519336004,0.579983907528037
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0053075209343138,0.00960308123849452,-0.0241295601617631,0.0135145182931355,0.580485353585234
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SERPINB5,Serpin B5,41900,0.00264109134275851,0.00481282290768938,-0.00679204155631268,0.0120742242418297,0.583178428397453
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NDRG1,Protein NDRG1,41839,-0.00356248201573009,0.00650937744818888,-0.0163208618141803,0.00919589778272012,0.584192449251905
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00384852656023648,0.00705563066647517,-0.0176775626665278,0.00998050954605485,0.585451936159292
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.00329936681885692,0.00605475836152149,-0.0085679595697252,0.015166693207439,0.58581871611758
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.00236551711517816,0.00435108398513656,-0.00616260749568951,0.0108936417260458,0.586685430666997
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NPTN,Neuroplastin,41843,-0.00419219459262878,0.00772736267734085,-0.0193378254402168,0.0109534362549593,0.587474293771515
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RPS10,40S ribosomal protein S10,39575,0.00224875860671833,0.00415538291156574,-0.00589579189995051,0.0103933091133872,0.588403049815865
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SHC1,SHC-transforming protein 1,39560,-0.00627154324346157,0.0116482622757998,-0.0291021373040292,0.016559050817106,0.590304818759693
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.00345339321181653,0.00642528612829096,-0.00914016759963376,0.0160469540232668,0.590954390359267
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00259510355056164,0.00486024617830481,-0.00693097895891578,0.0121211860600391,0.593390485911605
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00191870307223313,0.00360473244766319,-0.00514657252518672,0.00898397866965299,0.594547110032428
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.00311480559923494,0.00592419805844835,-0.0147262337937937,0.00849662259532383,0.59905396817939
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RCOR1,REST corepressor 1,41900,0.0023164095007869,0.00441195674532176,-0.00633102572004375,0.0109638447216175,0.59957111112648
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GBP2,Guanylate-binding protein 2,41913,-0.00314265201826603,0.00599404358841979,-0.0148909774515688,0.00860567341503675,0.600081530274689
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLF4,Krueppel-like factor 4,39586,-0.00211123810190843,0.00403854106173961,-0.0100267785829181,0.0058043023791012,0.601143139198791
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00259322861087266,0.00497425575369611,-0.012342769888117,0.00715631266637172,0.60214743409494
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PODXL2,Podocalyxin-like protein 2,42181,0.00146466560284246,0.00282158518235877,-0.00406564135458074,0.00699497256026565,0.603704228002563
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00136313649531014,0.00262862972242292,-0.00651525075125906,0.00378897776063878,0.604068971336378
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00600240318691016,0.0116937049701724,-0.0169172585546277,0.028922064928448,0.607750345024543
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0029208714201694,0.00571757832382254,-0.00828558209452279,0.0141273249348616,0.609460660688084
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00216549340911748,0.00424062400366434,-0.0104771164562996,0.00614612963806463,0.609603330173197
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GBP4,Guanylate-binding protein 4,41839,-0.00246531132051198,0.00483508501847615,-0.0119420779567252,0.00701145531570127,0.610144298973412
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VIM,Vimentin,41900,0.00575192698067807,0.011351501085535,-0.0164970151469704,0.0280008691083266,0.612366226753635
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00202911368222508,0.0040147792891916,-0.00583985372459046,0.00989808108904062,0.613280264205138
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00310954525057091,0.00615494697703181,-0.00895415082441144,0.0151732413255533,0.61342096993972
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BGN,Biglycan,41820,-0.00588183602420732,0.0116482268534247,-0.0287123606569198,0.0169486886085052,0.613598520166047
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.00123117626571316,0.00245623202174897,-0.00358303849691483,0.00604539102834115,0.616208060214408
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.00279202381936059,0.00557898597218892,-0.00814278868612968,0.0137268363248509,0.616764010507157
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NCLN,Nicalin,41913,0.00252364542962224,0.00506134100995988,-0.00739658294989913,0.0124438738091436,0.618060978181068
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDI2,Protein DDI1 homolog 2,39736,-0.00372015915109355,0.0074671862762592,-0.0183558442525616,0.0109155259503745,0.618352265383417
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00170939997013735,0.00343520740510783,-0.0084424064841487,0.00502360654387399,0.618767597389419
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00252578101186197,0.00514380130068962,-0.0126076315612136,0.00755606953748967,0.623412262042577
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.00257023629689618,0.00526440996338491,-0.0128884798251306,0.00774800723133824,0.625397433667291
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.00180440170186743,0.00369888851180328,-0.00544541978126701,0.00905422318500187,0.625685190925053
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CASP4,Caspase-4,39757,0.00804398852549106,0.0165262834476095,-0.0243475270318235,0.0404355040828056,0.626452785739476
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00800733207896956,0.016508538999752,-0.0243494043605444,0.0403640685184835,0.627656046531033
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EXOSC10,Exosome component 10,39575,-0.00280506162816312,0.00580145059767454,-0.0141759047996052,0.00856578154327897,0.628743031875752
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.00133963833592499,0.00278404868185665,-0.00411709708051405,0.00679637375236402,0.630393890785352
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMB1,Laminin subunit beta-1,39638,-0.00150074310897207,0.00311978978989562,-0.00761553109716748,0.00461404487922334,0.63049773515679
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.00398573047496698,0.00828941754109965,-0.0202329888555223,0.0122615279055883,0.63065133113086
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.00244104494255266,0.00511581385365905,-0.00758595021061908,0.0124680400957244,0.633259733277565
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSCA,Prostate stem cell antigen,39930,0.0122859966477978,0.0258291557487499,-0.0383391486197521,0.0629111419153477,0.634323022475666
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.00165061469608683,0.00347625642815155,-0.00846407729526387,0.0051628479030902,0.634919113980917
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CST6,Cystatin-M,41864,0.0023246302168356,0.00491114159033534,-0.00730120730022167,0.0119504677338929,0.635979804661785
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCRL3,Fc receptor-like protein 3,41913,0.00249836529436195,0.00529248551785969,-0.00787490632064304,0.0128716369093669,0.636892430425519
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FCRL1,Fc receptor-like protein 1,42145,-0.00212247960385124,0.00452783996215877,-0.0109970459296824,0.00675208672197995,0.639247263192307
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RYR1,Ryanodine receptor 1,39575,0.00157404597151182,0.00335997533525852,-0.00501150568559487,0.00815959762861851,0.639458179794484
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TG,Thyroglobulin,39919,0.0048581471803154,0.0103986763203936,-0.0155232584076561,0.0252395527682869,0.640373656722536
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.00197067049837273,0.00424699237853828,-0.0102947755603078,0.00635343456356229,0.642644134466241
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MLLT1,Protein ENL,39560,0.00306091129682725,0.00660609992186116,-0.00988704455002062,0.0160088671436751,0.643125435612056
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GBP1,Guanylate-binding protein 1,39911,-0.0029651503975456,0.00642900881550663,-0.0155660076759386,0.00963570688084739,0.644653776495544
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.00106181725572124,0.00230424730888949,-0.00557814198114463,0.00345450746970215,0.644944660802461
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00330889571594179,0.0072008209336399,-0.017422504745876,0.0108047133139924,0.645872430069827
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.00149917177543228,0.00327584690523828,-0.00492148815883475,0.00791983170969931,0.647216953802553
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00183314793420585,0.00400854509102426,-0.00602360044420171,0.0096898963126134,0.647457253885562
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,0.00181628801547917,0.00398339128489304,-0.00599115890291118,0.00962373493386952,0.648423682264359
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00345960023244406,0.0075933347758415,-0.0183425363930934,0.0114233359282053,0.648679225188013
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00234393678365075,0.00518939259348372,-0.00782727269957733,0.0125151462668788,0.651509585468443
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.00219327339697261,0.00490195684507367,-0.011801108813317,0.00741456201937178,0.654574517739846
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,-0.000991605600055161,0.0022208501505666,-0.0053444718951657,0.00336126069505538,0.65524452985377
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.00228586831171982,0.00512955271260638,-0.0123397916284283,0.00776805500498869,0.655873595244558
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,-0.00481299989119836,0.0108122112634692,-0.0260049339675979,0.0163789341852012,0.656223867328736
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL2,Interleukin-2,41913,-0.00140479505502714,0.00316070594018458,-0.00759977869778892,0.00479018858773463,0.656720081666105
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00218605432377103,0.00495336595421286,-0.0118946515940282,0.00752254294648617,0.658983767940577
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.00106367188595116,0.00241018997013839,-0.00366030045552009,0.00578764422742241,0.658986360200896
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,-0.00137761336614716,0.00313047999244376,-0.00751335415133692,0.0047581274190426,0.659897355599793
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00281165940487151,0.00639174738522072,-0.0153394842799041,0.0097161654701611,0.660026172614286
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.00248364498312603,0.00564987373128402,-0.00859010753019065,0.0135573974964427,0.660239041751709
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.00144024070480378,0.00328259837127985,-0.00499365210290474,0.00787413351251229,0.660849478483425
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAEP,Glycodelin,42016,-0.0044908755797933,0.0103412028956473,-0.0247596332552621,0.0157778820956755,0.664099271927537
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MORN4,MORN repeat-containing protein 4,39560,-0.00338220617026723,0.00779282287371691,-0.0186561390027524,0.0118917266622179,0.664285704858225
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMEM132A,Transmembrane protein 132A,39638,-0.00268949168156947,0.00623574521038696,-0.0149115522939279,0.00953256893078897,0.666256951017513
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.00261748848026553,0.00607889577395769,-0.00929714723669154,0.0145321241972226,0.666776146363601
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00207156839537568,0.00481389160661729,-0.0115067959443456,0.00736365915359421,0.666963087017288
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00179730261163115,0.00418633373051143,-0.0100025167234336,0.00640791150017126,0.667694048526637
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.00222482310069886,0.00522858749371531,-0.00802320838698315,0.0124728545883809,0.67047218758569
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.00233090105491648,0.00553887541411983,-0.0131870968665913,0.0085252947567584,0.673889165525035
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD82,CD82 antigen,39757,-0.00173057182707509,0.00412607724028397,-0.00981768321803167,0.00635653956388148,0.67491506961956
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00237221353202565,0.00568884864437852,-0.0135223568750075,0.00877792981095625,0.676691177067466
NMR metabolomics,X23505.Cholesterol in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.000863970892716299,0.00207202345577046,-0.00319719508059381,0.00492513686602641,0.67670876327242
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00282714134973479,0.00679566552311582,-0.0161466457750418,0.0104923630755722,0.67740244633152
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDH22,Cadherin-22,39757,0.0011415957048184,0.00274478742815761,-0.00423818765437051,0.00652137906400731,0.677480884395116
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00259669711260645,0.00625572950218746,-0.0148579269368939,0.00966453271168097,0.678083390259611
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00156458172666727,0.00379965081439149,-0.00588273386954004,0.00901189732287458,0.680515920703412
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.00132853691960972,0.00322946986839521,-0.0050012240224449,0.00765829786166434,0.680802433671621
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HEBP1,Heme-binding protein 1,41900,-0.00206423971206571,0.00514138680570011,-0.0121413578512379,0.00801287842710651,0.688062367407798
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.00220403518476221,0.00549414237715187,-0.0129725542439799,0.00856448387445545,0.688309464560784
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CAPG,Macrophage-capping protein,42015,-0.00229224430113299,0.00582375557374398,-0.0137068052256712,0.0091223166234052,0.693880847903824
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.00220240226314498,0.00563149044313688,-0.00883531900540331,0.0132401235316933,0.695739278758708
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00114148325863902,0.00292718104671896,-0.00459579159293014,0.00687875811020818,0.69657375147413
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF7,Fibroblast growth factor 7,39560,-0.00300069851222295,0.00773836893340215,-0.0181679016216912,0.0121665045972453,0.698194621254087
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00152172622790269,0.00393003222280556,-0.00922458938460158,0.00618113692879621,0.69861231452872
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CST1,Cystatin-SN,38503,0.0041069938919566,0.0106565602968129,-0.0167798642897967,0.0249938520737099,0.699952449791303
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.00353260954650991,0.00918875045703417,-0.0144773413492771,0.0215425604422969,0.70065284550519
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RBM25,RNA-binding protein 25,39560,-0.00177624791580027,0.00466191891841711,-0.0109136089958978,0.00736111316429726,0.703201591580869
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,39757,-0.00326268578826342,0.00858004107195201,-0.0200795662892893,0.0135541947127625,0.703756257683429
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL36A,Interleukin-36 alpha,39657,0.00216760485057543,0.00572324748938031,-0.00904996022860998,0.0133851699297609,0.704890541621342
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00235988158745051,0.00623781153373051,-0.0145859921935623,0.00986622901866128,0.705201018573994
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.0011352648791898,0.00300457763904368,-0.00702423705171541,0.00475370729333581,0.705552738317343
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00179031588708293,0.00477800139375947,-0.0111551986188515,0.00757456684468562,0.70789090618053
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,39638,-0.00357821745424257,0.00956418694908049,-0.0223240238744403,0.0151675889659552,0.708317260517284
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,39541,-0.00179421170386104,0.00481384553584735,-0.0112293489541218,0.00764092554639976,0.709364812190895
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BEX3,Protein BEX3,39560,0.0017343668883601,0.00465726222294587,-0.00739386706861381,0.010862600845334,0.709601864951869
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.00106060178976615,0.00285938772312062,-0.00454379814755026,0.00666500172708257,0.710703502196884
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNU13,NHP2-like protein 1,39575,0.00230180024804032,0.00627849802117327,-0.0100040558734593,0.0146076563695399,0.71391225199713
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DEFB118,Beta-defensin 118,39586,-0.00207728958602389,0.00567106591542572,-0.0131925787802583,0.00903799960821053,0.714151159052329
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.00140314761621725,0.00383562748970145,-0.00611468226359759,0.00892097749603209,0.714505367263476
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00114597952041745,0.00313727968990974,-0.00729504771264054,0.00500308867180565,0.714910866750637
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.000935426088843854,0.00258578271406223,-0.00600356020840583,0.00413270803071812,0.717540037136475
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00189976854198031,0.00525500935106767,-0.012199586870073,0.00840004978611233,0.717720916886452
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00178667541127615,0.00494442285939706,-0.00790439339314208,0.0114777442156944,0.717843535017353
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OSTN,Osteocrin,39649,-0.00144544289833809,0.00401540273850971,-0.00931563226581713,0.00642474646914095,0.71887302647147
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.00245343908172156,0.00684494715547917,-0.0109626573430176,0.0158695355064607,0.720026650472663
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.00274345698457687,0.00765493698826122,-0.0177471334815689,0.0122602195124151,0.720057918660715
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0040846748550247,0.0114468213616646,-0.0183510950138379,0.0265204447238873,0.721217825617323
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATG4A,Cysteine protease ATG4A,41843,0.00202545874884885,0.00574077841756371,-0.00922646694957601,0.0132773844472737,0.724229355776397
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00153771951904461,0.00438054861150122,-0.00704815575949777,0.010123594797587,0.725569927792752
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHRDL1,Chordin-like protein 1,42166,0.00113078095065352,0.00322951888793718,-0.00519907606970335,0.0074606379710104,0.726239717724672
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.00924592533137082,0.0264864563844205,-0.061159379844835,0.0426675291820934,0.727034970419129
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.00242301868746198,0.00696331345905883,-0.0160711130672173,0.0112250756922933,0.727869768761152
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00126014442413323,0.00362866457504761,-0.00837232699122654,0.00585203814296008,0.728391358612341
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CEP350,Centrosome-associated protein 350,39560,0.00126182290796859,0.00363963760181565,-0.00587186679159009,0.00839551260752726,0.728831509511551
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00261474734446921,0.00755411710562838,-0.0121913221825624,0.0174208168715008,0.729247589044866
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HNMT,Histamine N-methyltransferase,41961,-0.00162846271100331,0.00472883002214871,-0.0108969695544148,0.00764004413240816,0.730574179957159
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PLA2G1B,Phospholipase A2,42299,-0.00151157739105534,0.00440060049803749,-0.0101367543672088,0.00711359958509814,0.73123254850687
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.00115785654438153,0.00340994336602721,-0.0055256324530318,0.00784134554179486,0.734198500089321
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL18,Interleukin-18,42069,-0.0014818432273094,0.00437047042902248,-0.0100479652681935,0.00708427881357467,0.734571277642417
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZNF75D,Zinc finger protein 75D,39757,0.00204055094905547,0.0060904355469027,-0.00989670272287383,0.0139778046209848,0.737599796467225
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGAM,Integrin alpha-M,42137,-0.00104455951270071,0.0031189138228203,-0.0071576306054285,0.00506851158002707,0.737697179682216
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.00115751106967501,0.00347454026611461,-0.00565258785190962,0.00796760999125964,0.739033113885903
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.00192053106447926,0.00580925443954584,-0.0133066697659891,0.0094656076370306,0.740952868752521
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,0.001430529968811,0.00433863743385556,-0.0070731994015459,0.00993425933916791,0.741618605078605
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.0011544596724013,0.0035035807581753,-0.00802147795842489,0.0057125586136223,0.741776461454617
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALB2,Calretinin,41839,0.000953901079854342,0.00289957298942456,-0.0047292619794178,0.00663706413912648,0.742176124125807
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZPR1,Zinc finger protein ZPR1,39586,0.00312843861579002,0.00958974261609383,-0.0156674569117539,0.0219243341433339,0.74425838290619
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RELB,Transcription factor RelB,39657,0.00151139137865215,0.00467339851980073,-0.00764846972015727,0.0106712524774616,0.746396128987272
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00166888104597715,0.0051732594166239,-0.00847070741060569,0.01180846950256,0.747005109604683
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPQ,Carboxypeptidase Q,39960,-0.00119914497157537,0.00371761004220268,-0.00848566065429262,0.00608737071114187,0.747035919241773
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SEMA3F,Semaphorin-3F,42145,0.000848923369973659,0.00263402453820502,-0.00431376472490818,0.0060116114648555,0.74723694644177
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OTOA,Otoancorin,39586,-0.00167331666252023,0.00522902113184348,-0.0119221980809334,0.008575564755893,0.748970081358036
NMR metabolomics,X23505.Cholesterol in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.00213184199906239,0.00670400690525021,-0.011008011535228,0.0152716955333528,0.750494438452214
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00145911411298146,0.00460793999667448,-0.00757244828050052,0.0104906765064634,0.751512402083601
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MYOC,Myocilin,42137,-0.0013950965417755,0.00441693140820644,-0.0100522821018601,0.00726208901830913,0.752119729260872
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,39560,-0.00192859018689145,0.00613690081165384,-0.013956915777733,0.0100997354039501,0.75332859969716
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.00200280267092179,0.0063858973471284,-0.0145191614712934,0.0105135561294499,0.753808578035169
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00112106032944097,0.00359252179143476,-0.0081624030406531,0.00592028238177116,0.755005471604954
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PTN,Pleiotrophin,41900,-0.00153243456224206,0.00492144254693759,-0.0111784619542397,0.00811359282975562,0.755517288202212
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TEX33,Testis-expressed protein 33,39757,0.00119463794315949,0.00384030518540071,-0.00633236022022589,0.00872163610654487,0.755746446913479
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.00103284415701989,0.0033300829827715,-0.00549411848921224,0.00755980680325203,0.756448261309987
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00192885624413924,0.0062499568106391,-0.0103210591047134,0.0141787715929919,0.757617131491022
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TEK,Angiopoietin-1 receptor,42181,0.000674633678404772,0.00218623886372694,-0.00361039449450003,0.00495966185130958,0.757644346364753
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00111022453651992,0.00361903102655994,-0.00598307627553756,0.0082035253485774,0.759021194781135
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HEG1,Protein HEG homolog 1,39736,0.000840125058059682,0.00274963582884375,-0.00454916116647406,0.00622941128259342,0.759960253299524
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TSPAN15,Tetraspanin-15,39575,-0.001516247104271,0.0050049699227885,-0.0113259881529365,0.00829349394439446,0.761935007361221
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.00171258962869837,0.00570502269317474,-0.0128944341073209,0.00946925484992413,0.764037976709094
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00137128072402219,0.00456849139111416,-0.00758296240256156,0.0103255238506059,0.764059433756549
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.00158410176411655,0.0052808197768984,-0.0119345085268374,0.00876630499860431,0.76420260867237
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TCP11,T-complex protein 11 homolog,39757,0.00172141605584078,0.00575912002027726,-0.00956645918390266,0.0130092912955842,0.765019915917985
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PAPPA,Pappalysin-1,41913,0.00139501016036502,0.00468842441837134,-0.00779430169964281,0.0105843220203728,0.766056253569856
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRUNE2,Protein prune homolog 2,39757,-0.000854598512633605,0.00287549724734496,-0.00649057311742972,0.00478137609216251,0.76631916081589
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.001521923298352,0.00514428402986299,-0.0116047199968835,0.00856087340017947,0.767352308117951
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDA,Cytidine deaminase,39946,0.00139701418874472,0.00473188736622251,-0.0078774850490514,0.0106715134265408,0.767820507952525
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LUZP2,Leucine zipper protein 2,39919,0.00129969401249828,0.00446205608436259,-0.0074459359128524,0.010045323937849,0.770844864765216
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00120419413477646,0.00414767762436122,-0.00933364227852446,0.00692525400897154,0.77156944337966
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD55,Complement decay-accelerating factor,41714,0.000745153406976123,0.00260345825042767,-0.00435762476386211,0.00584793157781435,0.774716622523014
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.00102620914257894,0.00362010083796156,-0.00606918849982572,0.0081216067849836,0.776816859982072
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.002221156751516,0.00797223280206426,-0.0178467330435619,0.0134044195405299,0.78054805230804
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRXN3,Neurexin-3,39649,-0.000987023763943885,0.00356895085697445,-0.00798216744361381,0.00600811991572604,0.782124292583253
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.000743931251673087,0.00270070124392269,-0.00603730568976155,0.00454944318641538,0.782968174540971
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.00132514075951121,0.00490313883892629,-0.0109352928838067,0.00828501136478433,0.786961553010573
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PITHD1,PITH domain-containing protein 1,39539,0.00204174430204432,0.0076879704889373,-0.0130266778562728,0.0171101664603614,0.79057038997593
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF12,Fibroblast growth factor 12,39657,0.00118259352987983,0.00451682619055459,-0.00767038580360716,0.0100355728633668,0.793465420862331
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD33,Myeloid cell surface antigen CD33,42181,-0.00204269064901415,0.00784720175166559,-0.0174232060822787,0.0133378247842504,0.794630025074066
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0013335628189767,0.00512446146978601,-0.00871038166180388,0.0113775072997573,0.794687574452872
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.00173781831040099,0.00667972833210538,-0.0148300858413275,0.0113544492205256,0.794741980820591
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SATB1,DNA-binding protein SATB1,39934,-0.000755725074366265,0.00291227340244335,-0.00646378094315523,0.0049523307944227,0.795256810612463
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DEFB116,Beta-defensin 116,39586,-0.00193246419367772,0.00747160250311766,-0.0165768050997883,0.0127118767124329,0.79591694146331
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.00110586323762981,0.00432454451967658,-0.00737024402093628,0.00958197049619591,0.798173474009383
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MUCL3,Mucin-like protein 3,39560,-0.00108286580089834,0.00424288130979569,-0.0093989131680979,0.00723318156630122,0.798558404478678
NMR metabolomics,X23505.Cholesterol in Medium VLDL,F3,Tissue factor,42174,0.000657388680432531,0.00258367451254286,-0.00440661336415147,0.00572139072501654,0.799159943482741
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000720995088932236,0.00283490938140821,-0.00627741747649232,0.00483542729862785,0.799247236340857
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00148521970253663,0.00584640193665381,-0.00997372809330483,0.0129441674983781,0.79946944267729
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00108894889550602,0.00429993613624584,-0.00951682372254787,0.00733892593153583,0.800081523858618
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.000806001169342852,0.00318591889320102,-0.00705040220001686,0.00543839986133115,0.800280859666774
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00116684528369715,0.00462357570327877,-0.00789536309472924,0.0102290536621235,0.800760901607106
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.00117220765349766,0.00469809038946873,-0.00803604950986106,0.0103804648168564,0.80297302016425
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.000964781660196765,0.00392759358996198,-0.00866286509652225,0.00673330177612872,0.80596310682439
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CRX,Cone-rod homeobox protein,41900,-0.00260708464943993,0.0106295555424116,-0.0234410135125666,0.0182268442136867,0.806253088859278
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNASE3,Eosinophil cationic protein,42081,0.0026384704385752,0.0107592714635299,-0.0184497016299434,0.0237266425070938,0.806283931104312
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00110182174223767,0.00449341525977094,-0.00990891565138871,0.00770527216691337,0.80629982790597
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ELOA,Elongin-A,42070,-0.00129417651254718,0.0053178268185976,-0.0117171170769985,0.00912876405190411,0.807725837958537
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL17F,Interleukin-17F,41913,-0.00176246670860396,0.00725346553677676,-0.0159792591606864,0.0124543257434785,0.808022535435489
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.00197320475127867,0.00815303596270106,-0.0179531552381728,0.0140067457356154,0.808768450161833
NMR metabolomics,X23505.Cholesterol in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.000929751270983703,0.00385198633254125,-0.00847964448276455,0.00662014194079714,0.809273382594903
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CCL28,C-C motif chemokine 28,42075,-0.00140030751173764,0.00581247458848123,-0.0127927577051608,0.00999214268168557,0.809625302020608
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00105537828489636,0.00438225994588987,-0.0096446077788405,0.00753385120904779,0.809690829402159
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TREH,Trehalase,39966,0.00179425874140941,0.00747734667928466,-0.0128613407499885,0.0164498582328074,0.810366149883075
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.000743410110043905,0.00310642898508351,-0.00534519070071978,0.00683201092080759,0.8108670435065
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.0013161788416608,0.0055134955916662,-0.00949027251800495,0.0121226302013265,0.811327561883679
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00134793223029222,0.0056801661554491,-0.0124810578949725,0.00978519343438802,0.812424423463717
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.0013261402040511,0.00559126832968996,-0.0122850261302434,0.00963274572214122,0.812521142935272
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.00403351264973461,0.0171090270815563,-0.0375672057295849,0.0295001804301157,0.813628230488051
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.000902554640283131,0.00383810069923118,-0.00842523201077624,0.00662012273020998,0.814091591237496
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,39657,0.00207631221899379,0.00883366866600379,-0.0152376783663736,0.0193903028043612,0.814177933458892
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.00130457622929394,0.00557375006659248,-0.0122291263598152,0.00961997390122732,0.814944862494301
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.00112151223218426,0.00479869009788728,-0.0105269448240433,0.00828392035967482,0.815212672699207
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD5L,CD5 antigen-like,39925,-0.00110742704729254,0.0047793086505005,-0.0104748720022735,0.00826001790768844,0.81676526597726
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VEGFA,Vascular endothelial growth factor A,42253,-0.0012945088267651,0.0055894822961747,-0.0122498941272675,0.00966087647373731,0.816854300769229
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,0.000832198078341482,0.0035966163272597,-0.00621716992308753,0.0078815660797705,0.817020351111935
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NRTN,Neurturin,41913,0.00112307947926552,0.00489758581254571,-0.00847618871332407,0.0107223476718551,0.818629270532952
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL5,Interleukin-5,41913,0.00312466805578574,0.0136533599906353,-0.0236359175258595,0.029885253637431,0.818983518236277
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RCC1,Regulator of chromosome condensation,39919,0.00116765356545176,0.00517525641440061,-0.00897584900677344,0.011311156137677,0.821499221943948
NMR metabolomics,X23505.Cholesterol in Medium VLDL,NGRN,Neugrin,39929,-0.000502237436452149,0.00223000321460796,-0.00487304373708374,0.00386856886417944,0.821813549661309
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.00118932298255797,0.00529693621414802,-0.00919267199717214,0.0115713179622881,0.822348005633389
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSTA1,Glutathione S-transferase A1,42119,-0.00183345950398122,0.00836684977265687,-0.0182324850583887,0.0145655660504263,0.826549137620226
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PROCR,Endothelial protein C receptor,39575,0.000753988193231133,0.00344700382362819,-0.00600213930108013,0.00751011568754239,0.82685878482029
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDSN,Corneodesmosin,42246,-0.000933893212766738,0.00432419460670216,-0.00940931464190298,0.0075415282163695,0.829014918416389
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,-0.00113075213116282,0.00526231759654013,-0.0114448946203815,0.00918339035805583,0.829866361179613
NMR metabolomics,X23505.Cholesterol in Medium VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.000994071445044482,0.00464629723369779,-0.00811267113300318,0.0101008140230921,0.830589949091445
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.000997381860970201,0.00467345066327502,-0.00816258143904883,0.0101573451609892,0.831007655217351
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,-0.000902645109697662,0.00423544106350542,-0.00920410959416829,0.00739881937477296,0.831239549971658
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL34,Interleukin-34,41814,0.000761819633359965,0.00360227534857468,-0.0062986400498464,0.00782227931656633,0.832513736566799
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THBD,Thrombomodulin,42145,0.00061774815517303,0.00292123350488089,-0.00510786951439351,0.00634336582473957,0.832525081491833
NMR metabolomics,X23505.Cholesterol in Medium VLDL,STEAP4,Metalloreductase STEAP4,39586,-0.001528765511067,0.00724488409193703,-0.0157287383312636,0.0126712073091296,0.832880956526933
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LGALS3BP,Galectin-3-binding protein,39979,-0.000655953756307469,0.00310915126652208,-0.00674989023869075,0.00543798272607581,0.832910414771011
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.000915075331214799,0.00435193156525363,-0.00944486119911192,0.00761471053668232,0.833461683280185
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.000824573487807438,0.00396680805825798,-0.00695037030637819,0.00859951728199307,0.835335667845994
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRTG,Protogenin,42262,0.000502404188776015,0.0024272884503409,-0.00425508117389214,0.00525988955144417,0.836027267504556
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00110961146738847,0.00539768267329445,-0.0116890695070456,0.00946984657226864,0.837129173790103
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00109677029976046,0.00535452501746471,-0.0115916393339913,0.00939809873447038,0.83770825471045
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCGB1A1,Uteroglobin,42165,0.00107889173468288,0.00529278300515677,-0.00929496295542439,0.0114527464247902,0.83847998979105
NMR metabolomics,X23505.Cholesterol in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0021368135534714,0.0105444799726918,-0.0228039942999474,0.0185303671930046,0.839414239266441
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD300LF,CMRF35-like molecule 1,42262,0.00118119914240147,0.00593264248221648,-0.0104467801227428,0.0128091784075458,0.842186162394721
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DHPS,Deoxyhypusine synthase,39919,-0.000795596523487355,0.00400148685501122,-0.00863851075930935,0.00704731771233464,0.842403034389283
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00092510193624775,0.00467888916135791,-0.00824552082001375,0.0100957246925093,0.843269033925983
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.00286890116329824,0.0146654847784005,-0.0316132513289632,0.0258754490023667,0.844908523924981
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.000676255538463231,0.00349078957775064,-0.00616569203392803,0.00751820311085449,0.84639361318697
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HCG22,Protein PBMUCL2,39575,-0.00111227122810118,0.00578035399057732,-0.0124417650496327,0.0102172225934304,0.847414685524959
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GKN1,Gastrokine-1,41538,0.000536353435078212,0.00279934716101171,-0.00495036700050473,0.00602307387066115,0.848058963640566
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PDCD6,Programmed cell death protein 6,42145,-0.00132858418483604,0.00697485491677233,-0.0149992998217098,0.0123421314520377,0.848934316056772
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000792082672622764,0.00420000404541137,-0.00743992525638352,0.00902409060162904,0.850416871445817
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.000748693943241684,0.00397082260053211,-0.00853150624028461,0.00703411835380125,0.850449934390769
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.00144526471441593,0.0076847292773745,-0.01650733409807,0.0136168046692381,0.850825468414555
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLA,Alpha-galactosidase A,39713,0.000726024039485769,0.00390579017854221,-0.00692932471045695,0.00838137278942849,0.852539094603135
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LY75,Lymphocyte antigen 75,42119,0.000698692430618553,0.00381785595949809,-0.00678430524999771,0.00818169011123482,0.854795668142997
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00122401162558843,0.00679064201873259,-0.0145336699823043,0.0120856467311274,0.856959819586944
NMR metabolomics,X23505.Cholesterol in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.000610711320480016,0.0034228846755696,-0.00609814264363641,0.00731956528459644,0.858396382422403
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAS2,Growth arrest-specific protein 2,39757,-0.000918744168288617,0.00519224652174817,-0.011095547350915,0.0092580590143378,0.859554484418964
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ZBP1,Z-DNA-binding protein 1,39657,-0.000717353313735492,0.00412022912308942,-0.00879300239499075,0.00735829576751977,0.861785974345601
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SUSD4,Sushi domain-containing protein 4,39919,0.000653626443164202,0.00382519271250447,-0.00684375127334456,0.00815100415967296,0.864325799891708
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",39586,-0.00139810030746283,0.00818901742452828,-0.0174485744595383,0.0146523738446126,0.864440238064086
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LYZL2,Lysozyme-like protein 2,39560,0.000618207246682859,0.00362121530881582,-0.00647937475859614,0.00771578925196186,0.86444852716292
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.000790753675142185,0.00463240595738883,-0.00828876200133992,0.00987026935162429,0.86446193934391
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00104122610094872,0.006123091558529,-0.0130424855556656,0.0109600333537681,0.864974667748576
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TJP3,Tight junction protein ZO-3,39586,-0.000699701337201989,0.00413929488743787,-0.00881271931658021,0.00741331664217623,0.865769254275798
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.000681763751567841,0.00406391804297899,-0.00864704311580665,0.00728351561267097,0.866774993295733
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPN1,Epsin-1,39757,0.000717659142387888,0.00430750940190118,-0.00772505928533843,0.00916037757011421,0.867682683959196
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.000922752797457183,0.00568679843923132,-0.0120688777383506,0.0102233721434362,0.871102312870338
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GPR37,Prosaposin receptor GPR37,41900,-0.00102703770383823,0.00644302658023956,-0.0136553698011078,0.0116012943934313,0.873353803545269
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANXA1,Annexin A1,39699,-0.000692326916924448,0.00443109727855927,-0.00937727758290061,0.00799262374905172,0.875844506004917
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAGE2A,G antigen 2A,39560,-0.00100973199499278,0.00650737941870351,-0.0137641956556517,0.0117447316656661,0.876692344733344
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.000482108828097621,0.00311924151004038,-0.00659582218777677,0.00563160453158153,0.877170849731352
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.000775804140620789,0.00502752698561156,-0.0106297570324194,0.00907814875117787,0.877367138525985
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.000714946681213938,0.00463935543902547,-0.00980808334170385,0.00837818997927598,0.877529981468876
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.00183820560572781,0.0120017409432807,-0.0216852066431023,0.025361617854558,0.878273670611502
NMR metabolomics,X23505.Cholesterol in Medium VLDL,COMMD9,COMM domain-containing protein 9,39919,-0.000598682845690899,0.00395713626113556,-0.0083546699175166,0.0071573042261348,0.879748118415859
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.000492484454903345,0.00325962319489867,-0.00589637700709804,0.00688134591690473,0.879910389012222
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VWC2,Brorin,41973,-0.000609581448424278,0.00404299521906795,-0.00853385207779746,0.00731468918094891,0.880155707459708
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.000551639854569132,0.00372373890136579,-0.00674688839210782,0.00785016810124608,0.882233887103691
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,39919,-0.000645567390334265,0.00437820359851729,-0.00922684644342815,0.00793571166275962,0.882779239815772
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.000712657417967912,0.00491016561521353,-0.0103365820237864,0.0089112671878506,0.884603140340117
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,39649,0.000584183672961849,0.00403347694329712,-0.0073214311359005,0.00848979848182419,0.884844760216269
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EDNRB,Endothelin receptor type B,39657,0.000629675531319688,0.00436613919604924,-0.00792795729293683,0.0091873083555762,0.885331015830796
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.000686151834517283,0.00479988974792706,-0.00872163207141975,0.0100939357404543,0.886331047907622
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,39929,-0.000964959627475182,0.00677933339841588,-0.0142524530883703,0.0123225338334199,0.886815229166036
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.000875648073322901,0.00616760900847226,-0.0112128655832827,0.0129641617299285,0.887102127602446
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.000858386183937845,0.00607398932632917,-0.012763405263543,0.0110466328956673,0.887617931930722
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.00104606591908873,0.00745990479230461,-0.0135753474738283,0.0156674793120058,0.888484271608173
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.000827712917475108,0.00590524280265258,-0.0107465629757239,0.0124019888106742,0.888531102841225
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CPLX2,Complexin-2,39560,0.000426733946811775,0.00305226520487081,-0.00555570585473501,0.00640917374835856,0.888813522727545
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AMBN,Ameloblastin,41913,-0.000356102754684648,0.00270382714773433,-0.00565560396424393,0.00494339845487463,0.895221024918602
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A3,Protein S100-A3,39919,-0.000557500263235242,0.00423769014043913,-0.00886337293849595,0.00774837241202546,0.895336577572276
NMR metabolomics,X23505.Cholesterol in Medium VLDL,S100A11,Protein S100-A11,42027,-0.000588564371399647,0.00456960626126913,-0.00954499264348715,0.00836786390068785,0.897517993087939
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.000829732348368821,0.00648893469016946,-0.013548044341101,0.0118885796443633,0.898254697356502
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CFD,Complement factor D,39979,-0.000251718903913632,0.00201570637615236,-0.00420250340117225,0.00369906559334499,0.900621743211238
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.000616995403127405,0.00498597235974175,-0.00915551042196643,0.0103895012282212,0.901518025827939
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.000492076684233014,0.00408898130011161,-0.00850648003245177,0.00752232666398574,0.904214305383757
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENO1,Alpha-enolase,42119,-0.000934310661770923,0.00776838374858877,-0.0161603428090049,0.0142917214854631,0.904270326465362
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.000747579049319399,0.00630531264262048,-0.0131059918288555,0.0116108337302167,0.905623429915103
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,39560,0.000467756426553006,0.00398826769101474,-0.00734924824783589,0.0082847611009419,0.906637860306613
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.000648653348360861,0.00556507861275006,-0.011556207429351,0.0102589007326293,0.907212542401626
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.000865211547194262,0.00743672749076498,-0.0154411974290936,0.0137107743347051,0.907382798146026
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.000566961282656812,0.00530508646437991,-0.00983100818752782,0.0109649307528414,0.914893077075096
NMR metabolomics,X23505.Cholesterol in Medium VLDL,AHNAK2,Protein AHNAK2,39638,0.000328341860767459,0.00309509172930809,-0.0057380379286764,0.00639472165021132,0.915517082344272
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CHP1,Calcineurin B homologous protein 1,39586,-0.000756591256938881,0.0073448842151383,-0.0151525643186099,0.0136393818047322,0.9179574835036
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RLN1,Prorelaxin H1,39934,-0.000452974876023471,0.00440902870894687,-0.00909467114555934,0.0081887213935124,0.91817271592023
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.000526082959248781,0.00521652524341328,-0.00969830651784125,0.0107504724363388,0.919671916127517
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.000550162234660453,0.00550291600466901,-0.0102355531344908,0.0113358776038117,0.920364802898598
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.000474628337994578,0.00486740412704228,-0.0100147404269975,0.00906548375100829,0.922321910011541
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,0.000341416317316424,0.00352091812305091,-0.00655958320386337,0.00724241583849621,0.922753593634005
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.000399488117527918,0.0041214375931686,-0.00847750580013838,0.00767852956508255,0.922784286176828
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.000645414701174177,0.00676860238750041,-0.0126210459783266,0.013911875380675,0.924034932372588
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.000658676546057244,0.00719773583602652,-0.0147662387846692,0.0134488856925547,0.927087707678202
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.000726918839190699,0.00803435658142239,-0.0164742577387786,0.0150204200603972,0.927910368281132
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BSND,Barttin,39560,-0.000300514127133209,0.00334093948935822,-0.00684875552627532,0.0062477272720089,0.928329395468873
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.000363758037609825,0.00417131703564547,-0.0078120233522553,0.00853953942747495,0.930510161678641
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GSTP1,Glutathione S-transferase P,41759,0.00059975736971839,0.0068936812903977,-0.0129118579594611,0.0141113726988979,0.93067201750034
NMR metabolomics,X23505.Cholesterol in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.000496338818633351,0.0057107636806473,-0.0116894356327021,0.0106967579954354,0.930742061643212
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CALCA,Calcitonin,41997,0.000595684626067187,0.00685925223435942,-0.0128484497532773,0.0140398190054116,0.930796842516545
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00072193540744779,0.0085314874361672,-0.0159997799674399,0.0174436507823355,0.93256495628892
NMR metabolomics,X23505.Cholesterol in Medium VLDL,FAM171A2,Protein FAM171A2,39934,0.00118783181325759,0.0155384445059208,-0.0292675194183471,0.0316431830448623,0.939066653113906
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PXN,Paxillin,41839,0.00036843031394615,0.00505302178730334,-0.0095354923891684,0.0102723530170607,0.941876554958459
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TAP1,Antigen peptide transporter 1,39757,-0.000401334668450042,0.00580927023649688,-0.0117875043319839,0.0109848349950838,0.944923029729041
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ENPEP,Glutamyl aminopeptidase,39575,-0.0002844011379181,0.00422330245532904,-0.00856207395036301,0.00799327167452681,0.946311515752922
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL9,Interleukin-9,39757,0.0003735239152466,0.00559119036208321,-0.0105852091944365,0.0113322570249297,0.946737507279028
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ITGAX,Integrin alpha-X,39757,0.000338276308111348,0.00514240414881084,-0.0097408358235579,0.0104173884397806,0.947552770331687
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.000252116641827665,0.00385350831531516,-0.00780499293984538,0.00730075965619005,0.947836429401994
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLC44A4,Choline transporter-like protein 4,39649,0.000446615727533159,0.00682875759080646,-0.0129377491504475,0.0138309806055138,0.947854960632947
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GM2A,Ganglioside GM2 activator,39733,0.000238752623417151,0.00382931707955981,-0.00726670885252007,0.00774421409935438,0.950286332362647
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EPGN,Epigen,39919,0.000250906215806979,0.00459716334450527,-0.00875953393942335,0.00926134637103731,0.956475242030395
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,-0.000183118161639715,0.00361450610446012,-0.00726755012638155,0.00690131380310212,0.959595738334105
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.000217955353300727,0.00449958088259154,-0.00860122317657869,0.00903713388318015,0.961367225689687
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000160907425382208,0.00334067920305484,-0.00638682381260528,0.0067086386633697,0.961584759792646
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNX2,Sorting nexin-2,39919,0.000394596665397726,0.00848160243769669,-0.0162293441124878,0.0170185374432832,0.962893558473732
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RASA1,Ras GTPase-activating protein 1,41839,-0.000148097606197124,0.00321400181261965,-0.00644754115893164,0.00615134594653739,0.963248073856343
NMR metabolomics,X23505.Cholesterol in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.000137124681947759,0.00313801958543864,-0.0062876430694075,0.00601339370551198,0.965145918755667
NMR metabolomics,X23505.Cholesterol in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.000164153158080615,0.00384627288726311,-0.00737454170095507,0.0077028480171163,0.965958590277428
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.000249934464913824,0.00592206683902663,-0.0113573165395784,0.011857185469406,0.966336900589323
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,39575,-0.0001457990696362,0.00347035069268853,-0.00694768642730572,0.00665608828803332,0.966489276815588
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CST5,Cystatin-D,41846,-0.000225314397194431,0.00555055287657259,-0.0111043980352767,0.0106537692408878,0.967620861019453
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MN1,Transcriptional activator MN1,39649,0.000234881288226131,0.00584547667954589,-0.0112222530036838,0.0116920155801361,0.967948979764584
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ASAH1,Acid ceramidase,39876,0.000188630664774978,0.00469915425393256,-0.00902171167293283,0.00939897300248279,0.967981100814318
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.000144988393265424,0.00366641324554587,-0.00733115835453533,0.00704118156800448,0.96845655210699
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.00022326579049018,0.00565634870928584,-0.0113097092606904,0.0108631776797101,0.968515022141854
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SNCG,Gamma-synuclein,42016,0.000251646519992519,0.00659579939399455,-0.0126761202922368,0.0131794133322218,0.96956662618778
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00017737142481743,0.00502135364287637,-0.00966448171522026,0.0100192245648551,0.971822374534688
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.000256709857636522,0.00743659046941386,-0.0148324271776877,0.0143190074624147,0.972463254833237
NMR metabolomics,X23505.Cholesterol in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.000164933876913785,0.00482670998571074,-0.00929541769507927,0.00962528544890684,0.97274135134568
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TUBB3,Tubulin beta-3 chain,39586,-9.45426321594097e-05,0.00284846055773027,-0.00567752532531073,0.00548844006099191,0.973523052286568
NMR metabolomics,X23505.Cholesterol in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.000221503658838939,0.00693378202037677,-0.0133687091010995,0.0138117164187774,0.974516029980518
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GBP6,Guanylate-binding protein 6,39575,-0.000133490554168835,0.00445001016190691,-0.00885551047150637,0.0085885293631687,0.976069346129258
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.000127928612565564,0.00457044705041945,-0.00908600483138769,0.00883014760625656,0.977670317967563
NMR metabolomics,X23505.Cholesterol in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.000172283099783377,0.00658626315247968,-0.0130813588786436,0.0127367926790768,0.979131828395818
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CNTN2,Contactin-2,42262,0.000112831238105509,0.00434844445260669,-0.00841011988900361,0.00863578236521463,0.979299596695089
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK12,Kallikrein-12,41843,0.00032105610934407,0.0131642160476707,-0.0254808073440905,0.0261229195627786,0.980543050778063
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CD300LG,CMRF35-like molecule 9,42137,8.90957114972128e-05,0.00368450152769069,-0.00713252728277654,0.00731071870577096,0.980708421047095
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TEX101,Testis-expressed protein 101,39649,0.000142942424943259,0.00611261307586105,-0.0118377792037444,0.0121236640536309,0.981343726935312
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,-7.7069127821059e-05,0.00382614080484902,-0.00757630510532514,0.00742216684968302,0.983929773812454
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-8.55275135900264e-05,0.00443943922114697,-0.00878682838703808,0.00861577335985803,0.984629743778878
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLRX,Glutaredoxin-1,42057,-0.000104544841103439,0.00548940047054111,-0.010863769763364,0.0106546800811571,0.984805604378811
NMR metabolomics,X23505.Cholesterol in Medium VLDL,RAB37,Ras-related protein Rab-37,41913,-0.000146221643088625,0.00802633350759739,-0.0158778353179795,0.0155853920318023,0.98546542489597
NMR metabolomics,X23505.Cholesterol in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.000144233142575543,0.00833824317594992,-0.0164871897674374,0.0161987234822863,0.986199366622243
NMR metabolomics,X23505.Cholesterol in Medium VLDL,GLI2,Zinc finger protein GLI2,39657,3.9631733257243e-05,0.00330687309553836,-0.00644183953399795,0.00652110300051244,0.990438073914799
NMR metabolomics,X23505.Cholesterol in Medium VLDL,KLK8,Kallikrein-8,41668,-4.22538376822249e-05,0.00361773208393505,-0.00713300872219493,0.00704850104683048,0.990681379260128
NMR metabolomics,X23505.Cholesterol in Medium VLDL,EGFLAM,Pikachurin,39930,-3.27104055128423e-05,0.00307298732370555,-0.00605576555997572,0.00599034474895003,0.991507267677296
NMR metabolomics,X23505.Cholesterol in Medium VLDL,TAGLN3,Transgelin-3,39560,-5.08366768778154e-05,0.00597543906101336,-0.011762697236464,0.0116610238827084,0.993212149828332
NMR metabolomics,X23505.Cholesterol in Medium VLDL,MMP15,Matrix metalloproteinase-15,39958,-4.07828245435188e-05,0.00482913372362326,-0.00950588492284512,0.00942431927375808,0.993261962731468
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,4.48229180865355e-05,0.00533903442966354,-0.010419684564054,0.0105093304002271,0.993301732585941
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BOLA1,BolA-like protein 1,39586,-4.53592452769929e-05,0.00542579334069751,-0.0106799141930441,0.0105891957024901,0.993329971477457
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,-4.66180982543133e-05,0.00559030371086051,-0.0110036133715409,0.0109103771750323,0.993346564072666
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-3.26517825871603e-05,0.00440299470536633,-0.00866252140510517,0.00859721783993085,0.994083201081699
NMR metabolomics,X23505.Cholesterol in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,2.54652653753411e-05,0.00375145769899277,-0.00732739182465049,0.00737832235540118,0.994584022550689
NMR metabolomics,X23505.Cholesterol in Medium VLDL,IL13,Interleukin-13,41913,3.06637310659261e-05,0.00480307466128155,-0.00938336260504591,0.00944469006717776,0.994906285311531
NMR metabolomics,X23505.Cholesterol in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,5.77454281931573e-06,0.00498248302679261,-0.0097598921896942,0.00977144127533283,0.999075297866823
NMR metabolomics,X23505.Cholesterol in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,-2.14690124759889e-06,0.00364227238692128,-0.00714100077961332,0.00713670697711812,0.999529705546537
